----------
Model: gpt-4o-mini
Temperature: 0.5
Embedding model: avsolatorio/GIST-small-Embedding-v0
Prompt: input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'] input_types={} partial_variables={} messages=[HumanMessagePromptTemplate(prompt=PromptTemplate(input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'], input_types={}, partial_variables={}, template='Solve the question answering task alternating between Question, Thought, Action, Input and Observation steps.\nYou only have access to the following tools: {tools}\n\nUse the following format:\nThought: think about what step to take next.\nAction: the action to take, must be one of [{tool_names}]. If no action is needed, return your Final answer instead.\nAction Input: the input to the action.\nObservation: the output of the action. Use it to guide your next action.\n(this Thought/Action/Action Input/Observation can repeat any number of times)\n\nFinal Answer: provide the right alternative (one of A, B, C, or D).\n\nBegin!\nQuestion: {question}\nOptions: {options}\nThought: {agent_scratchpad}'), additional_kwargs={})]
----------
[{"0": {"question": "A 35-year-old woman comes to your office with a variety of complaints. As part of her evaluation, she undergoes laboratory testing which reveals the presence of anti-centromere antibodies. All of the following symptoms and signs would be expected to be present EXCEPT:", "options": {"A": "Pallor, cyanosis, and erythema of the hands", "B": "Blanching vascular abnormalities", "C": "Hypercoagulable state", "D": "Heartburn and regurgitation"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anti-centromere antibodies symptoms and signs in limited scleroderma", "log": "I need to determine which symptom or sign would NOT be expected in a patient with anti-centromere antibodies. This condition is often associated with limited scleroderma (CREST syndrome), which presents specific symptoms. \n\nAction: search_docs  \nAction Input: \"anti-centromere antibodies symptoms and signs in limited scleroderma\"  ", "type": "AgentAction"}}, "has been termed the CREST syndrome. Centromere antibodies have been reported in a very high percentage of patients with the CREST syndrome but in only a small minority of patients with scleroderma. Skin biopsy reveals thickening of the dermis and homogenization of collagen bundles. Direct\n\nDifferent autoantibodies may determine the clinical expression of the disease. Patients positive for anticentromere autoantibody present with a clinical picture similar to that of limited scleroderma (Chap. 382). Antimitochondrial antibodies may connote liver involvement in the form of primary\n\nbeen described in patients with scleroderma. An association has been found with a speckled pattern of antinuclear antibodies and with antibodies to RNA polymerases I and III. Anti-U3-RNP may identify young patients at risk for scleroderma renal crisis. Anticentromere antibody, in contrast, is a"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CREST syndrome symptoms anti-centromere antibodies", "log": "I need to extract more specific information about the common symptoms associated with anti-centromere antibodies and CREST syndrome to identify which option does not fit. \n\nAction: search_docs  \nAction Input: \"CREST syndrome symptoms anti-centromere antibodies\"  ", "type": "AgentAction"}}, "RF and ANA may be .\n\nAnticentromere antibodies are specific for CREST syndrome (see Table 2.9-4).\n\nAnti-Scl-70 (antitopoisomerase 1) antibodies are associated with diffuse disease and a poor prognosis (see Table 2.9-4).\n\nEosinophilia may be seen.\n\nhas been termed the CREST syndrome. Centromere antibodies have been reported in a very high percentage of patients with the CREST syndrome but in only a small minority of patients with scleroderma. Skin biopsy reveals thickening of the dermis and homogenization of collagen bundles. Direct\n\nExam may reveal symmetric thickening of the skin of face and/or distal extremities.\n\nCREST syndrome involves Calcinosis, Raynaud\u2019s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias.\n\n(lupus cerebritis,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "symptoms of CREST syndrome vs hypercoagulable state", "log": "I have gathered information about the symptoms associated with CREST syndrome, which includes Calcinosis, Raynaud\u2019s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias. I need to analyze the options to see which one does not fit with this clinical picture.\n\nAction: search_docs  \nAction Input: \"symptoms of CREST syndrome vs hypercoagulable state\"  ", "type": "AgentAction"}}, "Exam may reveal symmetric thickening of the skin of face and/or distal extremities.\n\nCREST syndrome involves Calcinosis, Raynaud\u2019s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias.\n\n(lupus cerebritis,\n\nsyndrome, which probably requires long-term anticoagulation to\n\nHypercoagulable states: Include those associated with antiphospholipid antibodies, activated protein C resistance, malignancy, and OCPs in the context of smoking.\n\nCraniocervical dissection: Trauma, fibromuscular dysplasia (young females), in\ufb02 ammatory/infectious diseases."]]},"1": {"question": "An 8-year-old boy is brought to the pediatrician because his mother is concerned about recent behavioral changes. His mother states that she has started to notice that he is slurring his speech and seems to be falling more than normal. On exam, the pediatrician observes the boy has pes cavus, hammer toes, and kyposcoliosis. Based on these findings, the pediatrician is concerned the child has a trinucleotide repeat disease. Which of the following trinucleotide repeats is this child most likely to possess?", "options": {"A": "CGG", "B": "GAA", "C": "CAG", "D": "GCC"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'trinucleotide repeat diseases symptoms pes cavus hammer toes kyphoscoliosis')", "tool_input": "'trinucleotide repeat diseases symptoms pes cavus hammer toes kyphoscoliosis'", "log": "I need to identify which trinucleotide repeat disease is associated with the symptoms presented in the case. The symptoms include slurred speech, falling more than normal, pes cavus, hammer toes, and kyphoscoliosis, which may suggest a specific genetic condition. \n\nAction: search_docs(query: 'trinucleotide repeat diseases symptoms pes cavus hammer toes kyphoscoliosis') \nAction Input: 'trinucleotide repeat diseases symptoms pes cavus hammer toes kyphoscoliosis' ", "type": "AgentAction"}}, "search_docs(query: 'trinucleotide repeat diseases symptoms pes cavus hammer toes kyphoscoliosis') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'trinucleotide repeat diseases slurred speech falling pes cavus hammer toes kyphoscoliosis')", "tool_input": "'trinucleotide repeat diseases slurred speech falling pes cavus hammer toes kyphoscoliosis'", "log": "I need to refine my query to focus on specific trinucleotide repeat diseases that could cause the symptoms observed in the child. \n\nAction: search_docs(query: 'trinucleotide repeat diseases slurred speech falling pes cavus hammer toes kyphoscoliosis') \nAction Input: 'trinucleotide repeat diseases slurred speech falling pes cavus hammer toes kyphoscoliosis' ", "type": "AgentAction"}}, "search_docs(query: 'trinucleotide repeat diseases slurred speech falling pes cavus hammer toes kyphoscoliosis') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'trinucleotide repeat disease pes cavus hammer toes kyphoscoliosis')", "tool_input": "'trinucleotide repeat disease pes cavus hammer toes kyphoscoliosis'", "log": "I need to simplify my search query to focus on the specific trinucleotide repeat diseases that are known to be associated with the symptoms observed, particularly the combination of neurological and orthopedic symptoms.\n\nAction: search_docs(query: 'trinucleotide repeat disease pes cavus hammer toes kyphoscoliosis') \nAction Input: 'trinucleotide repeat disease pes cavus hammer toes kyphoscoliosis' ", "type": "AgentAction"}}, "search_docs(query: 'trinucleotide repeat disease pes cavus hammer toes kyphoscoliosis') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'trinucleotide repeat disease symptoms slurred speech pes cavus')", "tool_input": "'trinucleotide repeat disease symptoms slurred speech pes cavus'", "log": "I need to focus on the specific symptoms presented and their association with known trinucleotide repeat diseases. The symptoms of slurred speech, falling, pes cavus, hammer toes, and kyphoscoliosis suggest a condition that affects both the nervous system and the musculoskeletal system.\n\nAction: search_docs(query: 'trinucleotide repeat disease symptoms slurred speech pes cavus') \nAction Input: 'trinucleotide repeat disease symptoms slurred speech pes cavus' ", "type": "AgentAction"}}, "search_docs(query: 'trinucleotide repeat disease symptoms slurred speech pes cavus') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'trinucleotide repeat disease symptoms slurred speech gait disturbance pes cavus')", "tool_input": "'trinucleotide repeat disease symptoms slurred speech gait disturbance pes cavus'", "log": "I need to identify which specific trinucleotide repeat disease is most likely associated with the symptoms of slurred speech, falling, pes cavus, hammer toes, and kyphoscoliosis. \n\nAction: search_docs(query: 'trinucleotide repeat disease symptoms slurred speech gait disturbance pes cavus') \nAction Input: 'trinucleotide repeat disease symptoms slurred speech gait disturbance pes cavus' ", "type": "AgentAction"}}, "search_docs(query: 'trinucleotide repeat disease symptoms slurred speech gait disturbance pes cavus') is not a valid tool, try one of [search_docs]."]]},"2": {"question": "A 36-year-old man is brought to the emergency department by his wife 20 minutes after having a seizure. Over the past 3 days, he has had a fever and worsening headaches. This morning, his wife noticed that he was irritable and demonstrated strange behavior; he put the back of his fork, the salt shaker, and the lid of the coffee can into his mouth. He has no history of serious illness and takes no medications. His temperature is 39\u00b0C (102.2\u00b0F), pulse is 88/min, and blood pressure is 118/76 mm Hg. Neurologic examination shows diffuse hyperreflexia and an extensor response to the plantar reflex on the right. A T2-weighted MRI of the brain shows edema and areas of hemorrhage in the left temporal lobe. Which of the following is most likely the primary mechanism of the development of edema in this patient?", "options": {"A": "Release of vascular endothelial growth factor", "B": "Cellular retention of sodium", "C": "Breakdown of endothelial tight junctions", "D": "Increased hydrostatic pressure"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "mechanism of edema in brain inflammation or infection", "log": "To determine the primary mechanism of edema in this patient, I need to consider the clinical scenario presented. The patient has a fever, worsening headaches, and neurological signs, along with MRI findings of edema and hemorrhage in the left temporal lobe. This suggests a pathological process affecting the brain, potentially related to inflammation or infection.\n\nThe options provided for the mechanism of edema include:\n- A: Release of vascular endothelial growth factor (VEGF) - often associated with angiogenesis and increased vascular permeability.\n- B: Cellular retention of sodium - typically associated with cellular swelling but less relevant in the context of brain edema.\n- C: Breakdown of endothelial tight junctions - this is a common mechanism in neuroinflammation, leading to increased permeability and edema.\n- D: Increased hydrostatic pressure - usually associated with systemic conditions rather than localized brain edema.\n\nGiven the context of the patient's symptoms and MRI findings, I need to confirm which mechanism is most relevant. \n\nAction: search_docs  \nAction Input: \"mechanism of edema in brain inflammation or infection\"  ", "type": "AgentAction"}}, "PATHOPHYSIOLOGY Brain Edema Swelling, or edema, of brain tissue occurs with many types of brain injury. The two principal types of edema are vasogenic and cytotoxic. Vasogenic edema refers to the influx of fluid and solutes into the brain through an incompetent blood-brain barrier (BBB). In the\n\nand hemorrhages. As mentioned earlier, edema is the main element in the genesis of brain swelling and of raised ICP in most head-injured patients (Marmarou et al). This reflects a failure of autoregulatory vascular mechanisms, with resulting transudative edema in damaged areas of the brain. The\n\nMarmarou A, Fatouros PP, Barzo P, et al: Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg 93:183, 2000."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "primary mechanism of brain edema in infection or inflammation", "log": "The observation highlights that vasogenic edema occurs due to the influx of fluid and solutes into the brain through an incompetent blood-brain barrier (BBB). This indicates that the breakdown of endothelial tight junctions is a significant mechanism leading to edema in the context of brain injury and inflammation. \n\nGiven that the patient's presentation includes neurological symptoms and MRI findings consistent with inflammation or infection, the breakdown of the blood-brain barrier and subsequent edema aligns with the expected pathophysiology. \n\nI will now confirm this understanding and ensure that it aligns with the options provided.\n\nAction: search_docs  \nAction Input: \"primary mechanism of brain edema in infection or inflammation\"  ", "type": "AgentAction"}}, "and hemorrhages. As mentioned earlier, edema is the main element in the genesis of brain swelling and of raised ICP in most head-injured patients (Marmarou et al). This reflects a failure of autoregulatory vascular mechanisms, with resulting transudative edema in damaged areas of the brain. The\n\nMarmarou A, Fatouros PP, Barzo P, et al: Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg 93:183, 2000.\n\nVasogenic edema occurs when the integrity of the normal blood-brain barrier is disrupted, allowing fluid to shift from the vascular compartment into the extracellular spaces of the brain. Vasogenic edema can be localized (e.g., the result of increased vascular permeability due to inflammation or in"]]},"3": {"question": "A 35-year-old woman presents to the ER with shortness of breath, cough, and severe lower limb enlargement. The dyspnea was of sudden onset, started a week ago, and increased with exercise but did not disappear with rest. Her cough was dry, persistent, and non-productive. She has a family history of maternal hypertension. Her vital signs include heart rate 106/min, respiratory rate 28/min, and blood pressure 140/90 mm Hg. On physical examination, thoracic expansion was diminished on the right side with rhonchi and crackles on the lower two-thirds of both sides, with left predominance. A systolic murmur was heard on the tricuspid foci, which increased in intensity with inspiration. There was jugular engorgement when the bed was placed at 50\u00b0. Palpation of the abdomen was painful on the right hypochondrium, with hepatomegaly 4 cm below the lower coastal edge. Hepatojugular reflux was present. Soft, painless, pitting edema was present in both lower limbs up until the middle third of both legs. Lung computed tomography (CT) and transthoracic echocardiogram were performed and detected right heart failure and severe pulmonary fibrosis. What is the most likely diagnosis?", "options": {"A": "Left-sided heart failure", "B": "Coronary artery disease", "C": "Budd-chiari syndrome", "D": "Cor pulmonale"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "diagnosis of right heart failure and pulmonary fibrosis", "log": "I need to analyze the symptoms and findings presented in the case to determine the most likely diagnosis. The key points include sudden onset dyspnea, lower limb edema, jugular engorgement, hepatomegaly, and findings of right heart failure and severe pulmonary fibrosis. I will consider the options provided and look for relevant information that could help clarify the diagnosis.\n\nAction: search_docs  \nAction Input: \"diagnosis of right heart failure and pulmonary fibrosis\"  ", "type": "AgentAction"}}, "Clinically,right ventricular heart failure\n\nradiologically on the basis of prominence of the right side of the heart and dilation of the pulmonary artery. Frank evidence of right-sided heart failure may be seen in late cases.\n\nmay occur, resulting in right-sided heart failure."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Budd-Chiari syndrome symptoms and diagnosis", "log": "The information retrieved discusses right ventricular heart failure and its relationship with pulmonary issues. However, I need to gather more specific details regarding the differential diagnoses related to the symptoms presented, particularly concerning Budd-Chiari syndrome and cor pulmonale, which could be relevant given the patient's signs of liver engorgement and pulmonary fibrosis.\n\nAction: search_docs  \nAction Input: \"Budd-Chiari syndrome symptoms and diagnosis\"  ", "type": "AgentAction"}}, "testicular atrophy, and peripheral edema. Budd-Chiari syndrome can occur due to HCC invasion of the hepatic veins, with tense ascites and a large tender liver (Chap. 365).\n\nblood flow. This is the first test ordered in patients suspected of having Budd-Chiari syndrome.\n\nAspergillus). May lead to Budd-Chiari syndrome."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cor pulmonale symptoms and diagnosis", "log": "The retrieved information provides some details about Budd-Chiari syndrome, mentioning symptoms like peripheral edema and liver engorgement. However, I need more specific information about the clinical presentation and how it relates to the other possible diagnoses, particularly cor pulmonale, which is characterized by right heart failure due to pulmonary issues. \n\nAction: search_docs  \nAction Input: \"cor pulmonale symptoms and diagnosis\"  ", "type": "AgentAction"}}, "CLINICAL MANIFESTATIONS Symptoms The symptoms of chronic cor pulmonale generally are related to the underlying pulmonary disorder. Dyspnea, the most common symptom, is usually the result of the increased work of breathing secondary to changes in elastic recoil of the lung (fibrosing lung diseases),\n\nApproach to the Patient with Disease of the Respiratory System 1662 the right side of the heart, patients may also present with symptoms of cor pulmonale, including abdominal bloating or distention and pedal edema (Chap. 279).\n\nCor pulmonale develops in response to acute or chronic changes in the pulmonary vasculature and/or the lung parenchyma that are sufficient to cause pulmonary hypertension. The true prevalence of cor pulmonale is difficult to ascertain. First, not all patients with chronic lung disease will develop"]]},"4": {"question": "A 5-year-old boy is brought in by his parents for recurrent abdominal pain. The child has been taken out of class 5 times this past week for abdominal pain that resulted in him being sent home. The mother reports that her son's stools have remained unchanged during this time and are brown in color, without blood, and with normal consistency and scent. She also notes that while at home he seems to be his usual self and does not complain of any symptoms. Of note she presents to you that she has been preparing her son's lunches which consist of couscous, vegetables, fried rice, and chicken. The patient denies difficulty with producing stool and does not complain of any functional pain. The child's vitals and labs including BMP and CBC are unremarkable and within normal limits. An abdominal exam is performed and there is no tenderness upon palpation, and the abdomen is soft and non-distended. After a conversation with the child exploring his symptoms, which of the following is the next step in management for this child?", "options": {"A": "Increase oral hydration and fiber intake", "B": "Check the stool for fecal red blood cells and leukocytes", "C": "Begin treatment with ciprofloxacin", "D": "Begin cognitive behavioral therapy"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of recurrent abdominal pain in children", "log": "The case describes a 5-year-old boy experiencing recurrent abdominal pain without any significant findings on examination or laboratory tests. His stools are normal, and he appears to be fine at home, indicating that the abdominal pain may not be of organic origin. Given the options provided, I need to consider what would be the most appropriate next step in management based on the child's situation.\n\nAction: search_docs  \nAction Input: \"management of recurrent abdominal pain in children\"  ", "type": "AgentAction"}}, "Treatment of Recurrent Abdominal Pain\n\nRecurrent abdominal pain is a common problem, affecting more than 10% of all children. The peak incidence occurs between ages 7 and 12 years. Although the differential diagnosis of recurrent abdominal pain is fairly extensive (Table 126-4),most children do not have a serious (or even identifiable)\n\nTable 126-2 lists the differential diagnosis of acute abdominal pain in children. The urgent task of the clinician is to rule out surgical emergencies. In young children, malrotation with volvulus, incarcerated hernia, congenital anomalies, and intussusception are common concerns. In older children"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of recurrent abdominal pain in children treatment options", "log": "Given the information from the search results, it seems that recurrent abdominal pain in children often does not have a serious underlying cause, especially in cases where there are no alarming symptoms or abnormal examination findings. The child in this scenario is otherwise healthy at home and has normal stool characteristics. \n\nAction: search_docs  \nAction Input: \"management of recurrent abdominal pain in children treatment options\"  ", "type": "AgentAction"}}, "Treatment of Recurrent Abdominal Pain\n\nRecurrent abdominal pain is a common problem, affecting more than 10% of all children. The peak incidence occurs between ages 7 and 12 years. Although the differential diagnosis of recurrent abdominal pain is fairly extensive (Table 126-4),most children do not have a serious (or even identifiable)\n\nTable 126-2 lists the differential diagnosis of acute abdominal pain in children. The urgent task of the clinician is to rule out surgical emergencies. In young children, malrotation with volvulus, incarcerated hernia, congenital anomalies, and intussusception are common concerns. In older children"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "recurrent abdominal pain in children management guidelines", "log": "The search results did not provide specific treatment options for recurrent abdominal pain in children. However, I need to consider the options provided in the question and what is generally advised in similar cases.\n\nAction: search_docs  \nAction Input: \"recurrent abdominal pain in children management guidelines\"  ", "type": "AgentAction"}}, "Recurrent abdominal pain is a common problem, affecting more than 10% of all children. The peak incidence occurs between ages 7 and 12 years. Although the differential diagnosis of recurrent abdominal pain is fairly extensive (Table 126-4),most children do not have a serious (or even identifiable)\n\nTreatment of Recurrent Abdominal Pain\n\nTable 126-2 lists the differential diagnosis of acute abdominal pain in children. The urgent task of the clinician is to rule out surgical emergencies. In young children, malrotation with volvulus, incarcerated hernia, congenital anomalies, and intussusception are common concerns. In older children"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "non-organic abdominal pain management in children", "log": "The search results continue to emphasize the prevalence of recurrent abdominal pain in children and the need to rule out serious conditions. However, they do not provide specific treatment recommendations or management guidelines. Given the context of the child's situation\u2014recurrent abdominal pain without alarming symptoms and normal laboratory findings\u2014it's likely that the management approach should focus on reassurance and possibly adjusting dietary habits or addressing psychological factors.\n\nAction: search_docs  \nAction Input: \"non-organic abdominal pain management in children\"  ", "type": "AgentAction"}}, "Nonmedical Methods for the Treatment of Pain\n\nand adequate pain management must accompany surgical interventions.6.\tPay particular attention to the postoperative pediatric patient whose pain cannot be soothed by the administration of stan-dard amounts of analgesic agents. Ask yourself whether a sig-nificant yet unrecognized postoperative\n\nchallenging tasks facing the pediatric surgeon. The classical presentation is known to all students and practitioners of surgery: generalized abdomi-nal pain that localizes to the right lower quadrant followed by nausea, vomiting, fever, and localized peritoneal irritation in the region of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cognitive behavioral therapy for children with abdominal pain", "log": "The search did not yield specific information about non-organic abdominal pain management in children. However, based on the case details and the options provided, it seems that the child's recurrent abdominal pain does not have a serious underlying cause, and addressing potential psychological factors may be beneficial. Cognitive behavioral therapy could be appropriate in this context.\n\nAction: search_docs  \nAction Input: \"cognitive behavioral therapy for children with abdominal pain\"  ", "type": "AgentAction"}}, "in treating IBS. In difficult and persistent cases, cognitive behavioral\n\nand disability, the childwith functional pain must be assisted in returning to normal activities immediately. Instead of being sent home fromschool with stomachaches, a child may be allowed to take ashort break from class until symptoms abate. The child and parents should be informed that pain is\n\nChildren with functional abdominal pain characteristically have pain almost daily. The pain is not associated with meals Meconium ileus equivalent (cystic fibrosis) or relieved by defecation and is often associated with a ten-Duplication cyst dency toward anxiety and perfectionism. Symptoms often"]]},"5": {"question": "A 5-day-old male newborn is brought to the emergency department 1 hour after having a seizure. It lasted approximately 1 minute, and involved blinking and lip-smacking movements as well as left-sided jerking of the hand and foot. His mother says she measured a temperature of 38.2\u00b0C (100.7\u00b0F) at that time. He has had increasing difficulty feeding since yesterday. He was born at 39 weeks' gestation and weighed 3189 g (7 lb, 1 oz); he currently weighs 2980 g (6 lb, 9 oz). The mother's prenatal course was significant for gonorrhea infection diagnosed early in pregnancy and treated with ceftriaxone and azithromycin combination therapy. The boy appears irritable and lethargic. His temperature is 36.0\u00b0C (96.8\u00b0F). Examination shows clusters of vesicular lesions with an erythematous base on the patient's face and trunk. There is profuse lacrimation. Laboratory studies show:\nLeukocyte count 16,200/mm3\nSegmented neutrophils 25%\nBands 5%\nLymphocytes 65%\nMonocytes 3%\nEosinophils 2%\nSerum\nGlucose 80 mg/dL\nA lumbar puncture is performed. Cerebrospinal fluid analysis shows a leukocyte count of 117/\u03bcL, a protein concentration of 52 mg/dL, and a glucose concentration of 58 mg/dL. Results of blood cultures are pending. Which of the following is the most appropriate pharmacotherapy?\"", "options": {"A": "IV ganciclovir", "B": "Pyrimethamine", "C": "IV acyclovir", "D": "IV vancomycin"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "neonatal seizures herpes simplex treatment acyclovir", "log": "The clinical presentation suggests a possible viral infection, especially considering the vesicular lesions and the newborn's symptoms. The lumbar puncture results indicate pleocytosis (elevated white blood cell count) in the cerebrospinal fluid, which is often associated with viral infections. Given the mother's history of gonorrhea and the infant's symptoms, herpes simplex virus (HSV) is a likely cause. IV acyclovir is the standard treatment for HSV infections in neonates. \n\nAction: search_docs  \nAction Input: \"neonatal seizures herpes simplex treatment acyclovir\"  ", "type": "AgentAction"}}, "Parenteral acyclovir is the treatment of choice for neonatal HSV infections. Acyclovir should be administered to all infants suspected to have infection or diagnosed with HSV. The most benign outcome with regard to morbidity and mortality is observed in infants with disease limited to the skin,\n\nAcyclovir is the only one of the three antiherpes agents that is available for intravenous use in the United States. Intravenous acyclovir is the treatment of choice for herpes simplex encephalitis, neonatal HSV infection, and serious HSV or VZV infections (Table 49\u20131). In neonates with central\n\nIn neonates with central nervous system HSV, oral acyclovir suppression for 6 months following acute treatment improves neurodevelopmental outcomes. In immunocompromised patients with VZV infection, intravenous acyclovir reduces the incidence of cutaneous and visceral dissemination."]]},"6": {"question": "A 30-year-old woman presents to the clinic for a 3-month history of painful hair loss. She was in her usual state of health until about 3 months ago when she started to develop some painfully itchy spots across her scalp. Since that time these spots have lost hair and scarred, with new spots continuing to form. On further questioning, she shares that, for the last couple of years, she has generally felt poorly, specifically noting intermittent fevers, muscle and joint pains, and fatigue. On physical exam, she has several erythematous and scaly plaques across her scalp. These areas have no hair growth, but some do demonstrate hyperpigmentation. Which of the following is the most likely diagnosis?", "options": {"A": "Alopecia areata", "B": "Discoid lupus erythematosus (DLE)", "C": "Tinea capitis", "D": "Trichotillomania"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "painful hair loss itchy spots scarring erythematous scaly plaques diagnosis", "log": "I need to analyze the symptoms and clinical presentation of the patient to determine the most likely diagnosis. The key features include painful hair loss, itchy spots, scarring, erythematous and scaly plaques, and a history of systemic symptoms like intermittent fevers and joint pains. \n\nAction: search_docs \nAction Input: \"painful hair loss itchy spots scarring erythematous scaly plaques diagnosis\" ", "type": "AgentAction"}}, "scaly, pruritic plaques, often mimicking atopic dermatitis. Even intermittent exposure can result in a persistentdermatitis.\n\nare usually asymptomatic but can be pruritic. They can be mistaken for vitiligo, but the latter is not scaly. Folliculitis occurs over the back and chest and mimics bacterial folliculitis. Seborrheic dermatitis manifests as erythematous pruritic scaly lesions in the eyebrows, moustache, nasolabial\n\nIn erythema gyratum repens, one sees numerous mobile concentric arcs and wavefronts that resemble the grain in wood. A search for an\n\nCHAPTER 72 Skin Manifestations of Internal Disease\n\nDiffuse shedding of normal hairs"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "scarring hair loss erythematous plaques fever joint pain diagnosis", "log": "The information obtained does not directly address the specific symptoms and potential diagnoses related to the patient's condition. I need to refine my search to focus more on the key symptoms and possible diagnoses, particularly related to scarring hair loss and systemic symptoms.\n\nAction: search_docs  \nAction Input: \"scarring hair loss erythematous plaques fever joint pain diagnosis\"  ", "type": "AgentAction"}}, "can be found on the extensor surfaces of any joint. Patients may have periungual erythema and dilated nail-fold capillaries. Less commonly, patients develop cutaneous vasculitis, with inflammation, erythema, and skin breakdown.\n\njoint pain. A nonitchy, diffuse, maculopapular rash (more common in Barmah Forest virus infection) generally develops coincidentally or follows shortly, but in some patients it can precede joint pains by several days. Constitutional symptoms such as low-grade fever, asthenia, headache, myalgia, and\n\nThe typical lesion is a round, sharply bordered erythematous patch with silvery scales (see Figure 2.2-4A).\n\nLesions are classically found on the extensor surfaces, including the elbows, knees, scalp, and lumbosacral regions."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "discoid lupus erythematosus symptoms diagnosis scarring hair loss", "log": "The information retrieved still does not provide a definitive diagnosis for the patient's symptoms. I need to focus specifically on conditions that involve scarring hair loss, erythematous and scaly plaques, and systemic symptoms. \n\nAction: search_docs  \nAction Input: \"discoid lupus erythematosus symptoms diagnosis scarring hair loss\"  ", "type": "AgentAction"}}, "discoid lupus can be seen in patients with systemic lupus, in the majority of patients, the disease process is limited to the skin. Less common causes of scarring alopecia include sarcoidosis (see \u201cPapulonodular Skin Lesions,\u201d below) and cutaneous metastases.\n\nFIguRE 76e-60 Discoid lupus erythematosus. Atrophic, depigmented plaques and patches surrounded by hyperpigmentation and erythema in association with scarring and alopecia are characteristic of this cutaneous form of lupus.\n\nScarring alopecia is more frequently the result of a primary cutaneous disorder such as lichen planus, folliculitis decalvans, chronic cutaneous (discoid) lupus, or linear scleroderma (morphea) than it is a sign of systemic disease. Although the scarring lesions of discoid lupus can be seen in"]]},"7": {"question": "A 68-year-old man is admitted to the intensive care unit after open abdominal aortic aneurysm repair. The patient has received 4 units of packed red blood cells during the surgery. During the first 24 hours following the procedure, he has only passed 200 mL of urine. He has congestive heart failure and hypertension. Current medications include atenolol, enalapril, and spironolactone. He appears ill. His temperature is 37.1\u00b0C (98.8\u00b0F), pulse is 110/min, respirations are 18/min, and blood pressure is 110/78 mm Hg. Examination shows dry mucous membranes and flat neck veins. The remainder of the examination shows no abnormalities. Laboratory studies show a serum creatinine level of 2.0 mg/dL and a BUN of 48 mg/dL. His serum creatinine and BUN on admission were 1.2 mg/dL and 18 mg/dL, respectively. Further evaluation of this patient is most likely to reveal which of the following findings?", "options": {"A": "Decreased urine osmolarity", "B": "Leukocyte casts", "C": "Low urine sodium", "D": "Proteinuria"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "prerenal azotemia urine findings", "log": "I need to analyze the clinical scenario presented in the question to determine the most likely finding in this patient after his abdominal aortic aneurysm repair and subsequent decline in urine output and renal function. \n\nThe patient has a history of congestive heart failure, has received multiple units of blood, and has low urine output, which suggests possible acute kidney injury (AKI). The laboratory findings show an increase in serum creatinine and BUN, indicating renal impairment. \n\nIn cases of prerenal azotemia (often due to volume depletion), we typically see low urine sodium and high urine osmolarity due to the kidneys conserving water and sodium. In contrast, intrinsic renal causes (like acute tubular necrosis) might show casts and proteinuria.\n\nGiven the patient's volume status (dry mucous membranes and flat neck veins) and clinical picture, I suspect prerenal azotemia. Therefore, I should look for findings consistent with this diagnosis.\n\nAction: search_docs  \nAction Input: \"prerenal azotemia urine findings\"  ", "type": "AgentAction"}}, "Prerenal azotemia may present with hyaline casts or an unremarkable urine sediment exam. Postrenal AKI may also lead to an unremarkable sediment, but hematuria and pyuria may be seen depending on the cause of obstruction. AKI from ATN due to ischemic injury, sepsis, or certain nephrotoxins has\n\nSeveral indices have been used to help differentiate prerenal azotemia from intrinsic AKI when the tubules are malfunctioning. The low tubular flow rate and increased renal medullary recycling of urea seen in prerenal azotemia may cause a disproportionate elevation of the BUN compared to\n\nosmolality of patients with prerenal azotemia can be predicted from the stimulatory actions of norepinephrine, angiotensin II, ADH, and low tubule fluid flow rate. In prerenal conditions, the tubules are intact, leading to a concentrated urine (>500 mosmol), avid Na retention (urine Na"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "prerenal azotemia urine sodium levels", "log": "I need to analyze the information obtained from the search to determine the most relevant findings associated with prerenal azotemia. The search indicates that in prerenal azotemia, the kidneys conserve water and sodium, leading to concentrated urine and low urine sodium levels. \n\nGiven that the patient shows signs of volume depletion and has a history of congestive heart failure, it is likely that he is experiencing prerenal azotemia, which would manifest as low urine sodium levels.\n\nAction: search_docs  \nAction Input: \"prerenal azotemia urine sodium levels\"  ", "type": "AgentAction"}}, "osmolality of patients with prerenal azotemia can be predicted from the stimulatory actions of norepinephrine, angiotensin II, ADH, and low tubule fluid flow rate. In prerenal conditions, the tubules are intact, leading to a concentrated urine (>500 mosmol), avid Na retention (urine Na\n\non the balance ofsodium and free water losses. The measured serum sodium concentration is artificially low, however, because of hyperglycemia. Hyperlipidemia also contributes to the decrease inmeasured serum sodium. The level of blood urea nitrogen(BUN) can be elevated with prerenal azotemia\n\nProlonged renal hypoperfusion may lead to acute tubular necrosis (ATN), an intrinsic renal disease that is discussed below. The urinalysis and urinary electrolyte measurements can be useful in distinguishing prerenal azotemia from ATN (Table 61-2). The urine Na and osmolality of patients with"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "urine sodium levels in prerenal azotemia", "log": "The information gathered from the previous searches confirms that in prerenal azotemia, the kidneys respond to perceived low blood volume by conserving sodium and water, leading to low urine sodium levels and concentrated urine. Since the patient is exhibiting signs of volume depletion and has a history that suggests prerenal azotemia, it is reasonable to conclude that he would have low urine sodium levels.\n\nGiven that the options include findings related to different types of acute kidney injury, the most fitting answer aligns with the characteristics of prerenal azotemia.\n\nAction: search_docs  \nAction Input: \"urine sodium levels in prerenal azotemia\"  ", "type": "AgentAction"}}, "osmolality of patients with prerenal azotemia can be predicted from the stimulatory actions of norepinephrine, angiotensin II, ADH, and low tubule fluid flow rate. In prerenal conditions, the tubules are intact, leading to a concentrated urine (>500 mosmol), avid Na retention (urine Na\n\non the balance ofsodium and free water losses. The measured serum sodium concentration is artificially low, however, because of hyperglycemia. Hyperlipidemia also contributes to the decrease inmeasured serum sodium. The level of blood urea nitrogen(BUN) can be elevated with prerenal azotemia\n\nProlonged renal hypoperfusion may lead to acute tubular necrosis (ATN), an intrinsic renal disease that is discussed below. The urinalysis and urinary electrolyte measurements can be useful in distinguishing prerenal azotemia from ATN (Table 61-2). The urine Na and osmolality of patients with"]]},"8": {"question": "A 44-year-old with a past medical history significant for human immunodeficiency virus infection presents to the emergency department after he was found to be experiencing worsening confusion. The patient was noted to be disoriented by residents and staff at the homeless shelter where he resides. On presentation he reports headache and muscle aches but is unable to provide more information. His temperature is 102.2\u00b0F (39\u00b0C), blood pressure is 112/71 mmHg, pulse is 115/min, and respirations are 24/min. Knee extension with hips flexed produces significant resistance and pain. A lumbar puncture is performed with the following results:\n\nOpening pressure: Normal\nFluid color: Clear\nCell count: Increased lymphocytes\nProtein: Slightly elevated\n\nWhich of the following is the most likely cause of this patient's symptoms?", "options": {"A": "Cryptococcus", "B": "Group B streptococcus", "C": "Herpes simplex virus", "D": "Neisseria meningitidis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HIV meningitis increased lymphocytes clear fluid causes", "log": "I need to analyze the clinical presentation and lumbar puncture results to determine the most likely cause of this patient's symptoms. The patient has HIV, fever, confusion, and signs of meningeal irritation, which suggests meningitis. The lumbar puncture shows increased lymphocytes and slightly elevated protein, but normal opening pressure and clear fluid. This presentation is more consistent with viral or fungal meningitis rather than bacterial meningitis.\n\nAction: search_docs  \nAction Input: \"HIV meningitis increased lymphocytes clear fluid causes\"  ", "type": "AgentAction"}}, "Chronic meningitis is not uncommon in the course of HIV infection. Pleocytosis and mild meningeal signs often occur at the onset of HIV infection, and occasionally low-grade meningitis persists. Toxoplasmosis commonly presents as intracranial abscesses and also may be associated with meningitis.\n\nIt has already been mentioned that HIV infection may present as an acute asymptomatic meningitis with a mild lymphocytic pleocytosis and modest elevation of CSF protein. The acute illness may also take the form of a meningoencephalitis or even a myelopathy or neuropathy (see Myelopathy, Peripheral\n\nasymptomatic HIV invasion of the nervous system have shown mild lymphocytic meningitis, perivascular inflammation, and some myelin loss in the hemispheres."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Cryptococcus meningitis lumbar puncture findings", "log": "The findings indicate that the patient has a lymphocytic pleocytosis and mildly elevated protein levels, which aligns with viral or fungal causes of meningitis. Given the patient's HIV status, Cryptococcus is a common opportunistic infection that can cause meningitis in immunocompromised individuals. The normal opening pressure and clear fluid further support this diagnosis, as bacterial meningitis typically presents with turbid fluid and elevated opening pressures.\n\nAction: search_docs  \nAction Input: \"Cryptococcus meningitis lumbar puncture findings\"  ", "type": "AgentAction"}}, "Unless contraindications exist (raised intracranial pressure, uncorrected shock, disordered coagulation, thrombocytopenia, respiratory insufficiency, local infection, ongoing convulsions), lumbar puncture should be undertaken to identify and confirm the etiology of suspected meningococcal\n\nAs already indicated, the lumbar puncture is an indispensable part of the examination of patients with the symptoms and signs of meningitis or of any patient in whom this diagnosis is suspected. Bacteremia is not a contraindication to lumbar puncture. The dilemma concerning the risk of promoting\n\nof suspected meningococcal meningitis, whose presentation cannot be distinguished from that of meningitis of other bacterial causes. Some authorities have recommended a CT brain scan prior to lumbar puncture because of the risk of cerebral herniation in patients with raised intracranial pressure."]]},"9": {"question": "A 8-month-old boy is brought to the physician for the evaluation of shortening of his arms and legs. The parents report that they have also noticed that their son's head is progressively enlarging. The patient was born at term via vaginal delivery. There is no personal or family history of serious illness. His immunizations are up-to-date. He is at the 3rd percentile for height, 25th percentile for weight, and 95th percentile for head circumference. Examination shows macrocephaly and prominent brow bones. The extremities are short and plump. Muscle strength is 3/5 in all muscle groups. Deep tendon reflexes are 4+ bilaterally. An x-ray of the lateral skull shows midfacial hypoplasia and frontal prominence. X-rays of the spine shows abnormally narrow interpedicular distance. Which of the following is the most appropriate next step in management?", "options": {"A": "Growth hormone therapy", "B": "Levothyroxine therapy", "C": "CT scan of the head", "D": "Bisphosphonate therapy\n\""}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of skeletal dysplasia in infants with macrocephaly and short limbs", "log": "The clinical presentation suggests a condition associated with skeletal abnormalities, macrocephaly, and potentially increased intracranial pressure or other structural brain issues. The prominent brow bones and midfacial hypoplasia raise suspicion for a specific type of skeletal dysplasia. Given the age and symptoms, imaging studies may be necessary to assess for any structural brain abnormalities or other complications. \n\nAction: search_docs  \nAction Input: \"management of skeletal dysplasia in infants with macrocephaly and short limbs\"  ", "type": "AgentAction"}}, "Krakow D, Rimoin DL: The skeletal dysplasias, Genet Med 12:327\u2013341, 2010. [Comprehensive summary of the dysplasias with very useful summary table.]\n\narray of congenital and developmental disorders makes pediatrics a uniquely intellectually challenging field as well. The authors hope that our readers will share our enthusi-asm for orthopedic surgery and all of its subspecialties: trauma, sports, spine, joint replacement, musculoskeletal\n\nEvaluation of a pregnancy with suspected skeletal dysplasia includes a survey of every long bone, as well as the hands and feet, skull size and shape, clavicles, scapulae, thorax, and spine. Reference tables are used to determine which long bones are afected and ascertain the degree of shortening"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next steps in management for infants with skeletal dysplasia and macrocephaly", "log": "The search did not yield specific management steps for the case presented, but it did provide some context on skeletal dysplasias. Given the symptoms of macrocephaly, short limbs, and prominent brow bones, it is crucial to consider potential intracranial complications. A CT scan of the head would help assess any structural abnormalities that could be contributing to the symptoms.\n\nAction: search_docs  \nAction Input: \"next steps in management for infants with skeletal dysplasia and macrocephaly\"  ", "type": "AgentAction"}}, "Krakow D, Rimoin DL: The skeletal dysplasias, Genet Med 12:327\u2013341, 2010. [Comprehensive summary of the dysplasias with very useful summary table.]\n\nManagement of Developmental Delay\n\narray of congenital and developmental disorders makes pediatrics a uniquely intellectually challenging field as well. The authors hope that our readers will share our enthusi-asm for orthopedic surgery and all of its subspecialties: trauma, sports, spine, joint replacement, musculoskeletal"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CT scan head management in infants with skeletal dysplasia", "log": "The search did not provide specific management steps for infants with skeletal dysplasia and macrocephaly. However, the presence of macrocephaly and short limbs suggests a need for imaging to evaluate for potential intracranial issues. A CT scan of the head would be an appropriate next step to rule out any structural abnormalities.\n\nAction: search_docs  \nAction Input: \"CT scan head management in infants with skeletal dysplasia\"  ", "type": "AgentAction"}}, "Krakow D, Rimoin DL: The skeletal dysplasias, Genet Med 12:327\u2013341, 2010. [Comprehensive summary of the dysplasias with very useful summary table.]\n\nEvaluation of a pregnancy with suspected skeletal dysplasia includes a survey of every long bone, as well as the hands and feet, skull size and shape, clavicles, scapulae, thorax, and spine. Reference tables are used to determine which long bones are afected and ascertain the degree of shortening\n\nStevenson DA, Carey JC, Byrne JL, et al: Analysis of skeletal dysplasias in the Utah population. Am J Med Genet 158A: 1046, 2012"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CT scan indications in infants with skeletal dysplasia and macrocephaly", "log": "The search did not yield specific information regarding the management steps for infants with skeletal dysplasia and macrocephaly. However, based on the clinical presentation, it is likely that imaging studies like a CT scan of the head are warranted to evaluate for potential intracranial abnormalities, especially given the significant macrocephaly and short limbs.\n\nAction: search_docs  \nAction Input: \"CT scan indications in infants with skeletal dysplasia and macrocephaly\"  ", "type": "AgentAction"}}, "Imaging studies performed in children diagnosed with cerebral palsy frequently show abnormal indings. Wu and associates (2006) used CT or MR imaging to study 273 children who were born after 36 weeks' gestation and who were diagnosed later in childhood with cerebral palsy. lthough a third of these\n\nKrakow D, Rimoin DL: The skeletal dysplasias, Genet Med 12:327\u2013341, 2010. [Comprehensive summary of the dysplasias with very useful summary table.]\n\nRadiologic imaging plays an important role in the evaluation of children with dysmorphic features. Individuals found to have multiple external malformations should have a careful evaluation to search for the presence of internal malformations. Testing might include ultrasound evaluations of the"]]},"10": {"question": "A 70-year-old woman, gravida 5, para 5, comes to the physician for the evaluation of sensation of vaginal fullness for the last six months. During this period, she has had lower back and pelvic pain that is worse with prolonged standing or walking. The patient underwent a hysterectomy at the age of 35 years because of severe dysmenorrhea. She has type 2 diabetes mellitus and hypercholesterolemia. Medications include metformin and atorvastatin. Vital signs are within normal limits. Pelvic examination elicits a feeling of pressure on the perineum. Pelvic floor muscle and anal sphincter tone are decreased. Pelvic examination shows protrusion of posterior vaginal wall with Valsalva maneuver and vaginal discharge. Which of the following is the most likely diagnosis?", "options": {"A": "Bartholin gland cyst", "B": "Atrophic vaginitis", "C": "Infectious vulvovaginitis", "D": "Enterocele"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vaginal fullness, pelvic pain, decreased pelvic floor muscle tone, protrusion of posterior vaginal wall, vaginal discharge diagnosis\" \n", "log": "I need to analyze the symptoms and the examination findings presented in the question to determine the most likely diagnosis. The key symptoms include vaginal fullness, lower back and pelvic pain, decreased pelvic floor muscle tone, protrusion of the posterior vaginal wall with Valsalva maneuver, and vaginal discharge. \n\nAction: search_docs\nAction Input: \"vaginal fullness, pelvic pain, decreased pelvic floor muscle tone, protrusion of posterior vaginal wall, vaginal discharge diagnosis\" \n", "type": "AgentAction"}}, "Look for pathology. Patients may have a palpable uterine mass, cervical motion tenderness, adnexal tenderness, a vaginal or cervical discharge, or visible vaginal pathology (mucosal tears, masses, prolapse). However, normal abdominal and pelvic exams do not rule out pathology.\n\nVaginal discharge is one of the most common vaginal symptoms. Conditions ranging from vaginal candidiasis to chlamydia cervicitis to bacterial vaginosis to cervical carcinoma may cause vaginal discharge. Infectious vaginal conditions are addressed more completely in Chapter 18. Vaginal lesions may\n\nvestibulodynia). Presence of cystocele, rectocele, or prolapse interfering with the woman\u2019s sexual self-image. Inability to tighten and relax perivaginal muscles (often associated with hypertonicity of pelvic muscles and midvaginal dyspareunia). Abnormal vaginal discharge associated with burning"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "pelvic organ prolapse symptoms diagnosis protrusion posterior vaginal wall\" \n", "log": "I need to further analyze the findings related to the symptoms and the examination results. The protrusion of the posterior vaginal wall with Valsalva maneuver and the sensation of vaginal fullness suggest a type of pelvic organ prolapse. The presence of vaginal discharge could indicate an associated condition, but it\u2019s important to focus on the structural findings.\n\nAction: search_docs\nAction Input: \"pelvic organ prolapse symptoms diagnosis protrusion posterior vaginal wall\" \n", "type": "AgentAction"}}, "Symptoms Pelvic organ prolapse often is accompanied by symptoms of voiding dysfunction, including urinary incontinence, obstructive voiding symptoms, urinary urgency and frequency, and, at the extreme, urinary retention and upper renal compromise with resultant pain or anuria. Other symptoms often\n\nRarely, the cervix, and occasionally a portion of the uterine body, may protrude from the vulva following delivery. his is accompanied by variable degrees of anterior and posterior vaginal wall prolapse. Symptoms include a palpable mass at or past the introitus, voiding diiculties, or pressure.\n\nData relating pelvic \ufb02oor symptoms to the extent and location of prolapse are weak (17\u201319). Any symptoms associated with physical findings of lower stage prolapse require careful evaluation, especially if surgery is being considered. A recent retrospective study of 330 patients reported that women"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Enterocele symptoms diagnosis pelvic organ prolapse\"  \n", "log": "The findings suggest that the patient is experiencing a type of pelvic organ prolapse, specifically an enterocele, which is characterized by the protrusion of the posterior vaginal wall and symptoms of pelvic fullness and discomfort. The presence of vaginal discharge may be secondary to the prolapse or could indicate another condition, but the key symptoms align with enterocele.\n\nAction: search_docs  \nAction Input: \"Enterocele symptoms diagnosis pelvic organ prolapse\"  \n", "type": "AgentAction"}}, "to superior breaks in the rectovaginal and pubocervical fascia. Patients with rectocele and enterocele may have similar symptoms, including pelvic pressure, vaginal protrusion, obstipation, fecal incontinence, and sexual dysfunction. Although associations have been made between defecatory\n\nof prolapse and pelvic \ufb02oor descent is quantified in relation to the pubococcygeal line. Pelvic \ufb02uoroscopy is superior to physical examination for diagnosing enterocele, and this technique has the advantage of being able to distinguish enteroceles from sigmoidoceles (90). Rectosphincteric\n\nand rectocele can result from chronic straining and increased intra-abdominal pressure due to other etiologies of defecatory dysfunction. Defecatory dysfunction related to pelvic organ prolapse can result from rectocele, enterocele, or perineal descent, either individually or in combination."]]},"11": {"question": "A 1-year-old boy is brought to the physician by his parents for the evaluation of recurrent seizures. He is at the 5th percentile for height and 10th percentile for weight. Examination shows coarse pale hair, inelastic hypopigmented skin, and generalized hypotonia. Laboratory studies show low serum ceruloplasmin levels. Decreased activity of which of the following enzymes is most likely responsible for this patient's condition?", "options": {"A": "Prolyl hydroxylase", "B": "Lysyl oxidase", "C": "Glucocerebrosidase", "D": "Homogentisate oxidase"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "low serum ceruloplasmin levels enzyme deficiency symptoms coarse hair hypopigmented skin hypotonia\" \n", "log": "I need to determine which enzyme deficiency is associated with the symptoms described in the question, particularly focusing on the patient's low serum ceruloplasmin levels, coarse hair, hypopigmented skin, and hypotonia. These symptoms suggest a specific metabolic disorder. \n\nAction: search_docs \nAction Input: \"low serum ceruloplasmin levels enzyme deficiency symptoms coarse hair hypopigmented skin hypotonia\" \n", "type": "AgentAction"}}, "blood levels due to decreased ceruloplasmin (Chap. 429).\n\nHereditary Deficiency of Ceruloplasmin (Aceruloplasminemia, CP Mutation)\n\nis exceeded, sometimes by 3 years of age. Defective copper incorporation into apoceruloplasmin leads to excess catabolism and low blood levels of ceruloplasmin. Serum copper levels are usually lower than normal because of low blood levels of ceruloplasmin, which normally binds >90% of serum copper."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "aceruloplasminemia enzyme deficiency prolyl hydroxylase lysyl oxidase glucocerebrosidase homogentisate oxidase\" \n", "log": "The observation indicates that low serum ceruloplasmin levels are associated with a condition known as aceruloplasminemia, which is linked to defective copper incorporation. This suggests that the enzyme involved may be related to copper metabolism. \n\nI need to identify which of the provided enzymes is associated with this condition or similar symptoms. The options include prolyl hydroxylase, lysyl oxidase, glucocerebrosidase, and homogentisate oxidase. \n\nAction: search_docs  \nAction Input: \"aceruloplasminemia enzyme deficiency prolyl hydroxylase lysyl oxidase glucocerebrosidase homogentisate oxidase\" \n", "type": "AgentAction"}}, "Aceruloplasminemia is a rare autosomal recessive disease characterized by tissue iron overload, mental deterioration, microcytic anemia, and low serum iron and copper concentrations.\n\nLysyl oxidase is one of several copper-containing enzymes. Others include ceruloplasmin (see p. 404), cytochrome c oxidase (see p. 76), dopamine hydroxylase (see p. 286), superoxide dismutase (see p. 148), and tyrosinase (see p. 273). Disruption in copper homeostasis causes copper deficiency\n\ncytochrome oxidase deficiency with psychomotor retardation, slowed growth, and lactic acidosis, many without the striatal or brainstem spinal necroses of Leigh syndrome."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "lysyl oxidase deficiency symptoms copper metabolism\" \n", "log": "The observation indicates that lysyl oxidase is a copper-containing enzyme and its deficiency could lead to symptoms associated with copper metabolism disorders. Given that the patient has low serum ceruloplasmin levels and symptoms like coarse hair and hypotonia, it points towards a potential deficiency in lysyl oxidase.\n\nNow I will confirm if lysyl oxidase deficiency is indeed connected to the symptoms presented in the question.\n\nAction: search_docs  \nAction Input: \"lysyl oxidase deficiency symptoms copper metabolism\" \n", "type": "AgentAction"}}, "Lysyl oxidase is one of several copper-containing enzymes. Others include ceruloplasmin (see p. 404), cytochrome c oxidase (see p. 76), dopamine hydroxylase (see p. 286), superoxide dismutase (see p. 148), and tyrosinase (see p. 273). Disruption in copper homeostasis causes copper deficiency\n\nof copper that indicates the problem is in mobilization of copper from the gut to the bloodstream. Other copper-dependent enzymes show impaired function, such as cytochrome oxidase. For the purposes of early diagnosis, Kaler and colleagues have taken advantage of the reduced activity of another\n\nthis clinical picture. Other potential causes of copper deficiency include malnutrition, prematurity, total parenteral nutrition, and ingestion of copper-chelating agents."]]},"12": {"question": "A 2-year-old boy is presented to the pediatrician due to poor weight gain and easy fatigability. His mother states that the patient barely engages in any physical activity as he becomes short of breath easily. The prenatal and birth histories are insignificant. Past medical history includes a few episodes of upper respiratory tract infection that were treated successfully. The patient is in the 10th percentile for weight and 40th percentile for height. The vital signs include: heart rate 122/min and respirations 32/min. Cardiac auscultation reveals clear lungs and a grade 2/6 holosystolic murmur loudest at the left lower sternal border. The remainder of the physical examination is negative for clubbing, cyanosis, and peripheral edema. Which of the following is the most likely diagnosis in this patient?", "options": {"A": "Atrial septal defect (ASD)", "B": "Ventricular septal defect (VSD)", "C": "Coarctation of aorta", "D": "Tetralogy of Fallot (TOF)"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Ventricular septal defect symptoms and diagnosis'", "log": "To determine the most likely diagnosis for the 2-year-old boy based on the provided clinical information, I need to consider the symptoms and examination findings in relation to the common pediatric heart conditions listed in the options.\n\nThe patient presents with poor weight gain, easy fatigability, and a holosystolic murmur, which suggests a possible left-to-right shunt condition. The absence of cyanosis and clubbing is also significant. \n\n- **Atrial septal defect (ASD)** generally presents with a systolic murmur and can lead to fatigue due to right heart volume overload, but it is less likely to cause significant weight gain issues in early childhood.\n- **Ventricular septal defect (VSD)** is characterized by a holosystolic murmur and can lead to failure to thrive due to increased pulmonary blood flow and heart failure.\n- **Coarctation of the aorta** usually presents with differential blood pressure in the arms and legs and may not typically present with a holosystolic murmur.\n- **Tetralogy of Fallot (TOF)** typically presents with cyanosis, which is not observed in this patient.\n\nGiven the presence of a holosystolic murmur and the symptoms of poor weight gain and fatigue, the most likely diagnosis is **Ventricular septal defect (VSD)**.\n\nAction: search_docs  \nAction Input: 'Ventricular septal defect symptoms and diagnosis'  ", "type": "AgentAction"}}, "and quantitation of a ventricular septal defect and mitral regurgitation, two serious complications of STEMI.\n\nFigure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.\n\nF, Reddy VM, McElhinney DB, Tworetzky W, Silverman NH, Hanley FL. Multiple ventricular septal defects: how and when should they be repaired? J Thorac Cardiovasc Surg. 1999;117(1):134-139.\t173.\tTsang VT, Hsia TY, Yates RW, Anderson RH. Surgical repair of supposedly multiple defects within the apical"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Ventricular septal defect clinical presentation in children'", "log": "The observation did not provide specific information about the symptoms and diagnosis of Ventricular Septal Defect (VSD) relevant to the patient's case. Therefore, I need to conduct another search to gather more pertinent information regarding VSD and its clinical presentation in children.\n\nAction: search_docs  \nAction Input: 'Ventricular septal defect clinical presentation in children'  ", "type": "AgentAction"}}, "Figure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.\n\nin 393 children with double-outlet right ventricle. J Thorac Cardiovasc Surg. 2007;134(4):967-973.e6.\t151.\tBelli E, Serraf A, Lacour-Gayet F, et al. Double-outlet right ventricle with non-committed ventricular septal defect. Eur J Cardiothorac Surg. 1999;15(6):747-752.\t152.\tKawashima Y, Matsuda H,\n\ndefects develop signs of congestive heart failure within the first few months of life.Physical examination may reveal a right ventricular heave and a systolic murmur. Children may also present with endo-carditis or paradoxical emboli as a result of the intracardiac communication. Chest radiography"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Ventricular septal defect symptoms in young children'", "log": "The observation provided some information regarding ventricular septal defects (VSD) but still lacks specific details about the clinical presentation in children, particularly in relation to the symptoms described in the patient's case. To make a more informed decision, I will conduct another search focusing specifically on the symptoms and clinical features of VSD in young children.\n\nAction: search_docs  \nAction Input: 'Ventricular septal defect symptoms in young children'  ", "type": "AgentAction"}}, "defects develop signs of congestive heart failure within the first few months of life.Physical examination may reveal a right ventricular heave and a systolic murmur. Children may also present with endo-carditis or paradoxical emboli as a result of the intracardiac communication. Chest radiography\n\npulmonary circulation often develops early. The presence of murmurs varies depending on the amount of shunting at both atrial and ventricular levels. If there is a large VSD component, S2 will be single. Growth is usually poor. Complete endocardial cushion defects are most commonly seen in children\n\nFigure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle."]]},"13": {"question": "A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?", "options": {"A": "Antigen contact with presensitized T-lymphocytes", "B": "Reactivation of virus dormant in dorsal root ganglion", "C": "Crosslinking of preformed IgE antibodies", "D": "Replication of the attenuated vaccine strain"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "13-month-old girl rash vaccination symptoms\"  \n", "log": "I need to analyze the symptoms and context provided in the question to determine which option is the most likely explanation for the girl's condition. The key points are the pruritic rash with maculopapular and pustular lesions, the recent vaccination history, and the age of the child.\n\nAction: search_docs  \nAction Input: \"13-month-old girl rash vaccination symptoms\"  \n", "type": "AgentAction"}}, "Human Services, Centers for Disease Control and Prevention, http://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html\n\nY, and W), with 50 \u03bcg of each polysaccharide per dose. Local reactions (erythema, induration, and tenderness) may occur in up to 40% of vaccinees, but serious adverse events (including febrile convulsions in young children) are very rarely reported. In adults, the vaccines are immunogenic, but\n\nthe prodromal illness; (2) when the rash is attenuated by passively acquired antibodies or prior immunization; (3) when the rash is absent or delayed in immunocompromised children or severely undernourished children with impaired cellular immunity; and (4) in regions where the incidence of measles"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vaccination rash maculopapular pustular lesions in children\"  \n", "log": "The search did not yield specific information directly related to the symptoms and vaccination context of the 13-month-old girl. I need to refine my search to focus more closely on the relationship between recent vaccinations and the types of rashes that can occur.\n\nAction: search_docs  \nAction Input: \"vaccination rash maculopapular pustular lesions in children\"  \n", "type": "AgentAction"}}, "the time that a maculopapular rash appears on the skin and oropharynx through the resolution and scabbing of the pustular lesions. Infection occurs principally during close contact, through the inhalation of saliva droplets containing virus from the oropharyngeal exanthem. Aerosolized material from\n\noccurrence of a macular, maculopapular, or vesicular rash; eschar; pneumonitis; and meningoencephalitis\u2014vary from one disease to another. Given the 15 etiologic agents with varied mechanisms of transmission, geographic distributions, and associated disease manifestations, the consideration of\n\nmaculopapular rash, which occasionally becomes pustular. Erythema nodosum occurs infrequently. The clinical manifestations of tularemia have been divided into various syndromes, which are listed in Table 195-2."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vaccination reactions maculopapular pustular rash children\"  \n", "log": "The previous search provided some information about rashes associated with vaccinations, but it did not directly address the specific case of a 13-month-old girl with a pruritic rash following immunization. I need to focus on vaccine-related reactions, particularly those that can lead to maculopapular and pustular lesions.\n\nAction: search_docs  \nAction Input: \"vaccination reactions maculopapular pustular rash children\"  \n", "type": "AgentAction"}}, "the time that a maculopapular rash appears on the skin and oropharynx through the resolution and scabbing of the pustular lesions. Infection occurs principally during close contact, through the inhalation of saliva droplets containing virus from the oropharyngeal exanthem. Aerosolized material from\n\nFIGURE 230e-1 Mild maculopapular rash of rubella in a child.\n\nAlthough rubella and CRS are no longer endemic in the\n\noccurrence of a macular, maculopapular, or vesicular rash; eschar; pneumonitis; and meningoencephalitis\u2014vary from one disease to another. Given the 15 etiologic agents with varied mechanisms of transmission, geographic distributions, and associated disease manifestations, the consideration of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "maculopapular pustular rash after vaccination in children\"  \n", "log": "The search did not yield specific and relevant information about vaccination reactions leading to maculopapular and pustular rashes in children. I need to refine my search further to focus on the specific types of vaccines that could lead to such reactions, especially in the context of recent immunizations.\n\nAction: search_docs  \nAction Input: \"maculopapular pustular rash after vaccination in children\"  \n", "type": "AgentAction"}}, "the time that a maculopapular rash appears on the skin and oropharynx through the resolution and scabbing of the pustular lesions. Infection occurs principally during close contact, through the inhalation of saliva droplets containing virus from the oropharyngeal exanthem. Aerosolized material from\n\nchildren with human monocytic ehrlichiosis present with a macular or maculopapular rash, although petechial lesions may occur. Symptoms usually last for 4 to 12 days.\n\nmaculopapular rash, which occasionally becomes pustular. Erythema nodosum occurs infrequently. The clinical manifestations of tularemia have been divided into various syndromes, which are listed in Table 195-2."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vaccine rash maculopapular pustular lesions explanation\"  \n", "log": "The searches have not provided the specific information needed to connect the symptoms of the 13-month-old girl to the potential explanations for her rash following vaccination. I need to consider the known effects of recent vaccinations, particularly those that can cause a rash, and analyze the options given in the question based on common vaccine reactions.\n\nAction: search_docs  \nAction Input: \"vaccine rash maculopapular pustular lesions explanation\"  \n", "type": "AgentAction"}}, "the time that a maculopapular rash appears on the skin and oropharynx through the resolution and scabbing of the pustular lesions. Infection occurs principally during close contact, through the inhalation of saliva droplets containing virus from the oropharyngeal exanthem. Aerosolized material from\n\nmaculopapular rash, which occasionally becomes pustular. Erythema nodosum occurs infrequently. The clinical manifestations of tularemia have been divided into various syndromes, which are listed in Table 195-2.\n\ndevelop a more extensive maculopapular rash due to immune complex\u2013mediated damage to the vessel wall."]]},"14": {"question": "A 65-year-old man was picked up by the security personnel for voiding urine and defecating at an inappropriate place in the community. On questioning, he was making offensive remarks and behaving inappropriately. On physical examination, the physician observed an ataxic gait and amnesia. Initial urine drug screen is negative for any drugs of abuse. Which is the most likely pathological finding present in this patient?", "options": {"A": "Drug abuse", "B": "Lewy bodies", "C": "Pick bodies", "D": "Amyloid plaques"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "ataxic gait amnesia inappropriate behavior neurodegenerative disorder pathological findings", "log": "I need to analyze the symptoms and signs presented in the question to determine the most likely pathological finding. The patient is 65 years old, has an ataxic gait, amnesia, and inappropriate behavior, which could suggest a neurodegenerative disorder. The negative urine drug screen also rules out acute drug intoxication. \n\nAction: search_docs  \nAction Input: \"ataxic gait amnesia inappropriate behavior neurodegenerative disorder pathological findings\"  ", "type": "AgentAction"}}, "an ataxic disorder (Miyajima et al).\n\nAtaxia is frequent, and the patient may appear to have Parkinson\u2019s disease, with a shuffling gait, hypertonia, and tremors. In the final phase, progressive neurologic impairment ends in coma and death.\n\nFrontal Lobe Disorders of Gait"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Lewy bodies pathology symptoms", "log": "The symptoms of ataxic gait, amnesia, and inappropriate behavior could indicate a frontal lobe disorder or a neurodegenerative condition such as dementia. The mention of Parkinson's disease in the observation also suggests a possible connection to Lewy bodies, which are associated with Lewy body dementia. \n\nAction: search_docs  \nAction Input: \"Lewy bodies pathology symptoms\"  ", "type": "AgentAction"}}, "Disorder With Lewy Bodiesb\n\nlisted in Table 449-1 characterized by their lack of satisfactory response to dopaminergic replacement therapy. There is evidence that Lewy body pathology first begins in the peripheral autonomic nervous system, olfactory system, and dorsal motor nucleus of the vagus nerve in the lower brainstem,\n\nHely MA, Reid WGJ, Halliday GM, et al: Diffuse Lewy body disease: Clinical features in nine cases without coexistent Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60:531, 1996."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Pick bodies pathology symptoms", "log": "The findings related to Lewy bodies indicate a connection to the symptoms observed in the patient, such as ataxic gait and inappropriate behavior. Given that Lewy bodies are associated with neurodegenerative disorders like Lewy body dementia, this strengthens the case for option B. \n\nAction: search_docs  \nAction Input: \"Pick bodies pathology symptoms\"  ", "type": "AgentAction"}}, "Although the term Pick\u2019s disease was once used to describe a progressive degenerative disorder characterized by selective involvement of the anterior frontal and temporal neocortex and pathologically by intraneuronal cytoplasmic inclusions (Pick bodies), it is now used only in reference to a\n\nMost individuals with excoriation disorder admit to skin picking; therefore, dermato- pathological diagnosis is rarely required. However, the disorder may have characteristic features on histopathology.\n\nA rare, progressive form of dementia characterized by atrophy of the frontal and temporal lobes. Round intraneuronal inclusions known as Pick bodies are the classic pathologic finding."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Amyloid plaques pathology symptoms", "log": "The information about Pick bodies indicates that they are associated with a specific type of dementia, primarily affecting the frontal and temporal lobes, which could lead to changes in behavior and cognition. However, the symptoms of ataxic gait and the patient's age may not align as closely with Pick's disease as they do with Lewy body dementia.\n\nAction: search_docs  \nAction Input: \"Amyloid plaques pathology symptoms\"  ", "type": "AgentAction"}}, "Amyloidosis may be found as an unsuspected anatomic change, having produced no clinical manifestations, or it may cause serious clinical problems and even death. The symptoms depend on the magnitude of the deposits and on the sites or organs affected. Clinical manifestations at first are often\n\nEng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250, 2004.\n\nA. Amyloid diseases"]]},"15": {"question": "A 58-year-old man is brought to the emergency department after a witnessed tonic-clonic seizure. His wife says he has had a persistent dry cough for 6 months. During this time period, he has also had fatigue and a 4.5-kg (10-lb) weight loss. The patient has no history of serious illness and does not take any medications. He has smoked 1 pack of cigarettes daily for 35 years. He is confused and oriented only to person. Laboratory studies show a serum sodium concentration of 119 mEq/L and glucose concentration of 102 mg/dL. An x-ray of the chest shows an irregular, poorly demarcated density at the right hilum. Microscopic examination of this density is most likely to confirm which of the following diagnoses?", "options": {"A": "Squamous cell lung carcinoma", "B": "Small cell lung carcinoma", "C": "Large cell lung carcinoma", "D": "Bronchial carcinoid tumor"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Squamous cell lung carcinoma characteristics, Small cell lung carcinoma characteristics, Large cell lung carcinoma characteristics, Bronchial carcinoid tumor characteristics'", "log": "I need to determine the most likely diagnosis based on the provided clinical information, including the patient's symptoms, smoking history, and x-ray findings. The persistent dry cough, weight loss, and confusion, along with the x-ray showing an irregular density at the right hilum, suggest a malignancy. \n\nTo narrow down the options, I will search for information on the common characteristics of the lung cancers listed in the options, particularly focusing on those that might correlate with the patient's smoking history and presentation.\n\nAction: search_docs  \nAction Input: 'Squamous cell lung carcinoma characteristics, Small cell lung carcinoma characteristics, Large cell lung carcinoma characteristics, Bronchial carcinoid tumor characteristics'  ", "type": "AgentAction"}}, "Characteristics favoring carcinoma: Age > 45\u201350; smoking history; history of malignancy; new or enlarging (unless very rapidly enlarging) lesions; absence of calcifcation or irregular calcifcation; size > 2 cm; irregular margins.\n\nLung nodule clues based on the history:\n\nThe four major histologic types of carcinomas of the lung are adenocarcinoma, squamous cell carcinoma, small cell carcinoma (a subtype of neuroendocrine carcinoma), and large cell carcinoma (\n\nUntil recently, carcinomas of the lung were classified into two broad groups: small cell lung cancer (SCLC) and non\u2013small cell lung cancer (NSCLC), the latter including adenocarcinoma, squamous and large cell carcinoma, and large cell neuroendocrine carcinomas. This classification has been recently"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Squamous cell lung carcinoma symptoms, Small cell lung carcinoma symptoms, Large cell lung carcinoma symptoms, Bronchial carcinoid tumor symptoms'", "log": "I have gathered information about the characteristics of lung cancers, particularly with respect to the patient's age, smoking history, and the x-ray findings. The clinical presentation suggests a malignancy, and the irregular density at the right hilum is indicative of a possible lung cancer.\n\nNext, I will focus on the specific types of lung cancer listed in the options and their associations with the symptoms presented by the patient.\n\nAction: search_docs  \nAction Input: 'Squamous cell lung carcinoma symptoms, Small cell lung carcinoma symptoms, Large cell lung carcinoma symptoms, Bronchial carcinoid tumor symptoms'  ", "type": "AgentAction"}}, "that explain the presenting symptoms and signs such as pneumonia, emphysema, pulmonary fibrosis, pulmonary mass, and aortic pathology. Sometimes asymptomatic early-stage lung cancer is diagnosed incidentally.\n\npresentation of lung cancerCATEGORYSYMPTOMCAUSEPulmonary symptomsCoughBronchus irritation or compressionDyspneaAirway obstruction or compressionWheezing>50% airway obstructionHemoptysisTumor erosion or irritationPneumoniaAirway obstructionNonpulmonary thoracic symptoms\u00a0Pleuritic painParietal\n\nSymptoms.\u2002Pulmonary symptoms result from the direct effect of the tumor on the bronchus or lung tissue. Symptoms (in order of frequency) include cough (secondary to irritation or compression of a bronchus), dyspnea (usually due to central airway obstruction or compression, with or without"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Squamous cell lung carcinoma smoking history, Small cell lung carcinoma smoking history, Large cell lung carcinoma smoking history, Bronchial carcinoid tumor smoking history'", "log": "I have obtained information regarding the symptoms associated with different types of lung cancers. The persistent dry cough, fatigue, weight loss, and confusion in this patient, along with the x-ray findings, point towards a malignancy affecting the lungs.\n\nNext, I will look for specific associations between the types of lung cancer listed in the options and the patient's smoking history, as well as their typical presentations.\n\nAction: search_docs  \nAction Input: 'Squamous cell lung carcinoma smoking history, Small cell lung carcinoma smoking history, Large cell lung carcinoma smoking history, Bronchial carcinoid tumor smoking history'  ", "type": "AgentAction"}}, "All histologic types of lung cancer can develop in current and former smokers, although squamous and small-cell carcinomas are most commonly associated with heavy tobacco use. Through the first half of the twentieth century, squamous carcinoma was the most common subtype of NSCLC diagnosed in the\n\nlung cancer types\u2014squamous cell and small cell carcinoma\u2014are extraordinarily rare in the absence of cigarette smoking. The risk of developing lung cancer escalates with the number of cigarettes smoked, the number of years of smoking, and the use of unfiltered cigarettes. Conversely, the risk of\n\nTable 8.4 lists organ-specific carcinogens contained in tobacco smoke. Moreover, smoking multiplies the risk of disease associated with other carcinogens; well-recognized examples are the 10-fold increased incidence of lung carcinomas in asbestos workers and uranium miners who smoke than in those"]]},"16": {"question": "A 55-year-old man presents to the physician with tiredness, lethargy, bone pain, and colicky right abdominal pain for 1 month. He has no comorbidities. He does not have any significant past medical history. His height is 176 cm (5 ft 7 in), weight is 88 kg (194 lb), and his BMI is 28.47 kg/m2. The physical examination is normal, except for mild right lumbar region tenderness. Laboratory studies show:\nHemoglobin 13.5 g/dL\nSerum TSH 2.2 mU/L\nSerum calcium 12.3 mg/dL\nSerum phosphorus 1.1 mg/dL\nSerum sodium 136 mEq/L\nSerum potassium 3.5 mEq/L\nSerum creatinine 1.1 mg/dL\nUrine calcium Elevated\nAn ultrasound of the abdomen reveals a single stone in the right ureter without hydroureteronephrosis. Clinically, no evidence of malignancy was observed. An X-ray of the long bones reveals diffuse osteopenia with subperiosteal bone resorption. The serum parathyroid hormone level is tested and it is grossly elevated. What is the most appropriate next step in his management?", "options": {"A": "99mTc sestamibi scan with ultrasound of the neck", "B": "CT scan of the neck", "C": "Bone scan (DEXA)", "D": "Sestamibi scan only"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of primary hyperparathyroidism\"  \n", "log": "I need to determine the most appropriate next step in the management of this patient, who presents with symptoms and laboratory findings suggestive of primary hyperparathyroidism. The elevated serum calcium, low phosphorus, and grossly elevated parathyroid hormone level indicate this condition. The options provided include imaging studies that could help identify potential causes or confirm the diagnosis.\n\nAction: search_docs  \nAction Input: \"management of primary hyperparathyroidism\"  \n", "type": "AgentAction"}}, "G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3595-3606.\t82.\tBilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary\n\nMuch attention has been paid in recent years to the manifestations of and optimum management strategies for asymptomatic hyperparathyroidism. This is now the most prevalent form of the disease. Asymptomatic primary hyperparathyroidism is defined as biochemically confirmed hyperparathyroidism\n\nMR, Bilezikian JP, McMahon DJ, et al. The natu-ral history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-3470.\t78.\tMarcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next step management primary hyperparathyroidism elevated PTH calcium\"  \n", "log": "The observation did not provide a clear answer regarding the most appropriate next step in managing primary hyperparathyroidism. I need more specific information about the diagnostic imaging or management steps related to elevated parathyroid hormone levels and hypercalcemia.\n\nAction: search_docs  \nAction Input: \"next step management primary hyperparathyroidism elevated PTH calcium\"  \n", "type": "AgentAction"}}, "PRIMARY HYPERPARATHYROIDISM Natural History and Incidence Primary hyperparathyroidism is a generalized disorder of calcium, phosphate, and bone metabolism due to an increased secretion of PTH. The elevation of circulating hormone usually leads to hypercalcemia and hypophosphatemia. There is great\n\nhas been shown to improve the clas-sic and the so-called nonspecific symptoms and metabolic complications of primary hyperparathyroidism.8\tNormocalcemic hyperparathyroidism is being increasingly recognized; however, there are no definitive guidelines for management.9\tVery high calcium and\n\nnormal calcium balance to prevent osteomalacia and severe secondary hyperparathyroidism (it is usually recommended to maintain PTH levels between 100 and 300 pg/ mL) and, in light of evidence of genetic changes and monoclonal outgrowths of parathyroid glands in CKD patients, to prevent secondary"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "imaging studies primary hyperparathyroidism management guidelines\"  \n", "log": "The observations are still not providing specific guidance on the next management steps for primary hyperparathyroidism. I need to find more focused information on the recommended imaging studies for this condition.\n\nAction: search_docs  \nAction Input: \"imaging studies primary hyperparathyroidism management guidelines\"  \n", "type": "AgentAction"}}, "from the previous guidelines pertain to the fact that (a) patients with nephrolithiasis or nephrocalcinosis by X-ray, ultrasound, or CT scan and (b) those with vertebral fracture by X-ray, CT, MRI, or VFA are also candidates for parathyroidectomy.81,82 The current guidelines are summarized in Table\n\nBilezikian ]P, Khan A, Potts]T]r: Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement of the Third International Workshop. ] Clin Endocrinol Metab 94(2):335, 2009\n\nBilezikian ]P, Silverberg S]: Asymptomatic primary hyperparathyroidism.\n\nBilezikian JP, Cusano NE, Khan AA, et al: Primary hyperparathyroidism, Nat Rev Dis Primers 2:16033, 2016. [This review follows the format of other reviews in this journal that is heavy on summary figures and overviews written for a broad audience. The reader is encouraged to periodically browse the"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next step management primary hyperparathyroidism after elevated PTH and calcium\"  \n", "log": "The observations still do not provide clear guidance on the next management steps for primary hyperparathyroidism. I will look for specific recommendations regarding the next steps after confirming elevated PTH and calcium levels in patients with suspected primary hyperparathyroidism.\n\nAction: search_docs  \nAction Input: \"next step management primary hyperparathyroidism after elevated PTH and calcium\"  \n", "type": "AgentAction"}}, "has been shown to improve the clas-sic and the so-called nonspecific symptoms and metabolic complications of primary hyperparathyroidism.8\tNormocalcemic hyperparathyroidism is being increasingly recognized; however, there are no definitive guidelines for management.9\tVery high calcium and\n\nBilezikian JP, Cusano NE, Khan AA, et al: Primary hyperparathyroidism, Nat Rev Dis Primers 2:16033, 2016. [This review follows the format of other reviews in this journal that is heavy on summary figures and overviews written for a broad audience. The reader is encouraged to periodically browse the\n\nPRIMARY HYPERPARATHYROIDISM Natural History and Incidence Primary hyperparathyroidism is a generalized disorder of calcium, phosphate, and bone metabolism due to an increased secretion of PTH. The elevation of circulating hormone usually leads to hypercalcemia and hypophosphatemia. There is great"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "recommended imaging for primary hyperparathyroidism elevated calcium and PTH\"  \n", "log": "The observations are still not providing a clear answer regarding the next management steps for primary hyperparathyroidism. I will refine my search to focus specifically on the recommended imaging studies for parathyroid evaluation in the context of elevated calcium and PTH levels.\n\nAction: search_docs  \nAction Input: \"recommended imaging for primary hyperparathyroidism elevated calcium and PTH\"  \n", "type": "AgentAction"}}, "Bilezikian JP, Cusano NE, Khan AA, et al: Primary hyperparathyroidism, Nat Rev Dis Primers 2:16033, 2016. [This review follows the format of other reviews in this journal that is heavy on summary figures and overviews written for a broad audience. The reader is encouraged to periodically browse the\n\nPRIMARY HYPERPARATHYROIDISM Natural History and Incidence Primary hyperparathyroidism is a generalized disorder of calcium, phosphate, and bone metabolism due to an increased secretion of PTH. The elevation of circulating hormone usually leads to hypercalcemia and hypophosphatemia. There is great\n\non the double-antibody method for PTH exhibit very high sensitivity (especially if serum calcium is simultaneously evaluated) and specificity for the diagnosis of primary hyperparathyroidism (Fig. 424-4). In summary, PTH values are elevated in >90% of parathyroid-related causes of hypercalcemia,"]]},"17": {"question": "An 8-year-old boy is brought to the emergency department because of shortness of breath and dry cough for 2 days. His symptoms began after he helped his father clean the basement. He is allergic to shellfish. Respirations are 26/min. Physical examination shows diffuse end-expiratory wheezing and decreased inspiratory-to-expiratory ratio. This patient's symptoms are most likely being caused by inflammation of which of the following structures?", "options": {"A": "Pleural cavity", "B": "Alveoli", "C": "Distal trachea", "D": "Terminal bronchioles"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma inflammation structures terminal bronchioles", "log": "The patient's symptoms, including shortness of breath, dry cough, wheezing, and the context of exposure to potential allergens or irritants while cleaning the basement, suggest a likely case of asthma or an allergic reaction affecting the airways. The presence of wheezing indicates that the issue is likely occurring in the smaller airways rather than the pleural cavity or alveoli. I need to determine which structure is most involved in this scenario.\n\nAction: search_docs  \nAction Input: \"asthma inflammation structures terminal bronchioles\"  ", "type": "AgentAction"}}, "Terminal bronchiole, lungs, human, H&E \u00d7550.\n\nThe respiratory bronchiole has a wall composed of two components: One consists of recesses that have a wall similar to that of the alveoli and are thus capable of gas exchange; the other has a wall formed by small cuboidal cells that appear to rest on a small bundle of eosinophilic material. This\n\nIn this figure, a short length of a bronchiole (B) is shown longitudinally sectioned as it branches into two respiratory bronchioles (RB ). The last portion of a bronchiole that leads into respiratory bronchioles is called a terminal bronchiole. It is not engaged in exchange of air with the blood;"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma inflammation terminal bronchioles symptoms", "log": "The information obtained indicates that the terminal bronchioles are the last part of the airway that does not participate in gas exchange. Given the symptoms of wheezing and shortness of breath, it is likely that inflammation is occurring in the terminal bronchioles, which are part of the conducting zone of the airways and can be affected in conditions like asthma. \n\nAction: search_docs  \nAction Input: \"asthma inflammation terminal bronchioles symptoms\"  ", "type": "AgentAction"}}, "asthma symptoms in most patients.\n\nVaried manifestations of asthma have led to a simple classiication that considers severity, onset, and duration of symptoms (Table 51-1). With persistent or worsening bronchial obstruction, clinical stages progress as shown in Figure\n\nAirway Inflammation There is inflammation in the respiratory mucosa from the trachea to terminal bronchioles, but with a predominance in the bronchi (cartilaginous airways); however, it is still uncertain as to how inflammatory cells interact and how inflammation translates into the symptoms of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma terminal bronchioles role inflammation symptoms", "log": "The observation confirms that airway inflammation occurs from the trachea to the terminal bronchioles, with a focus on bronchial inflammation in asthma. This aligns with the patient's symptoms of wheezing and shortness of breath, indicating that the terminal bronchioles are indeed involved in the inflammatory process during an asthma attack.\n\nAction: search_docs  \nAction Input: \"asthma terminal bronchioles role inflammation symptoms\"  ", "type": "AgentAction"}}, "asthma symptoms, and reduce exacerbations. There are, however, uncertainties about the role of mast cells in more chronic allergic inflammatory events. Mast cells release several bronchoconstrictor mediators, including histamine, prostaglandin D2, and cysteinyl-leukotrienes, but also several\n\nFIGURE 20\u20132 Inflammatory mechanism of asthma. Airway epithelial cells exposed to activation stimuli, including allergens, viruses, and irritants, release cytokines that promote dendritic cell (DC) mobilization to draining lymph nodes, where they present antigens and thereby activate naive CD4 T\n\nii. Inflammation, especially major basic protein derived from eosinophils, damages cells and perpetuates bronchoconstriction (late-phase reaction).\n\nD. Clinical features are episodic and related to allergen exposure.\n\n1.\n\n2."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma inflammation terminal bronchioles role in symptoms", "log": "The observations indicate that inflammation in asthma primarily affects the airway epithelial cells and can lead to bronchoconstriction, particularly in the terminal bronchioles. Given that the boy's symptoms began after exposure to potential allergens in the basement, it is likely that the inflammation is localized in the terminal bronchioles, which are crucial in asthma pathophysiology.\n\nAction: search_docs  \nAction Input: \"asthma inflammation terminal bronchioles role in symptoms\"  ", "type": "AgentAction"}}, "asthma symptoms, and reduce exacerbations. There are, however, uncertainties about the role of mast cells in more chronic allergic inflammatory events. Mast cells release several bronchoconstrictor mediators, including histamine, prostaglandin D2, and cysteinyl-leukotrienes, but also several\n\nInflammatory cells (mast cells, eosinophils, T lymphocytes, neutrophils), chemical mediators (histamine, leukotrienes, platelet-activating factor, bradykinin), and chemotactic factors (cytokines, eotaxin) mediate the underlying inflammation found in asthmatic airways. Inflammation contributes to\n\nBousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M., and Vignola, A.M.: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000, 161:1720\u20131745."]]},"18": {"question": "A 79-year-old man is brought to the emergency department after he noted the abrupt onset of weakness accompanied by decreased sensation on his left side. His symptoms developed rapidly, peaked within 1 minute, and began to spontaneously resolve 10 minutes later. Upon arrival in the emergency room 40 minutes after the initial onset of symptoms, they had largely resolved. The patient has essential hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and a 50 pack-year smoking history. He also had an ST-elevation myocardial infarction 3 years ago. His brain CT scan without contrast is reported as normal. Carotid duplex ultrasonography reveals 90% stenosis of the right internal carotid. His transthoracic echocardiogram does not reveal any intracardiac abnormalities. Which of the following interventions is most appropriate for this patient's condition?", "options": {"A": "Aspirin and clopidogrel", "B": "Warfarin", "C": "Carotid stenting", "D": "Hypercoagulability studies"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for guidelines or recommendations regarding the management of patients with a history of TIA and significant carotid artery stenosis.", "tool_input": "'management of TIA with significant carotid artery stenosis' \n", "log": "I need to analyze the patient's symptoms and medical history to determine the most appropriate intervention. The patient experienced a transient ischemic attack (TIA) given the abrupt onset of weakness and decreased sensation that resolved spontaneously. The carotid duplex ultrasonography indicates significant stenosis of the right internal carotid artery, which is a risk factor for future strokes.\n\nAction: I will search for guidelines or recommendations regarding the management of patients with a history of TIA and significant carotid artery stenosis. \nAction Input: 'management of TIA with significant carotid artery stenosis' \n", "type": "AgentAction"}}, "I will search for guidelines or recommendations regarding the management of patients with a history of TIA and significant carotid artery stenosis. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'management of TIA with significant carotid artery stenosis'  \n", "log": "I need to perform a search to find relevant guidelines or recommendations regarding the management of patients with a history of TIA and significant carotid artery stenosis.\n\nAction: search_docs  \nAction Input: 'management of TIA with significant carotid artery stenosis'  \n", "type": "AgentAction"}}, "with asymptomatic carotid stenosis. As with atrial fibrillation, it is imperative to counsel the patient about TIAs so that therapy can be revised if symptoms develop.\n\nIf there is a reduction in diameter of greater than 70 percent when compared with an adjacent normal segment of vessel, and probably if there is a severely ulcerated but not critically stenotic plaque, carotid surgery (or angioplasty with stenting) is advisable. If a single TIA lasted more than 1 h\n\nrecently, these may be forerunners of complete occlusion. If the TIA was far in the past\u2014more than several weeks previously\u2014the immediate risks of occlusion are reduced. The initial approach is to establish the patency of the carotid arteries by ultrasonography or MRA. If there is a reduction in"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will perform another search to confirm the most appropriate intervention for a patient with a TIA and significant carotid artery stenosis.", "tool_input": "'appropriate intervention for TIA with 90% carotid artery stenosis'  \n", "log": "The information gathered suggests that patients with significant carotid artery stenosis who have experienced a TIA may benefit from surgical intervention, such as carotid endarterectomy or stenting, especially if the stenosis is greater than 70%. The patient in question has a 90% stenosis of the right internal carotid artery and has experienced a TIA. \n\nAction: I will perform another search to confirm the most appropriate intervention for a patient with a TIA and significant carotid artery stenosis.  \nAction Input: 'appropriate intervention for TIA with 90% carotid artery stenosis'  \n", "type": "AgentAction"}}, "I will perform another search to confirm the most appropriate intervention for a patient with a TIA and significant carotid artery stenosis. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'appropriate intervention for TIA with 90% carotid artery stenosis'  \n", "log": "I need to perform a search to find specific recommendations for the appropriate intervention for a patient with TIA and significant carotid artery stenosis.\n\nAction: search_docs  \nAction Input: 'appropriate intervention for TIA with 90% carotid artery stenosis'  \n", "type": "AgentAction"}}, "If there is a reduction in diameter of greater than 70 percent when compared with an adjacent normal segment of vessel, and probably if there is a severely ulcerated but not critically stenotic plaque, carotid surgery (or angioplasty with stenting) is advisable. If a single TIA lasted more than 1 h\n\nwith asymptomatic carotid stenosis. As with atrial fibrillation, it is imperative to counsel the patient about TIAs so that therapy can be revised if symptoms develop.\n\nThere is evidence that well-executed surgery or stenting in appropriately chosen cases arrests the TIAs and diminishes the risk of future strokes. These views initially received strong affirmation from two often-cited randomized studies\u2014the North American Symptomatic Carotid Endarterectomy Trial"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will finalize the decision based on the gathered evidence regarding the management of TIA with significant carotid artery stenosis.", "tool_input": "None (final decision).  \n", "log": "The information indicates that for patients with significant carotid artery stenosis (greater than 70%) who have experienced a TIA, surgical intervention such as carotid endarterectomy or stenting is advisable. The patient in this scenario has a 90% stenosis of the right internal carotid artery and a history of TIA, making him a candidate for such intervention.\n\nAction: I will finalize the decision based on the gathered evidence regarding the management of TIA with significant carotid artery stenosis.  \nAction Input: None (final decision).  \n", "type": "AgentAction"}}, "I will finalize the decision based on the gathered evidence regarding the management of TIA with significant carotid artery stenosis. is not a valid tool, try one of [search_docs]."]]},"19": {"question": "A 65-year-old woman comes to the physician because of a 2-month history of persistent pain in her right shoulder. The pain is localized to the top of the shoulder and is worse with movement. She has stiffness in the right shoulder that is worse in the morning and usually lasts 20 minutes. The patient reports that she is unable to brush her hair and has stopped going to her regular tennis lessons because of the pain. She does not recall any fall or trauma. When her right arm is passively abducted in an arc, there is pain between 60 and 120 degrees of abduction. When asked to lower the right arm slowly from 90 degrees of abduction, she is unable to hold her arm up and it drops to her side. Passive range of motion is normal. Injection of 5 mL of 1% lidocaine into the right subacromial space does not relieve the pain or improve active range of motion of the right arm. Which of the following is the most likely diagnosis?", "options": {"A": "Cervical radiculopathy", "B": "Rotator cuff tear", "C": "Subacromial bursitis", "D": "Biceps tendinitis"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "shoulder pain diagnosis rotator cuff tear subacromial bursitis biceps tendinitis cervical radiculopathy", "log": "I need to analyze the symptoms and clinical findings presented in the case to determine the most likely diagnosis. The patient has persistent shoulder pain, stiffness worse in the morning, and pain during specific movements. The injection of lidocaine into the subacromial space not relieving pain suggests that the issue may not be related to the subacromial structures. \n\nAction: search_docs  \nAction Input: \"shoulder pain diagnosis rotator cuff tear subacromial bursitis biceps tendinitis cervical radiculopathy\"  ", "type": "AgentAction"}}, "Pain arising from the shoulder can on occasion mimic pain from the spine. If symptoms and signs of radiculopathy are absent, then the differential diagnosis includes mechanical shoulder pain (tendonitis, bursitis, rotator cuff tear, dislocation, adhesive capsulitis, or rotator cuff impingement\n\nPain localized to the shoulder region, worsened by motion, and associated with tenderness and limitation of movement, especially internal and external rotation and abduction, points to a tendonitis, subacromial bursitis, or tear of the rotator cuff, which is made up of the tendons of the muscles\n\nmay suggest infection, RA, amyloidosis, or an acute tear of the rotator cuff. The examiner should apply direct manual pressure over the subacromial bursa that lies lateral to and immediately beneath the acromion (Fig. 393-4). Subacromial bursitis is a frequent cause of shoulder pain. Anterior to"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "rotator cuff tear symptoms diagnosis", "log": "The information gathered indicates that the patient's symptoms are consistent with shoulder conditions such as rotator cuff tears, subacromial bursitis, or biceps tendinitis. The fact that the lidocaine injection into the subacromial space did not relieve pain suggests that the pain may not be due to subacromial bursitis. The inability to hold the arm up during abduction and the specific pain during the 60 to 120 degrees of abduction are more indicative of a rotator cuff issue.\n\nAction: search_docs  \nAction Input: \"rotator cuff tear symptoms diagnosis\"  ", "type": "AgentAction"}}, "A positive sign is present if pain develops before 180\u00b0 of forward flexion. Tear of the rotator cuff is common in the elderly and often results from trauma; it may manifest in the same manner as tendinitis. The drop arm test is abnormal with supraspinatus pathology and is demonstrated by passive\n\nrotatorcuff,whichevolvestofibroticthickeningandeventuallytorotator cuff degeneration with tendon tears and bone spurs. Subacromial bursitis also accompanies this syndrome. Symptoms usually appear after injury or overuse, especially with activities involving elevation of the arm with some degree of\n\nPatients may tear the supraspinatus tendon acutely by falling on an outstretched arm or lifting a heavy object. Symptoms are pain along with weakness of abduction and external rotation of the shoulder. Atrophy of the supraspinatus muscles develops. The diagnosis is"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "shoulder pain drop arm test rotator cuff tear", "log": "The information suggests that a rotator cuff tear is characterized by weakness in abduction and external rotation, along with pain that can be exacerbated during specific movements. The patient's inability to hold her arm up during abduction and the pain experienced during the 60 to 120 degrees of abduction strongly point towards a rotator cuff issue. \n\nAction: search_docs  \nAction Input: \"shoulder pain drop arm test rotator cuff tear\"  ", "type": "AgentAction"}}, "A positive sign is present if pain develops before 180\u00b0 of forward flexion. Tear of the rotator cuff is common in the elderly and often results from trauma; it may manifest in the same manner as tendinitis. The drop arm test is abnormal with supraspinatus pathology and is demonstrated by passive\n\nis demonstrated by passive abduction of the arm to 90\u00b0 by the examiner. If the patient is unable to hold the arm up actively or unable to lower the arm slowly without dropping, the test is positive. Tendinitis or tear of the rotator cuff is best confirmed by magnetic resonance imaging (MRI) or\n\npermanent damage and loss of function. This injury is typical (Fig. 7.70) and the nerve should always be tested when a fracture of the midshaft of the humerus is suspected. The patient\u2019s symptoms usually include wrist drop (due to denervation of the extensor muscles) and sensory changes over the"]]},"20": {"question": "A 72-year-old man presents to the emergency department after a fall. The patient was found lying down on the floor in his room in his retirement community. The patient has a past medical history of Alzheimer dementia and a prosthetic valve. His current medications include donepezil and warfarin. His temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 85/50 mmHg, pulse is 160/min, respirations are 13/min, and oxygen saturation is 97% on room air. That patient is started on IV fluids and a type and screen is performed. Laboratory values are ordered as seen below.\n\nHemoglobin: 13 g/dL\nHematocrit: 39%\nLeukocyte count: 5,500 cells/mm^3 with normal differential\nPlatelet count: 225,000/mm^3\n\nINR: 2.5\nAST: 10 U/L\nALT: 12 U/L\n\nA chest radiograph and EKG are performed and are within normal limits. A full physical exam is within normal limits. The patient\u2019s vitals are repeated. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 110/70 mmHg, pulse is 90/min, respirations are 10/min, and oxygen saturation is 98% on room air. Which of the following is the best next step in management?", "options": {"A": "CT scan", "B": "Exploratory laparoscopy", "C": "Exploratory laparotomy", "D": "Fresh frozen plasma"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "elevated INR management in elderly patients after fall", "log": "The patient is a 72-year-old man who has presented after a fall, with a history of Alzheimer dementia and a prosthetic valve. His vital signs indicate he was initially hypotensive and tachycardic but have since stabilized with IV fluids. His laboratory values show an elevated INR of 2.5, which suggests that he is anticoagulated due to his warfarin therapy. Given these factors, the concern is for potential bleeding, particularly given his fall and the elevated INR. \n\nThe options provided include imaging studies and surgical interventions. A CT scan could help evaluate for internal bleeding, while exploratory laparotomy and laparoscopy are more invasive surgical options. Fresh frozen plasma could be administered to reverse the effects of warfarin and correct the INR.\n\nBased on the clinical scenario, the best next step in management is likely to address the elevated INR to prevent any potential bleeding complications from his anticoagulation therapy.\n\nAction: search_docs  \nAction Input: \"elevated INR management in elderly patients after fall\"  ", "type": "AgentAction"}}, "Falls in the Elderly\n\ncause of falling in the elderly.\n\nEVAR remains a viable option in older adult patients. Nonoperative management is justified in frail older adult patients with multiple comorbidi-ties and reduced life expectancy whose operative risks outweigh the risk of rupture and in those who are unlikely to survive long enough to benefit from"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of elevated INR in patients on warfarin after fall", "log": "The search did not yield relevant information regarding the management of elevated INR in elderly patients after a fall. I need to refine my search to focus specifically on the management of elevated INR in the context of warfarin use and potential bleeding complications after a fall.\n\nAction: search_docs  \nAction Input: \"management of elevated INR in patients on warfarin after fall\"  ", "type": "AgentAction"}}, "Do not give warfarin until the platelet count returns to its baseline level. If warfarin was administered, give vitamin K to restore the INR to normal.\n\nEvaluate for thrombosis, particularly deep vein thrombosis.\n\nAbbreviation: INR, international normalized ratio.\n\nrecommended range of 2.5\u20133.5. While a prolonged INR is widely used as an indication of integrity of the coagulation system in liver disease and other disorders, it has been validated only in patients in steady state on chronic warfarin therapy.\n\nreversal of the INR but may render events, two randomized trials showed that targeting an INR of 2.0\u20133.0 patients temporarily resistant to warfarin when the drug is restarted."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "fresh frozen plasma use in elevated INR after fall", "log": "The search results indicate that when managing an elevated INR in patients on warfarin, especially in the context of potential bleeding after a fall, administering vitamin K is a typical approach to restore the INR to normal. Additionally, fresh frozen plasma (FFP) can be used for more immediate reversal of anticoagulation effects. Given that the patient has an elevated INR of 2.5 and has experienced a fall, this suggests a significant risk for bleeding.\n\nAction: search_docs  \nAction Input: \"fresh frozen plasma use in elevated INR after fall\"  ", "type": "AgentAction"}}, "(e.g., myocardial ischemia, hemorrhage). It is not necessary to use fresh frozen plasma to correct INR abnormalities in the absence of bleeding. Consider prophylactic transfusion of platelets when counts are less than 10,000/mL in the absence of bleeding, <20,000/mL if there is a risk of bleeding,\n\nE, Nadler R, Gendler S, et al. Freeze-dried plasma at the point of injury: from concept to doctrine. Shock. 2013;40(6):444-450.\t96.\tPusateri AE, Given MB, Schreiber MA, et al. Dried plasma: state of the science and recent developments. Transfusion. 2016 Apr;56 Suppl 2:S128-139. Due to challenges in\n\nshock resuscitation. J Trauma Acute Care Surg. 2015;78 (6 Suppl 1):S26-S30.\t94.\tMartinaud C, Ausset S, Deshayes AV, Cauet A, Demazeau N, Sailliol A. Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma. 2011 Dec;71(6):1761-1764.\t95.\tGlassberg E, Nadler R, Gendler S, et"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "indications for fresh frozen plasma in elevated INR", "log": "The search results did not provide specific information about the use of fresh frozen plasma (FFP) in the context of elevated INR after a fall. However, it is generally understood that FFP can be used to reverse anticoagulation effects in cases of significant bleeding or when there is a high risk of bleeding due to an elevated INR. In this patient's case, the elevated INR of 2.5, combined with the history of a fall, raises concerns for potential bleeding complications.\n\nGiven this context, I need to assess the appropriateness of administering fresh frozen plasma as a management step for this patient.\n\nAction: search_docs  \nAction Input: \"indications for fresh frozen plasma in elevated INR\"  ", "type": "AgentAction"}}, "(e.g., myocardial ischemia, hemorrhage). It is not necessary to use fresh frozen plasma to correct INR abnormalities in the absence of bleeding. Consider prophylactic transfusion of platelets when counts are less than 10,000/mL in the absence of bleeding, <20,000/mL if there is a risk of bleeding,\n\nGonzalez EA, Moore FA, Holcomb JB, et al: Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 62: 1n12, 2007 Goodnough LT, Levy JH: he judicious use of recombinant factor VIla. Semin\n\nThromb Hemost 42(2):125,n2016\n\n2.\n\nFresh frozen plasma therapy is indicated if the prothrombin or activated partial thromboplastin time values exceed 1.5 times the normal value.\n\n3.\n\nCryoprecipitate transfusion is indicated if fibrinogen concentrations decrease to less than 80 to 100 mg/dL."]]},"21": {"question": "A 42-year-old man presents for evaluation of vitamin D deficiency with possible osteomalacia. The patient had a pathologic fracture 3 weeks ago and was found to have dangerously low levels of vitamin D with normal serum calcium levels. Bone density has been drastically affected, leading to the fracture this patient experienced. The lack of what compound is most responsible for the formation of this disease?", "options": {"A": "Calcifediol", "B": "Calcitriol", "C": "Vitamin D binding protein", "D": "PTH"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'osteomalacia vitamin D deficiency compounds responsible', retriever=VectorStoreRetriever())", "tool_input": "'osteomalacia vitamin D deficiency compounds responsible'", "log": "To determine which compound is most responsible for the formation of osteomalacia in this patient with vitamin D deficiency, I need to analyze the role of each option in relation to vitamin D metabolism and bone health. \n\nAction: search_docs(query: 'osteomalacia vitamin D deficiency compounds responsible', retriever=VectorStoreRetriever()) \nAction Input: 'osteomalacia vitamin D deficiency compounds responsible' ", "type": "AgentAction"}}, "search_docs(query: 'osteomalacia vitamin D deficiency compounds responsible', retriever=VectorStoreRetriever()) is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'osteomalacia vitamin D deficiency compounds responsible'", "log": "I need to perform a search to gather information regarding the compounds related to osteomalacia and vitamin D deficiency. \n\nAction: search_docs \nAction Input: 'osteomalacia vitamin D deficiency compounds responsible' ", "type": "AgentAction"}}, "D. Osteomalacia is due to low vitamin D in adults.\n\n1.\n\nInadequate mineralization results in weak bone with an increased risk for fracture.\n\n2.\n\nLaboratory findings include --1.-serum calcium, --1.-serum phosphate, t PTH, and t alkaline phosphatase.\n\nV.\n\nA. Reduction in trabecular bone mass\n\nAlthough vitamin D deficiency is the most common cause of rickets and osteomalacia, many disorders lead to inadequate mineralization of the growth plate and bone. Calcium deficiency without vitamin D deficiency, the disorders of vitamin D metabolism previously discussed, and hypophosphatemia can\n\nBoth rickets and osteomalacia are manifestations of vitamin D deficiency or its abnormal metabolism (detailed in Chapter 8). Rickets refers to the disorder in children, in whom it interferes with the deposition of bone in the growth plates. Osteomalacia is the adult counterpart, in which bone"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "_Exception", "tool_input": "Invalid Format: Missing 'Action Input:' after 'Action:'", "log": "I need to analyze the information gathered from the search results to identify which compound is specifically responsible for osteomalacia due to vitamin D deficiency.\n\nAction: None needed at this point; I will analyze the information provided in the observation.\n", "type": "AgentAction"}}, "Invalid Format: Missing 'Action Input:' after 'Action:'"]]},"22": {"question": "A 22-year-old man comes to the physician because of headaches and blurry vision for the past 6 months. He also reports frequent episodes of vomiting over the last month. His father has died of renal cell carcinoma at the age of 37 years. Examination shows 20/40 vision bilaterally. Fundoscopic examination shows bilateral optic disc swelling and growth of capillary vessels in the temporal peripheral retina. An MRI of the brain shows an infratentorial mass. The patient undergoes surgical resection of the mass. A photomicrograph of the resected specimen is shown. Which of the following is the most likely diagnosis?", "options": {"A": "Medulloblastoma", "B": "Oligodendroglioma", "C": "Hemangioblastoma", "D": "Ependymoma"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Medulloblastoma, Oligodendroglioma, Hemangioblastoma, Ependymoma characteristics in young adults", "log": "I need to identify the most likely diagnosis based on the symptoms and findings described in the question. The key points to consider are the patient's age, symptoms (headaches, blurry vision, vomiting), family history of renal cell carcinoma, bilateral optic disc swelling, growth of capillary vessels in the retina, and the presence of an infratentorial mass seen on MRI.\n\nGiven the age (22 years) and the nature of the symptoms, I should focus on the types of brain tumors that are common in young adults. Medulloblastoma is a common pediatric brain tumor but can occur in young adults. Hemangioblastoma is associated with von Hippel-Lindau syndrome, which could correlate with the family history of renal cell carcinoma. Oligodendroglioma and ependymoma are also possibilities but are less likely given the age and presentation.\n\nTo make a more informed decision, I will search for information on the characteristics of these tumors, particularly focusing on their presentation in young adults and any associations with symptoms like those described in the question.\n\nAction: search_docs  \nAction Input: \"Medulloblastoma, Oligodendroglioma, Hemangioblastoma, Ependymoma characteristics in young adults\"  ", "type": "AgentAction"}}, "astrocytoma, ependymoma, and medulloblastoma.\n\nMost central nervous system (CNS) tumors in children and adolescents are primary tumors that originate in the CNS and include low-grade astrocytomas or embryonic neoplasms (medulloblastoma, ependymoma, germ cell tumor). In contrast CNS tumors in adults are high-grade astrocytomas or secondary\n\nThe tumors that most often produce these unique intracranial syndromes are the ones listed above as well as a number of other erosive tumors at the base of the skull. The aforementioned medulloblastoma, hemangioblastoma, and ependymoma of the fourth ventricle may have a similar regional clinical"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "hemangioblastoma presentation symptoms young adults", "log": "I need to analyze the information retrieved to determine which tumor is most consistent with the patient's presentation. The key symptoms to consider include the patient's age, the presence of an infratentorial mass, bilateral optic disc swelling, and the family history of renal cell carcinoma.\n\nFrom the previous search, I learned that medulloblastoma is common in younger individuals and can present with symptoms like headaches and vomiting due to increased intracranial pressure. Hemangioblastoma is associated with von Hippel-Lindau syndrome and can also present with retinal findings, which aligns with the growth of capillary vessels in the retina seen in this patient. Ependymoma can occur in young adults but is less common than the other two options.\n\nGiven that the patient's family history suggests a possible genetic predisposition (renal cell carcinoma could be linked to von Hippel-Lindau syndrome), I should consider hemangioblastoma more seriously. Additionally, the presence of bilateral optic disc swelling and retinal changes further supports the likelihood of hemangioblastoma.\n\nAction: search_docs  \nAction Input: \"hemangioblastoma presentation symptoms young adults\"  ", "type": "AgentAction"}}, "The cerebellar hemangioblastoma typically develops in the fourth decade and causes symptoms of ataxia and headache. On imaging studies, the lesions have a striking appearance of a cyst with a nodule contained in its wall, and angiography demonstrates the highly vascular nature of the nodule, which\n\npheochromocytomas; and pancreatic islet cell tumors. The retinal and CNS hemangioblastomas are benign vascular tumors that may be multiple; those in the CNS may cause symptoms\n\nTable 153-2 Common Manifestations of Childhood Malignancies SIGN/SYMPTOM SIGNIFICANCE EXAMPLE Hematologic Pallor, anemia Bone marrow infiltration Leukemia, neuroblastoma\n\nPetechiae, thrombocytopenia Bone marrow infiltration Leukemia, neuroblastoma"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "medulloblastoma symptoms young adults infratentorial mass", "log": "The information retrieved indicates that hemangioblastomas are benign vascular tumors that can be associated with retinal findings and may cause symptoms such as headaches due to increased intracranial pressure. However, it also suggests that cerebellar hemangioblastomas typically develop in older individuals, particularly in the fourth decade of life. This raises a question about the appropriateness of hemangioblastoma as a diagnosis for this 22-year-old patient.\n\nOn the other hand, medulloblastoma is a tumor that is more common in younger individuals and can present with symptoms like headaches and vomiting due to increased intracranial pressure. The infratentorial location of the mass aligns well with medulloblastoma, which typically arises in the cerebellum.\n\nGiven the patient's age, the presence of an infratentorial mass, and the commonality of medulloblastoma in young adults, I should lean towards considering it as a primary diagnosis.\n\nAction: search_docs  \nAction Input: \"medulloblastoma symptoms young adults infratentorial mass\"  ", "type": "AgentAction"}}, "children, in whom the tumor may simulate the cerebellar symptomatology of medulloblastoma.\n\nMedulloblastoma\u2002Medulloblastoma is an invasive and rapidly growing tumor, mainly of childhood, that arises in the posterior part of the cerebellar vermis and neuroepithelial roof of the fourth ventricle in children. It accounts for 20 percent of childhood brain tumors. Rarely, it presents elsewhere\n\nfourth ventricle, leading to headache, nausea, vomiting, or diplopia. Cerebellar hemisphere or brain stem dysfunction can result in ataxia, nystagmus, or cranial nerve palsies. Infratentorial tumors rarely cause seizures.All patients with symptoms concerning for brain tumor should undergo MRI with"]]},"23": {"question": "A 53-year-old woman presents to her primary care physician with joint pain. She reports a 6-month history of progressive pain in her hands that is worse around her knuckles. The pain is symmetric bilaterally and seems to improve after she starts working in the morning at her job in a local grocery store. She has also lost 10 pounds over the past 6 months despite no changes in her weight or exercise regimen. Her past medical history is notable for seasonal allergies, hypertension, and intermittent constipation. She takes losartan and a laxative as needed. She had adolescent idiopathic scoliosis as a child and underwent a spinal fusion at the age of 14. She does not smoke or drink alcohol. Her temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 135/75 mmHg, pulse is 92/min, and respirations are 16/min. On examination, she appears well and is appropriately interactive. Strength is 5/5 and sensation to light touch is intact in the bilateral upper and lower extremities. An examination of her hands demonstrates symmetric swelling of the metacarpophalangeal joints bilaterally. This patient\u2019s condition is most strongly characterized by which of the following?", "options": {"A": "HLA-B27", "B": "HLA-DR2", "C": "HLA-DR3", "D": "HLA-DR4"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 rheumatoid arthritis association", "log": "I need to determine which HLA type is most strongly associated with the patient's symptoms, particularly considering the symmetric joint pain and swelling in the hands, which suggests a possible autoimmune or inflammatory condition such as rheumatoid arthritis. \n\nAction: search_docs \nAction Input: \"HLA-DR4 rheumatoid arthritis association\" ", "type": "AgentAction"}}, "Rheumatoid Arthritis The HLA genes associated with rheumatoid arthritis (RA) (Chap.\n\nrheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals\n\nextends across large segments of the MHC region, it is quite possible that combinations of genes may account for the particular associations of HLA haplotypes with disease. For example, on some haplotypes associated with rheumatoid arthritis, both HLA-DRB1 alleles and a particular polymorphism"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 rheumatoid arthritis symptoms", "log": "The association of HLA-DR4 with rheumatoid arthritis has been confirmed, which aligns with the patient's symptoms of symmetric joint pain and swelling. This suggests that the patient's condition is likely characterized by HLA-DR4.\n\nAction: search_docs \nAction Input: \"HLA-DR4 rheumatoid arthritis symptoms\" ", "type": "AgentAction"}}, "rheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals\n\nRheumatoid Arthritis The HLA genes associated with rheumatoid arthritis (RA) (Chap.\n\nabsence in some patients with rheumatoid arthritis, suggested that more complex mechanisms orchestrate this pathology. The discovery that RA has an association with particular class II HLA-DR genes of the MHC suggested that T cells are also involved in the pathogenesis of this disease. In RA, as in"]]},"24": {"question": "A 34-year-old man presents to a clinic with complaints of abdominal discomfort and blood in the urine for 2 days. He has had similar abdominal discomfort during the past 5 years, although he does not remember passing blood in the urine. He has had hypertension for the past 2 years, for which he has been prescribed medication. There is no history of weight loss, skin rashes, joint pain, vomiting, change in bowel habits, and smoking. On physical examination, there are ballotable flank masses bilaterally. The bowel sounds are normal. Renal function tests are as follows:\nUrea 50 mg/dL\nCreatinine 1.4 mg/dL\nProtein Negative\nRBC Numerous\nThe patient underwent ultrasonography of the abdomen, which revealed enlarged kidneys and multiple anechoic cysts with well-defined walls. A CT scan confirmed the presence of multiple cysts in the kidneys. What is the most likely diagnosis?", "options": {"A": "Autosomal dominant polycystic kidney disease (ADPKD)", "B": "Autosomal recessive polycystic kidney disease (ARPKD)", "C": "Medullary cystic disease", "D": "Acquired cystic kidney disease"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis' \n", "log": "The patient presents with abdominal discomfort, blood in the urine, and imaging findings of enlarged kidneys with multiple cysts. Given the age of the patient and the presence of bilateral flank masses, the most likely diagnosis is related to polycystic kidney disease. I need to determine which type of polycystic kidney disease is most consistent with the clinical presentation and imaging findings.\n\nAction: search_docs \nAction Input: 'Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis' \n", "type": "AgentAction"}}, "C. Autosomal Dominant Polycystic Kidney Disease\n\nAuTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Etiology and Pathogenesis (Fig. 339-1) ADPKD is characterized by progressive formation of epithelial-lined cysts in the kidney. Although cysts only occur in 5% of the tubules in the kidney, the enormous growth of these cysts ultimately leads to the loss\n\nAutosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, occurring in about 1 in 1000 people. Approximately 12.5 million people worldwide have ADPKD, which is caused primarily by mutations in PKD1 (85%\u201390% of cases) or PKD2 (\u224815% of cases). The major"]]},"25": {"question": "A 40-year-old woman comes to the physician because of a 2-week history of anal pain that occurs during defecation and lasts for several hours. She reports that she often strains during defecation and sees bright red blood on toilet paper after wiping. She typically has 3 bowel movements per week. Physical examination shows a longitudinal, perianal tear. This patient's symptoms are most likely caused by tissue injury in which of the following locations?", "options": {"A": "Posterior midline of the anal canal, distal to the pectinate line", "B": "Anterior midline of the anal canal, distal to the pectinate line", "C": "Posterior midline of the anal canal, proximal to the pectinate line", "D": "Lateral aspect of the anal canal, distal to the pectinate line"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anal fissure location posterior midline anal canal", "log": "I need to analyze the clinical scenario presented in the question to determine the most likely location of the tissue injury causing the patient's symptoms. The key details include anal pain during defecation, bright red blood on toilet paper, and a longitudinal perianal tear, along with the patient's bowel habits. \n\nAction: search_docs \nAction Input: \"anal fissure location posterior midline anal canal\" ", "type": "AgentAction"}}, "Anal fissure\u2014tear in anal mucosa below Pectinate line. Pain while Pooping; blood on toilet Paper. Located Posteriorly because this area is Poorly Perfused. Innervated by Pudendal nerve. Associated with low-fiber diets and constipation.\n\nwith hemorrhoids. On examination, most fissures are located in either the posterior or anterior position. A lateral fissure is worrisome because it may have a less benign nature, and systemic disorders should be ruled out. A chronic fissure is indicated by the presence of a hypertrophied anal\n\ncycle of pain, spasm, and ischemia contributes to development of a poorly healing wound that becomes a chronic fissure. The vast major-ity of anal fissures occur in the posterior midline. Ten percent to 15% occur in the anterior midline. Less than 1% of fissures occur off midline.Symptoms and"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "Based on this information, I will analyze the provided options to determine which one aligns with the findings from the search.", "tool_input": "None needed; I'll evaluate the options directly.\n", "log": "The search results indicate that the majority of anal fissures occur in the posterior midline of the anal canal, particularly distal to the pectinate line, which correlates with the symptoms described in the clinical scenario. The patient's history of straining during defecation, along with the presence of bright red blood and a longitudinal tear, suggests a typical presentation of an anal fissure. \n\nAction: Based on this information, I will analyze the provided options to determine which one aligns with the findings from the search. \n\nAction Input: None needed; I'll evaluate the options directly.\n", "type": "AgentAction"}}, "Based on this information, I will analyze the provided options to determine which one aligns with the findings from the search. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "_Exception", "tool_input": "Invalid Format: Missing 'Action Input:' after 'Action:'", "log": "I need to evaluate the options based on the information I gathered from the search results. \n\nAction: None needed; I'm ready to select the answer.\n", "type": "AgentAction"}}, "Invalid Format: Missing 'Action Input:' after 'Action:'"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "None needed; I'm ready to select the answer.", "tool_input": "None\n", "log": "I need to evaluate the options based on the information I gathered from the search results. \n\nAction: None needed; I'm ready to select the answer.\n\nAction Input: None\n", "type": "AgentAction"}}, "None needed; I'm ready to select the answer. is not a valid tool, try one of [search_docs]."]]},"26": {"question": "A 40-year-old G1P0010 presents to the clinic with nausea and vomiting 8 weeks after a spontaneous abortion at 10 weeks gestation. She admits to heavy drinking (7\u20138 glasses of wine per day) for the last 20 years; however, after the pregnancy loss, she increased her drinking to 8\u20139 glasses per day. Hepatomegaly, right upper quadrant pain, and jaundice are noted on abdominal examination. The lungs are clear to auscultation with no abnormalities on chest X-ray. Liver function tests are obtained and a biopsy is performed. Which of the following findings is most likely to be true in her condition?", "options": {"A": "\u2191 NADH/NAD+; AST:ALT \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2191; lactic acid \u2191", "B": "\u2191 NAD+/NADH; ALT:AST \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate, no change; lactic acid \u2193", "C": "\u2191 NAD+/NADH; AST:ALT \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate \u2193; lactic acid \u2193", "D": "\u2191 NADH/NAD+; ALT:AST \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2193; lactic acid \u2191"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "alcoholic liver disease laboratory findings", "log": "To determine the most likely findings in this patient's condition, I need to analyze the clinical context, particularly regarding her heavy alcohol consumption and the resulting liver damage. Alcoholic liver disease typically presents with specific laboratory findings, which I can compare with the options provided.\n\nAction: search_docs  \nAction Input: \"alcoholic liver disease laboratory findings\"  ", "type": "AgentAction"}}, "Patients with alcoholic liver disease are often identified through routine screening tests. The typical laboratory abnormalities seen in fatty liver are nonspecific and include modest elevations of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and \u03b3-glutamyl transpeptidase\n\ndiseases  (Table 31-3). In the diagnosis of alcoholic liver disease, docu-mentation of chronic alcohol abuse is imperative. Liver biopsy will reveal the typical findings of alcoholic hepatitis, including hepatocyte necrosis, Mallory bodies, neutrophil infiltration, and perivenular\n\nLaboratory tests may be completely normal in patients with early compensated alcoholic cirrhosis. Alternatively, in advanced liver disease, many abnormalities usually are present. Patients may be anemic either from chronic GI blood loss, nutritional deficiencies, or hypersplenism related to portal"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "alcoholic liver disease laboratory findings AST ALT NADH lactic acid", "log": "The information gathered indicates that alcoholic liver disease is characterized by specific laboratory findings, including elevated AST and ALT levels, with a typical AST:ALT ratio of \u2265 2:1. The presence of elevated NADH/NAD+ ratio and increased lactic acid levels are also common in this condition. I need to evaluate the options against this context.\n\nAction: search_docs  \nAction Input: \"alcoholic liver disease laboratory findings AST ALT NADH lactic acid\"  ", "type": "AgentAction"}}, "Patients with alcoholic liver disease are often identified through routine screening tests. The typical laboratory abnormalities seen in fatty liver are nonspecific and include modest elevations of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and \u03b3-glutamyl transpeptidase\n\nas NADH. The excess NADH production appears to contribute to the metabolic disorders that accompany chronic alcoholism and to both the lactic acidosis and hypoglycemia that frequently accompany acute alcohol poisoning.\n\n(AST), alanine aminotransferase (ALT), aldolase, and lactic dehydrogenase (LDH) are enzymes sharing an origin in both muscle and liver. Problems arise when the levels of these enzymes are found to be elevated in a routine screening battery, leading to the erroneous assumption that liver disease is"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "_Exception", "tool_input": "Invalid Format: Missing 'Action Input:' after 'Action:'", "log": "The gathered information reinforces that in alcoholic liver disease, the AST:ALT ratio is typically \u2265 2:1, and there is an elevation in the NADH/NAD+ ratio, leading to metabolic disturbances such as lactic acidosis. The increased NADH can also result in decreased \u03b2-oxidation and alterations in other metabolic pathways. I will now analyze the provided options in light of this information.\n\nAction: None needed, as I can evaluate the options based on the established findings.  ", "type": "AgentAction"}}, "Invalid Format: Missing 'Action Input:' after 'Action:'"]]},"27": {"question": "A 24-year-old professional athlete is advised to train in the mountains to enhance his performance. After 5 months of training at an altitude of 1.5 km (5,000 feet), he is able to increase his running pace while competing at sea-level venues. Which of the following changes would produce the same effect on the oxygen-hemoglobin dissociation curve as this athlete's training did?", "options": {"A": "Decreased pH", "B": "Decreased temperature", "C": "Decreased 2,3-bisphosphoglycerate", "D": "Increased partial pressure of oxygen"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "oxygen-hemoglobin dissociation curve changes altitude training", "log": "I need to determine which option would produce a similar effect on the oxygen-hemoglobin dissociation curve as training at high altitude. Training at altitude typically results in increased efficiency of oxygen utilization, which can be related to shifts in the dissociation curve. \n\nAction: search_docs  \nAction Input: \"oxygen-hemoglobin dissociation curve changes altitude training\"  ", "type": "AgentAction"}}, "part of the curve), shifts in the oxyhemoglobin dissociation curve can dramatically influence O2 transport.\n\nhypoxia during exercise are independent predictors of severe altitude illness. However, because there may be overlap between groups of susceptible and nonsusceptible individuals, accurate cutoff values are hard to define. Prediction is made more difficult because the pretest probabilities of HAPE\n\nb. Significance of the sigmoidal oxygen-dissociation curve: The steep slope of the oxygen-dissociation curve over the range of oxygen concentrations that occur between the lungs and the tissues permits hemoglobin to carry and deliver O2 efficiently from sites of high to sites of low pO2. A molecule"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "effects of altitude training on oxygen-hemoglobin dissociation curve", "log": "The search results did not provide a clear answer about how altitude training affects the oxygen-hemoglobin dissociation curve. I need to think about the physiological changes that occur with altitude training and how they relate to the options provided.\n\nAction: search_docs  \nAction Input: \"effects of altitude training on oxygen-hemoglobin dissociation curve\"  ", "type": "AgentAction"}}, "hypoxia during exercise are independent predictors of severe altitude illness. However, because there may be overlap between groups of susceptible and nonsusceptible individuals, accurate cutoff values are hard to define. Prediction is made more difficult because the pretest probabilities of HAPE\n\nO2\u2013hemoglobin dissociation curve account for some of the compensatory response to anemia. With chronic anemia, intracellular levels of 2,3-bisphosphoglycerate rise, shifting the dissociation curve to the right and facilitating O2 unloading. This compensatory mechanism can only maintain normal\n\nMajority of blood CO2 is carried as HCO3 \u2212 in the plasma.\n\nResponse to high altitude sickness. Chronic \u008f in ventilation.\n\nerythropoietin \u008e\u008f Hct and Hb (due to chronic hypoxia).\n\n2,3-BPG (binds to Hb causing rightward shift of the ODC so that Hb releases more O2). Cellular changes (\u008f mitochondria)."]]},"28": {"question": "A 35-year-old man presents to pulmonary function clinic for preoperative evaluation for a right pneumonectomy. His arterial blood gas at room air is as follows:\n\npH: 7.34\nPaCO2: 68 mmHg\nPaO2: 56 mmHg\nBase excess: +1\nO2 saturation: 89%\n\nWhat underlying condition most likely explains these findings?", "options": {"A": "Acute respiratory distress syndrome", "B": "Chronic obstructive pulmonary disease", "C": "Cystic fibrosis", "D": "Obesity"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "underlying condition for ABG respiratory acidosis with hypoxemia\"  \n", "log": "I need to analyze the arterial blood gas (ABG) results to determine the underlying condition that best explains the patient's findings. The patient has a low pH (7.34), elevated PaCO2 (68 mmHg), low PaO2 (56 mmHg), and a base excess of +1. This indicates respiratory acidosis with hypoxemia.\n\nAction: search_docs  \nAction Input: \"underlying condition for ABG respiratory acidosis with hypoxemia\"  \n", "type": "AgentAction"}}, "Metabolic acidosis, defined as a reduced pH (<7.25) and bicarbonate concentration (<18 mEq/L) accompanied by a normal or low Pco2 level, may be caused by hypoxia or by insufficient tissue perfusion. The origin of the disorder may be pulmonary, cardiac, infectious, renal, hematologic, nutritional,\n\nthat is exhaled. Respiratory acidosis will result from carbon dioxide retention in patients who have hypoventilation from central nervous system depression. This condition can result from oversedation with narcotics, particularly in the presence of concurrent severe chronic obstructive pulmonary\n\nRespiratory acidosis can be due to severe pulmonary disease, respiratory muscle fatigue, or abnormalities in ventilatory control and is recognized by an increase in Paco2 and decrease in pH (Table 66-7). In acute respiratory acidosis, there is an immediate compensatory elevation (due to cellular"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "chronic obstructive pulmonary disease and respiratory acidosis\"  \n", "log": "The observation provides information about respiratory acidosis and its causes, including severe pulmonary disease and chronic obstructive pulmonary disease (COPD). The patient's ABG results indicate respiratory acidosis with hypoxemia, which aligns with COPD. \n\nAction: search_docs  \nAction Input: \"chronic obstructive pulmonary disease and respiratory acidosis\"  \n", "type": "AgentAction"}}, "Chronic obstructive pulmonary disease such as emphysema, fibrosing lung disease, neuromuscular weakness, and, in some instances, inadequacy of the medullary respiratory centers each may lead to persistent respiratory acidosis, with elevated Pco2 and reduced arterial Po2. The complete clinical\n\nChronic obstructive pulmonary disease\n\nchronic obstructive pulmonary disease. Respiratory alkalosis can result from hyperventilation caused by excitation of the central nervous system by drugs, pain, or excess ventilator support. Numerous metabolic derangements can result in metabolic alkalosis or acidosis. Proper \ufb02uid and electrolyte"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "common causes of respiratory acidosis in young adults\"  \n", "log": "The observation confirms that chronic obstructive pulmonary disease (COPD) can lead to persistent respiratory acidosis, which aligns with the patient's ABG results showing elevated PaCO2 and reduced PaO2. Given the patient's age and the context of the case, COPD is a likely underlying condition.\n\nAction: search_docs  \nAction Input: \"common causes of respiratory acidosis in young adults\"  \n", "type": "AgentAction"}}, "Respiratory acidosis, defined as an elevated Pco2 level and reduced pH without a reduction in the bicarbonate concentration, may be caused by pulmonary insufficiency or central hypoventilation. Most disorders producing respiratory distress can lead to hypercapnia. Treatment involves assisted\n\nDuring a respiratory acidosis, there is a decrease in the effectiveness of CO2 removal by the lungs. The causes of a respiratory acidosis are either pulmonary or nonpulmonary (Table 37-4). A respiratory alkalosis is an inappropriate reduction in the blood CO2 concentration. A variety of stimuli can\n\nthe diagnosis, because it is increased in metabolic alkalosis and decreased or normal in respiratory acidosis. Metabolic alkalosis frequently occurs in association with other disorders such as respiratory acidosis or alkalosis or metabolic acidosis."]]},"29": {"question": "A 48-year old man comes to the physician for the evaluation of an 8-month history of fatigue and profuse, watery, odorless diarrhea. He reports that he has had a 10.5-kg (23-lb) weight loss during this time. Physical examination shows conjunctival pallor and poor skin turgor. Laboratory studies show:\nHemoglobin 9.8 g/dl\nSerum\nGlucose (fasting) 130 mg/dl\nK+ 2.5 mEq/L\nCa2+ 12 mg/dl\nA CT scan of the abdomen with contrast shows a 3.0 \u00d7 3.2 \u00d7 4.4 cm, well-defined, enhancing lesion in the pancreatic tail. Further evaluation of this patient is most likely to show which of the following findings?\"", "options": {"A": "Achlorhydria", "B": "Cholelithiasis", "C": "Deep vein thrombosis", "D": "Episodic hypertension"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "pancreatic neuroendocrine tumor VIPoma findings\" \n", "log": "The clinical presentation of the patient, including diarrhea, weight loss, and electrolyte imbalances (notably hypokalemia), suggests a possible neuroendocrine tumor of the pancreas, such as a VIPoma, which can cause profuse watery diarrhea and hypokalemia. Given the presence of a well-defined lesion in the pancreatic tail, it is important to consider what further evaluation might reveal.\n\nAction: search_docs\nAction Input: \"pancreatic neuroendocrine tumor VIPoma findings\" \n", "type": "AgentAction"}}, "abnormalities should raise suspicion of the diagnosis. Serum VIP levels must be measured on multiple occasions because the excess secretion of VIP is episodic and single measurements might be normal and misleading. A CT scan localizes most VIPomas, although as with all islet cell tumors, EUS is the\n\nAbbreviations: del, deletion; ins, insertion; MTC, medullary thyroid cancer; NET, neuroendocrine tumor; PPoma, pancreatic polypeptide\u2013secreting tumor; VIPoma, vasoactive intestinal polypeptide\u2013secreting tumor.\n\nSource: Reproduced from RV Thakker et al: J Clin Endocrinol Metab 97:2990, 2012.\n\nvasoactive intestinal polypeptide [VIP]) and are associated with distinct clinical syndromes, although some are nonfunctioning or non-secretory. These pancreatic islet cell tumors have an earlier age at onset in patients with MEN 1 than in patients without MEN 1."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "VIPoma associated findings diagnosis\"  \n", "log": "The information gathered indicates that VIPomas can cause symptoms such as profuse watery diarrhea and hypokalemia due to increased secretion of vasoactive intestinal peptide (VIP). The next logical step is to determine what specific findings are associated with VIPoma or pancreatic neuroendocrine tumors in general, particularly in relation to the options provided.\n\nAction: search_docs  \nAction Input: \"VIPoma associated findings diagnosis\"  \n", "type": "AgentAction"}}, "abnormalities should raise suspicion of the diagnosis. Serum VIP levels must be measured on multiple occasions because the excess secretion of VIP is episodic and single measurements might be normal and misleading. A CT scan localizes most VIPomas, although as with all islet cell tumors, EUS is the\n\nVasoactive Intestinal Peptide (VIP) Tumors (VIPomas) VIPomas have been reported in only a few patients with MEN 1. This clinical syndrome is characterized by watery diarrhea, hypokalemia, and achlorhydria and is also referred to as the Verner-Morrison syndrome, the WDHA (watery diarrhea,\n\nDiagnosis The diagnosis requires the demonstration of an elevated plasma VIP level and the presence of large-volume diarrhea. A stool volume <700 mL/d is proposed to exclude the diagnosis of VIPoma. When the patient fasts, a number of diseases can be excluded that can cause marked diarrhea because"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "None", "tool_input": "N/A", "log": "The information gathered confirms that VIPomas are associated with a clinical syndrome that includes watery diarrhea, hypokalemia, and achlorhydria. Given the options provided, achlorhydria is a specific finding that aligns with the expected presentation of a VIPoma. The next step is to finalize the answer based on this information.\n\nAction: None  \nAction Input: N/A  ", "type": "AgentAction"}}, "None is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "VIPoma clinical findings achlorhydria\"  \n", "log": "Since I need to confirm the findings associated with VIPoma and the specific options provided, I will perform another search to gather more information.\n\nAction: search_docs  \nAction Input: \"VIPoma clinical findings achlorhydria\"  \n", "type": "AgentAction"}}, "Vasoactive Intestinal Peptide (VIP) Tumors (VIPomas) VIPomas have been reported in only a few patients with MEN 1. This clinical syndrome is characterized by watery diarrhea, hypokalemia, and achlorhydria and is also referred to as the Verner-Morrison syndrome, the WDHA (watery diarrhea,\n\nD. Somatostatinomas present as achlorhydria (due to inhibition of gastrin) and cholelithiasis with steatorrhea (due to inhibition of cholecystokinin).\n\nE. VIPomas secrete excessive vasoactive intestinal peptide leading to watery diarrhea, hypokalemia, and achlorhydria.\n\nI. BASIC PRINCIPLES\n\nthe WDHA (watery diarrhea, hypokalemia, and achlorhydria) syndrome, or the VIPoma syndrome. The diagnosis is established by excluding laxative and diuretic abuse, by confirming a stool volume in excess of 0.5\u20131.0 L/d during a fast, and by documenting a markedly increased plasma VIP concentration."]]},"30": {"question": "A 74-year-old man presents to the emergency department with sudden-onset abdominal pain that is most painful around the umbilicus. The pain began 16 hours ago and has no association with meals. He has not been vomiting, but he has had several episodes of bloody loose bowel movements. He was hospitalized 1 week ago for an acute myocardial infarction. He has had diabetes mellitus for 35 years and hypertension for 20 years. He has smoked 15\u201320 cigarettes per day for the past 40 years. His temperature is 36.9\u00b0C (98.42\u00b0F), blood pressure is 95/65 mm Hg, and pulse is 95/min. On physical examination, the patient is in severe pain, there is mild periumbilical tenderness, and a bruit is heard over the epigastric area. Which of the following is the definitive test to assess the patient condition?", "options": {"A": "Mesenteric angiography", "B": "CT scanning", "C": "Plain abdominal X-rays", "D": "Colonoscopy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "definitive test for mesenteric ischemia", "log": "To determine the definitive test for this patient's condition, I need to consider the symptoms and clinical background presented. The patient's sudden-onset abdominal pain, bloody loose bowel movements, and history of cardiovascular issues suggest a possible vascular problem, such as mesenteric ischemia. Mesenteric angiography is the gold standard for diagnosing this condition. However, CT scanning is also commonly used in practice for its rapidity and ability to visualize other potential causes of abdominal pain. \n\nAction: search_docs  \nAction Input: \"definitive test for mesenteric ischemia\"  ", "type": "AgentAction"}}, "during the test. This tool is frequently used as a screening test for patients with symptoms suggestive of chronic mesenteric ischemia. The gold standard for confirmation of mesenteric arterial occlusion is mesenteric angiography. Evaluation with mesenteric angiography allows for identification and\n\nvalue of mesenteric ischemia. More significantly, a negative duplex scan virtually precludes the diagnosis of mesenteric ischemia. Duplex imaging serves as a screening test; further investigations with angiography are needed. The biggest limitation of duplex scanning is body habitus; in obese\n\nF. Surgical management of mesenteric ischemia. Tech Vasc Interv Radiol. 2004;7(3):151-154.\t90.\tMitchell EL, Moneta GL. Mesenteric duplex scanning. Per-spect Vasc Surg Endovasc Ther. 2006;18(2):175-183.\t91.\tMoneta GL, Lee RW, Yeager RA, Taylor LM Jr, Porter JM. Mesenteric duplex scanning: a blinded"]]},"31": {"question": "An investigator is studying the principles of cell-to-cell signaling of the autonomic nervous system. It is found that the adrenal medulla has receptors that, when activated, result in the immediate opening of Na+, Ca2+, and K+ channels, which subsequently leads to the secretion of epinephrine and norepinephrine. These receptors are structurally most similar to which of the following receptors?", "options": {"A": "H2 receptors of the stomach", "B": "M2 receptors of heart", "C": "D2 receptors of the basal ganglia", "D": "NM receptors of the quadriceps femoris muscle"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptors similarity H2 M2 D2 NM receptors", "log": "I need to identify which type of receptor is structurally most similar to the receptors in the adrenal medulla that are involved in the secretion of epinephrine and norepinephrine. This requires some background knowledge on receptor types and their characteristics.\n\nAction: search_docs  \nAction Input: \"adrenal medulla receptors similarity H2 M2 D2 NM receptors\"  ", "type": "AgentAction"}}, "which is called the adrenal medulla (see\n\nMedulla, adrenal gland, human, H&E \u00d7125.\n\nThe endocrine cells of the adrenal medulla are similar in many ways to sympathetic postganglionic neurons (see also ). They receive input from sympathetic preganglionic neurons, are excited by acetylcholine, and release catecholamines. However, the cells of the adrenal medulla differ from"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptor types structural similarity H2 M2 D2 NM", "log": "I need to refine my search to find specific information about the structural similarities between the receptors in the adrenal medulla and the listed receptor types (H2, M2, D2, NM). \n\nAction: search_docs  \nAction Input: \"adrenal medulla receptor types structural similarity H2 M2 D2 NM\"  ", "type": "AgentAction"}}, "which is called the adrenal medulla (see\n\nMedulla, adrenal gland, human, H&E \u00d7125.\n\nand the adrenal medulla (see Chapter 6)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "structural characteristics of H2 M2 D2 NM receptors", "log": "It seems that the previous searches did not yield specific information regarding the structural similarities between the receptors in the adrenal medulla and the options provided. I need to be more focused on the receptor types and their structural characteristics.\n\nAction: search_docs  \nAction Input: \"structural characteristics of H2 M2 D2 NM receptors\"  ", "type": "AgentAction"}}, "and H2 receptors, and several other receptor systems.\n\nreceptors within these groups (see Chapter 2).\n\nreceptors?"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptors catecholamines structural similarity with other receptors", "log": "The observations are still not providing clear information on the structural similarities between the adrenal medulla receptors and the receptor types in the options. I need to focus on the specific characteristics of the receptors related to the autonomic nervous system and their structural classifications.\n\nAction: search_docs  \nAction Input: \"adrenal medulla receptors catecholamines structural similarity with other receptors\"  ", "type": "AgentAction"}}, "The endocrine cells of the adrenal medulla are similar in many ways to sympathetic postganglionic neurons (see also ). They receive input from sympathetic preganglionic neurons, are excited by acetylcholine, and release catecholamines. However, the cells of the adrenal medulla differ from\n\nadrenal medulla differ from sympathetic postganglionic neurons in that they release catecholamines into the circulation rather than into a synapse. Moreover, the main catecholamine released is epinephrine, not norepinephrine. In humans, 80% of the catecholamine released by the adrenal medulla is\n\nwhich is called the adrenal medulla (see"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptors catecholamines comparison with H2 M2 D2 NM receptors", "log": "The searches have not provided specific structural similarities between the adrenal medulla receptors and the receptor types in the options. I need to focus on the known characteristics of the receptors involved in the autonomic nervous system, particularly those that lead to the secretion of catecholamines.\n\nAction: search_docs  \nAction Input: \"adrenal medulla receptors catecholamines comparison with H2 M2 D2 NM receptors\"  ", "type": "AgentAction"}}, "adrenal medulla differ from sympathetic postganglionic neurons in that they release catecholamines into the circulation rather than into a synapse. Moreover, the main catecholamine released is epinephrine, not norepinephrine. In humans, 80% of the catecholamine released by the adrenal medulla is\n\nthe adrenal medulla is less important than norepinephrine release from sympathetic nerve endings.\n\nby the adrenal medulla is epinephrine, and 20% is norepinephrine."]]},"32": {"question": "A 27-year-old G1P0 presents to her obstetrician for her normal 30-week obstetric appointment. She reports that she feels well and has no complaints. Her past medical history is notable for intermittent asthma. Her only medications are prenatal vitamins. She has gained 10 pounds, more than expected given her current stage of pregnancy. Abdominal ultrasound reveals the presence of twins with separate amniotic sacs that share a common chorion and placenta. During which time interval following fertilization did the morula divide into two in this mother?", "options": {"A": "Days 4-8", "B": "Days 9-12", "C": "Days 13-15", "D": "Day 16+"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "morula division time interval following fertilization twins", "log": "To determine the time interval following fertilization when the morula divides into two, I need to recall the stages of embryonic development. The morula is formed around 3-4 days post-fertilization, and if it divides into two embryos, this typically occurs before implantation. The division into two separate entities is indicative of a monozygotic (identical) twin formation, which occurs during the early stages after fertilization.\n\nAction: search_docs  \nAction Input: \"morula division time interval following fertilization twins\"  ", "type": "AgentAction"}}, "Rayburn WF, Lavin]P Jr, Miodovnik M, et al: Multiple gestation: time interval between delivery of the irst and second twins. Obstet Gynecol 63:502, 1984\n\nThe outcome of the monozygotic twinning process depends on when division oCCuts. If zygotes divide within the irst 72 hours after fertilization, two embryos, two amnions, and two chorions develop, and a diamnionic, dichorionic twin pregnancy evolves (Fig. 45-1). Two distinct placentas or a single,\n\nStein W, Misselwitz B, Schmidt 5: Twin-to-twin delivery time interval: influencing factors and efect on short term outcome of the second twin. Acta Obstet Gynecol Scand 87(3):346, 2008"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "time interval morula divides twins embryonic development", "log": "The observation indicates that the division of the zygote into two embryos occurs within the first 72 hours after fertilization for diamniotic, dichorionic twins. This suggests that the morula division into two typically happens around Days 4-8 post-fertilization. \n\nAction: search_docs  \nAction Input: \"time interval morula divides twins embryonic development\"  ", "type": "AgentAction"}}, "the variation we see in the tempo of developmental events.\n\nThe outcome of the monozygotic twinning process depends on when division oCCuts. If zygotes divide within the irst 72 hours after fertilization, two embryos, two amnions, and two chorions develop, and a diamnionic, dichorionic twin pregnancy evolves (Fig. 45-1). Two distinct placentas or a single,\n\nFIGURE 45-1 Mechanism of monozygotic twinning. Black boxing and blue arrows in columns A, B, and C indicates timing of division."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "morula twin division timeline embryonic development", "log": "The observation reinforces that the division of the zygote into two embryos occurs within the first 72 hours after fertilization, leading to diamniotic, dichorionic twins. This aligns with the time frame of Days 4-8 post-fertilization for the morula to divide into two. \n\nAction: search_docs  \nAction Input: \"morula twin division timeline embryonic development\"  ", "type": "AgentAction"}}, "placentas or a single, fused placenta may develop. If division occurs between the fourth and eighth day, a diamnionic, monochorionic twin pregnancy results. By approximately 8 days after fertilization, the chorion and the amnion have already diferentiated, and division results in two embryos within\n\nThe outcome of the monozygotic twinning process depends on when division oCCuts. If zygotes divide within the irst 72 hours after fertilization, two embryos, two amnions, and two chorions develop, and a diamnionic, dichorionic twin pregnancy evolves (Fig. 45-1). Two distinct placentas or a single,\n\nFIGURE 5-7 Zygote cleavage and blastocyst formation. The morula period begins at the 12-to 16-cell stage and ends when the blastocyst forms, which occurs when there are 50 to 60 blastomeres present. The polar bodies, shown in the 2-cell stage, are small nonfunctional cells that soon degenerate."]]},"33": {"question": "A 72-year-old man is brought to the emergency department with increasing fever and abdominal pain over the past week. The pain is constant and limited to the lower right part of his abdomen. He has nausea but no vomiting or diarrhea. His past medical history is unremarkable for any serious illnesses. He takes acetaminophen for knee arthritis. He is fully alert and oriented. His temperature is 39.5\u00b0C (103.1\u00b0F), pulse is 89/min, respirations are 15/min, and blood pressure is 135/70 mm Hg. Abdominal examination shows a tender mass in the right lower quadrant. CT shows obstruction of the appendiceal neck with a fecalith and the appendiceal tip leading to an irregular walled-off fluid collection. Stranding of the surrounding fat planes is also noted. Intravenous hydration is initiated. Which of the following is the most appropriate next step in management?", "options": {"A": "Antibiotics + CT-guided drainage", "B": "Antibiotics + interval appendectomy", "C": "Appendectomy within 12 hours", "D": "Early surgical drainage + interval appendectomy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of appendicitis with obstruction and fluid collection\" \n", "log": "I need to determine the most appropriate management step for a patient with appendiceal obstruction and a walled-off fluid collection. Given the clinical scenario and the options provided, it is important to consider the current approach to treating complicated appendicitis, which often involves antibiotics and possibly drainage before any surgical intervention.\n\nAction: search_docs\nAction Input: \"management of appendicitis with obstruction and fluid collection\" \n", "type": "AgentAction"}}, "All patients should be fully prepared for surgery and have any fluid and electrolyte abnormalities corrected. Either laparoscopic or open appendectomy is a satisfactory choice for patients with uncomplicated appendicitis. Management of those who present with a mass representing a phlegmon or\n\nmanagement of appendicitis, except in patients with significant phobia of surgery.30 Societal costs and long-term implications of the conservative strategy have not yet been completely evaluated.Timing of Surgery.\u2002Emergent surgery is often performed in patients with appendicitis, but studies have\n\nTreatment of appendicitis is surgical. Simple appendectomy iscurative if performed before perforation. With perforation, a course of postoperative IV antibiotics is required. Broad-spectrumcoverage is necessary to cover the mixed bowel flora."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "complicated appendicitis management guidelines\" \n", "log": "The information retrieved discusses the management of appendicitis, emphasizing that treatment is generally surgical, especially in uncomplicated cases. However, it also hints at the complexity involved when there is an obstruction or fluid collection, suggesting that antibiotics and possibly drainage may be necessary before surgery. I need to focus on the specific management of complicated appendicitis, particularly with the presence of a walled-off fluid collection.\n\nAction: search_docs\nAction Input: \"complicated appendicitis management guidelines\" \n", "type": "AgentAction"}}, "who recurred presented more frequently with complicated appen-dicitis (RR 2.52, 95% CI 1.17\u20135.43, P = 0.02).28,29 Currently, conservative management can be offered to informed patients using techniques of shared decision-making, but it is not the standard modality of management of appendicitis,\n\nmanagement of appendicitis, except in patients with significant phobia of surgery.30 Societal costs and long-term implications of the conservative strategy have not yet been completely evaluated.Timing of Surgery.\u2002Emergent surgery is often performed in patients with appendicitis, but studies have\n\n2001;101(5):243-245.\t58.\tWang HT, Sax HC. Incidental appendectomy in the era of managed care and laparoscopy. J Am Coll Surg. 2001;192(2): 182-188.\t59.\tFisher KS, Ross DS. Guidelines for therapeutic deci-sion in incidental appendectomy. Surg Gynecol Obstet. 1990;171(1):95-98.\t60.\tScholer SJ, Pituch"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appendicitis with abscess management guidelines\" \n", "log": "The retrieved information is still not specific enough regarding the management of complicated appendicitis with a walled-off fluid collection. I need to refine my search further to find more targeted guidelines or recommendations for this particular scenario.\n\nAction: search_docs\nAction Input: \"appendicitis with abscess management guidelines\" \n", "type": "AgentAction"}}, "versus initial nonoperative management Brunicardi_Ch30_p1331-p1344.indd   134101/03/19   7:05 PM 1342SPECIFIC CONSIDERATIONSPART\u2008IIand interval appendectomy for perforated appendicitis with abscess: a prospective, randomized trial. J Pediatr Surg. 2010;45(1):236-240.\t44.\tDixon MR, Haukoos JS, Park\n\nAbscess: Treat with broad-spectrum antibiotics and percutaneous drainage; an elective appendectomy should be performed 6\u20138 weeks later.\n\nor conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "current guidelines for treating appendicitis with abscess\" \n", "log": "The information retrieved indicates that the management of appendiceal abscess typically involves broad-spectrum antibiotics and percutaneous drainage, followed by an elective appendectomy after a period of 6\u20138 weeks. This aligns with the complexities of treating a patient with a walled-off fluid collection due to appendiceal obstruction. \n\nGiven this, I need to analyze the options provided in the context of this information.\n\nAction: search_docs\nAction Input: \"current guidelines for treating appendicitis with abscess\" \n", "type": "AgentAction"}}, "Abscess: Treat with broad-spectrum antibiotics and percutaneous drainage; an elective appendectomy should be performed 6\u20138 weeks later.\n\nor conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15,\n\nTreatment of appendicitis is surgical. Simple appendectomy iscurative if performed before perforation. With perforation, a course of postoperative IV antibiotics is required. Broad-spectrumcoverage is necessary to cover the mixed bowel flora."]]},"34": {"question": "A 29-year-old man comes to the physician because of a 3-month history of fatigue, weight loss, and multiple painless swellings on his neck and axilla. He reports that his swellings become painful after he drinks alcohol. Physical examination shows nontender cervical and axillary lymphadenopathy. A lymph node biopsy specimen shows giant binucleate cells. Which of the following is the most likely diagnosis?", "options": {"A": "Hodgkin lymphoma", "B": "Diffuse large B-cell lymphoma", "C": "Adult T-cell lymphoma", "D": "Acute lymphocytic leukemia"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "giant binucleate cells Hodgkin lymphoma symptoms alcohol pain lymphadenopathy\" \n", "log": "I need to analyze the symptoms and findings presented in the case to determine the most likely diagnosis. The key points include the patient's age, symptoms of fatigue and weight loss, multiple painless swellings in the neck and axilla, and the specific mention that the swellings become painful after drinking alcohol. Additionally, the biopsy shows giant binucleate cells, which are characteristic of a specific condition. \n\nGiven these details, I should consider the options provided and look for any relevant medical literature or guidelines that could help confirm the diagnosis.\n\nAction: search_docs\nAction Input: \"giant binucleate cells Hodgkin lymphoma symptoms alcohol pain lymphadenopathy\" \n", "type": "AgentAction"}}, "The most common clinical presentation of Hodgkin disease is painless, firm lymphadenopathy often confined to one or two lymph node areas, usually the supraclavicular and cervical nodes. Mediastinal lymphadenopathy producing cough or shortness of breath is another frequent initial presentation. The\n\nClinical Features. Hodgkin lymphoma, like NHL, usually manifests as painless lymphadenopathy. Although a definitive distinction from NHL can be made only by\n\nTable 12.9 Clinical Differences Between Hodgkin and Non-Hodgkin Lymphomas\n\nIn more than 70 percent of Hodgkin disease cases, lymph nodes painlessly enlarge at sites above the diaphragm, that is, in the axillary, cervical, or submandibular chains. Approximately one third of patients have symptoms such as fever, night sweats, malaise, weight loss, and pruritus. Diagnosis is"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Hodgkin lymphoma diagnosis symptoms treatment\" \n", "log": "The symptoms and findings align closely with Hodgkin lymphoma, particularly the presence of painless lymphadenopathy that becomes painful after alcohol consumption and the identification of giant binucleate cells in the biopsy. \n\nAction: search_docs\nAction Input: \"Hodgkin lymphoma diagnosis symptoms treatment\" \n", "type": "AgentAction"}}, "radiation therapy is now the recommended approach. The main advance for patients with advanced stage III and IV Hodgkin\u2019s lymphoma came with the development of MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) chemotherapy in the 1960s. This regimen resulted initially in high\n\nWith all of these regimens, over 80% of previously untreated patients with advanced Hodgkin\u2019s lymphoma (stages III and IV) are expected to go into complete remission, with disappearance of all disease-related symptoms and objective evidence of disease. In general, approximately 50\u201360% of all\n\nThe treatment of patients with nodular lymphocyte-predominant Hodgkin\u2019s lymphoma is controversial. Some clinicians favor no treatment and merely close follow-up. In the United States, most physicians will treat localized disease with radiotherapy and disseminated disease with regimens used for"]]},"35": {"question": "A 33-year-old primigravid visits the clinic at the 22 weeks\u2019 gestation with concerns about several episodes of loose watery stool over the past 4 months, which are sometimes mixed with blood. Use of over-the-counter antidiarrheal medications has not been helpful. She also reports having painful ulcers in her mouth for the last 2 months. Pregnancy has been otherwise uncomplicated so far. On physical examination, the blood pressure is 110/60 mm Hg, the pulse rate is 90/min, the respiratory rate is 19/min, and the temperature is 36.6\u00b0C (97.8\u00b0F). There is bilateral conjunctival redness. Abdominal examination shows minimal tenderness but no guarding or rebound tenderness. Fundal height is proportionate to 22 weeks of gestation, and fetal heart sounds are audible. Colonoscopy shows focal areas of inflammation in the ileum, separated by normal mucosa, with rectal sparing. Based on the colonoscopy results, which of the following complications is the patient at risk for?", "options": {"A": "Metastasis to the liver", "B": "Carcinoid syndrome", "C": "Intestinal obstruction", "D": "Paralytic ileus"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "complications of Crohn's disease\"  \n", "log": "The clinical scenario describes a pregnant woman with symptoms suggestive of inflammatory bowel disease (IBD), particularly Crohn's disease, given the colonoscopy findings of focal inflammation in the ileum with rectal sparing. I need to consider the complications associated with Crohn's disease to determine which option is most relevant.\n\nAction: search_docs  \nAction Input: \"complications of Crohn's disease\"  \n", "type": "AgentAction"}}, "intervention. Less common complications that require surgical intervention are acute gastro-intestinal hemorrhage, perforations, and development of cancer.Although surgery for Crohn\u2019s disease is usually planned, an uncommon, but not rare, scenario is the intraoperative dis-covery of inflammation\n\nThe incidence of ocular complications in IBD patients is 1\u201310%. The most common are conjunctivitis, anterior uveitis/iritis, and episcleritis. Uveitis is associated with both UC and Crohn\u2019s colitis, may be found during periods of remission, and may develop in patients following bowel resection.\n\nmanifestation. Many of these complications can be seen with both Crohn\u2019s disease and ulcerative colitis, although they are more prevalent among patients with Crohn\u2019s disease. The most common extraintestinal manifestations are listed in Table 28-7. The clinical severity of some of these"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease intestinal obstruction complications\"  \n", "log": "I need to refine my search to focus specifically on the complications of Crohn's disease, particularly those that could lead to intestinal obstruction, since that is one of the options provided. \n\nAction: search_docs  \nAction Input: \"Crohn's disease intestinal obstruction complications\"  \n", "type": "AgentAction"}}, "Disorders associated with clinical presentations that resemble those of Crohn\u2019s dis-ease include ulcerative colitis, functional bowel disorders such as irritable bowel syndrome, mesenteric ischemia, collagen vascular diseases, carcinoma and lymphoma, diverticular dis-ease, and infectious\n\nare com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is\n\nintervention. Less common complications that require surgical intervention are acute gastro-intestinal hemorrhage, perforations, and development of cancer.Although surgery for Crohn\u2019s disease is usually planned, an uncommon, but not rare, scenario is the intraoperative dis-covery of inflammation"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease complications intestinal obstruction risk\"  \n", "log": "I still need more specific information about complications of Crohn's disease that lead to intestinal obstruction. The previous searches did not provide clear insights into this aspect. \n\nAction: search_docs  \nAction Input: \"Crohn's disease complications intestinal obstruction risk\"  \n", "type": "AgentAction"}}, "are com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is\n\nwith inflammatory bowel disease (especially Crohn\u2019s disease).\n\nintervention. Less common complications that require surgical intervention are acute gastro-intestinal hemorrhage, perforations, and development of cancer.Although surgery for Crohn\u2019s disease is usually planned, an uncommon, but not rare, scenario is the intraoperative dis-covery of inflammation"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease complications strictures intestinal obstruction\"  \n", "log": "The information gathered so far indicates that Crohn's disease can lead to complications such as strictures, which can cause intestinal obstruction. This aligns with one of the options provided in the question. However, I still haven't found a definitive conclusion about the specific risk of intestinal obstruction as a complication in this case.\n\nAction: search_docs  \nAction Input: \"Crohn's disease complications strictures intestinal obstruction\"  \n", "type": "AgentAction"}}, "are com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is\n\nStricturing can occur in the colon in 4\u201316% of patients and produce symptoms of bowel obstruction. If the endoscopist is unable to traverse a stricture in Crohn\u2019s colitis, surgical resection should be considered, especially if the patient has symptoms of chronic obstruction.\n\nFIGURE 351-5 Crohn\u2019s disease of the colon showing thickening of the wall, with stenosis, linear serpiginous ulcers and cobbleston-ing of the mucosa. (Courtesy of Dr. R Odze, Division of Gastrointestinal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital, Boston, Massachusetts; with"]]},"36": {"question": "A 25-year-old woman has dysuria, pyuria, increased frequency of urination, and fever of 1-day duration. She is sexually active. Urine cultures show gram-positive bacteria in clusters that are catalase-positive and coagulase-negative. The patient is started on trimethoprim-sulfamethoxazole. Which of the following characteristics is used to identify the offending organism?", "options": {"A": "Beta hemolysis", "B": "Sensitivity to novobiocin", "C": "Sensitivity to bacitracin", "D": "Resistance to novobiocin"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "coagulase-negative staphylococcus identification characteristics\" \n", "log": "I need to determine which characteristic is used to identify the organism based on the provided clinical information. The patient's symptoms and the urine culture results suggest a urinary tract infection caused by a coagulase-negative staphylococcus, likely Staphylococcus saprophyticus, which is known to be resistant to novobiocin. This information points towards option D, but I should confirm this by searching for more specific details regarding the identification of coagulase-negative staphylococci and their characteristics.\n\nAction: search_docs\nAction Input: \"coagulase-negative staphylococcus identification characteristics\" \n", "type": "AgentAction"}}, "The \u201cother\u201d staphylococci, collectively designated coagulase-negative staphylococci (CoNS), are considerably less virulent than S. aureus but remain important pathogens in infections that are primarily associated with prosthetic devices.\n\nspecies identification. With few exceptions, S. aureus is distinguished from other staphylococcal species by its production of coagulase, a surface enzyme that converts fibrinogen to fibrin. Latex kits that detect both protein A and clumping factor also distinguish S. aureus from most other\n\nsequence-based methods (e.g., 16S rRNA) are being used to identify different staphylococcal species."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Staphylococcus saprophyticus novobiocin resistance characteristic\" \n", "log": "I need to gather more specific information about the identification of coagulase-negative staphylococci, particularly regarding their sensitivity or resistance to novobiocin, as this is crucial for confirming the answer.\n\nAction: search_docs\nAction Input: \"Staphylococcus saprophyticus novobiocin resistance characteristic\" \n", "type": "AgentAction"}}, "of drug that occurs with inhibition of cell wall synthesis. Resistance to gentamicin rapidly emerges in staphylococci during monotherapy owing to selection of permeability mutants. Ribosomal resistance is rare. Among Gram-negative bacteria, resistance is most commonly due to plasmid-encoded\n\nThree types of staphylococcal resistance to vancomycin have 961 emerged. (1) Minimal inhibitory concentration (MIC) \u201ccreep\u201d refers to the incremental increase in vancomycin MICs that has been detected in various geographic areas. Studies suggest that infections due to S. aureus strains with\n\nWe have already observed the accumulation of new or unanticipated modes of resistance from ongoing evolutionary pressure caused by the widespread clinical use of antibiotics. Even with MRSA, perhaps the best-studied case of antibiotic resistance and a model of relative simplicity with a single"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Staphylococcus saprophyticus novobiocin sensitivity resistance\"  \n", "log": "I still need to find specific information about Staphylococcus saprophyticus and its characteristic resistance to novobiocin. This will help confirm whether option D is correct.\n\nAction: search_docs  \nAction Input: \"Staphylococcus saprophyticus novobiocin sensitivity resistance\"  \n", "type": "AgentAction"}}, "Optochin sensitivity Sensitive: S pneumoniae; resistant: viridans streptococci 134 (S\u00a0mutans, S sanguis)\n\nNovobiocin response Sensitive: S epidermidis; resistant: S saprophyticus 134 Bacitracin response Sensitive: S pyogenes (group A); resistant: S agalactiae 134 (group B)\n\nof drug that occurs with inhibition of cell wall synthesis. Resistance to gentamicin rapidly emerges in staphylococci during monotherapy owing to selection of permeability mutants. Ribosomal resistance is rare. Among Gram-negative bacteria, resistance is most commonly due to plasmid-encoded\n\nFor several reasons, the challenge of predicting antibiotic susceptibility from genotype has not yet been met in bacteria to the same degree as in HIV. In general, bacteria have evolved diverse resistance mechanisms to most antibiotics; thus, the task cannot be reduced to probing for a single"]]},"37": {"question": "A 9-year-old boy, otherwise healthy, presents with persistent bleeding following tooth extraction. The patient\u2019s mother states that yesterday, the patient had a tooth extracted that was complicated intraoperatively by persistent bleeding that continued postoperatively. She also says he has had no bleeding issues in the past. The past medical history is unremarkable. The patient is fully immunized and has been meeting all developmental milestones. The vital signs include: temperature 37.0\u00b0C (98.6\u00b0F), blood pressure 101/65 mm Hg, pulse 101/min, respirations 22/min, and oxygen saturation 98% on room air. The physical examination is significant for a wound consistent with the extraction of the second upper right molar, which is slowly oozing blood with no sign of a stable clot. There are no signs of infection. The laboratory findings are significant for the following:\nSodium 141 mEq/L\nPotassium 4.1 mEq/L\nChloride   101 mEq/L\nBicarbonate 25 mEq/L\nBUN 12 mg/dL\nCreatinine 1.0 mg/dL\nGlucose (fasting) 80 mg/dL\n   Bilirubin, conjugated 0.2 mg/dL\nBilirubin, total 1.0 mg/dL\nAST (SGOT) 11 U/L\nALT (SGPT) 12 U/L\nAlkaline Phosphatase 45 U/L\n   Prothrombin Time (PT) 14 s\nPartial Thromboplastin Time (PTT) 35 s\n  WBC 8,500/mm3\nRBC 4.00 x 106/mm3\nHematocrit 37.5%\nHemoglobin 13.1 g/dL\nPlatelet Count 225,000/mm3\nThis patient\u2019s condition would most likely also present with which of the following symptoms?", "options": {"A": "Epistaxis", "B": "Hemarthrosis", "C": "Purpura fulminans", "D": "Intracranial hemorrhage"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "persistent bleeding after tooth extraction symptoms associated conditions", "log": "I need to analyze the clinical scenario presented in the question to determine which of the options is most likely associated with the patient's condition. The patient has a history of persistent bleeding after a dental procedure, and the laboratory findings do not indicate any obvious coagulopathy. \n\nGiven that the patient is otherwise healthy and has no prior bleeding issues, I should consider common bleeding disorders or conditions that could lead to similar symptoms. The options provided include various types of bleeding presentations, and I need to determine which one aligns best with the patient's symptoms.\n\nAction: search_docs  \nAction Input: \"persistent bleeding after tooth extraction symptoms associated conditions\"  ", "type": "AgentAction"}}, "Hematologic and Nutritional Disease Internists are more likely to encounter patients with acquired, rather than congenital, bleeding disorders. Bleeding should stop 15 min after minor trauma and within an hour after tooth extraction if local pressure is applied. More prolonged bleeding, if not due\n\nthat appear to be more common in patients with bleeding disorders include prolonged bleeding with surgery, dental procedures and extractions, and/or trauma, menorrhagia or postpartum hemorrhage, and large bruises (often described with lumps).\n\nPatients have predominantly mucosal bleeding symptoms, although postoperative bleeding can also be seen. Bleeding symptoms are very uncommon in infancy and usually manifest later in childhood with excessive bruising and epistaxis. Because these symptoms occur commonly in childhood, the clinician"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "epistaxis common bleeding disorders symptoms", "log": "The information gathered suggests that prolonged bleeding after minor trauma, such as a tooth extraction, may indicate a bleeding disorder. The mention of mucosal bleeding symptoms, excessive bruising, and epistaxis in children is particularly relevant. Since the patient has persistent bleeding after a dental procedure and no prior bleeding issues, it is reasonable to consider that he may present with symptoms like epistaxis, which is common in bleeding disorders.\n\nAction: search_docs  \nAction Input: \"epistaxis common bleeding disorders symptoms\"  ", "type": "AgentAction"}}, "Epistaxis is a common symptom, particularly in children and in dry climates, and may not reflect an underlying bleeding disorder. However, it is the most common symptom in hereditary hemorrhagic telangiectasia and in boys with VWD. Clues that epistaxis is a symptom of an underlying bleeding\n\nMucosal bleeding may appear as hematemesis, melena, or epistaxis.\n\n1.\n\nSymptoms of mucosa! bleeding include epistaxis (most common overall symptom), hemoptysis, GI bleeding, hematuria, and menorrhagia. Intracranial bleeding occurs with severe thrombocytopenia.\n\n2."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "bleeding disorders symptoms epistaxis hemarthrosis purpura fulminans intracranial hemorrhage", "log": "The information indicates that epistaxis is a common symptom of bleeding disorders, particularly in children, and is associated with conditions like von Willebrand disease (VWD). Given that the patient has experienced persistent bleeding following a dental procedure, it aligns with the possibility of underlying bleeding disorders that may also present with epistaxis.\n\nAction: search_docs  \nAction Input: \"bleeding disorders symptoms epistaxis hemarthrosis purpura fulminans intracranial hemorrhage\"  ", "type": "AgentAction"}}, "1.\n\nSymptoms of mucosa! bleeding include epistaxis (most common overall symptom), hemoptysis, GI bleeding, hematuria, and menorrhagia. Intracranial bleeding occurs with severe thrombocytopenia.\n\n2.\n\nEpistaxis is a common symptom, particularly in children and in dry climates, and may not reflect an underlying bleeding disorder. However, it is the most common symptom in hereditary hemorrhagic telangiectasia and in boys with VWD. Clues that epistaxis is a symptom of an underlying bleeding\n\nMucosal bleeding may appear as hematemesis, melena, or epistaxis."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "hemarthrosis symptoms bleeding disorders", "log": "The information reinforces that epistaxis is a prevalent symptom in children with bleeding disorders, particularly in conditions like von Willebrand disease. The patient\u2019s persistent bleeding after a tooth extraction aligns with the type of bleeding seen in such disorders. \n\nI should now evaluate the other options to confirm if they are less likely than epistaxis based on the context provided.\n\nAction: search_docs  \nAction Input: \"hemarthrosis symptoms bleeding disorders\"  ", "type": "AgentAction"}}, "is a common problem with both types of hemophilia and can lead to a deforming arthritis. The frequency and severity of hemarthrosis are related to the degree of clotting factor deficiency. Hemarthrosis is not common in other disorders of coagulation such as von Willebrand disease, factor V\n\nby bleeding into the joints (hemarthrosis), soft tissues, and\n\nsimilar to hemophilia A (hemarthrosis). Findings in classic von Willebrand disease differ from findings in hemophilia A and B (see Table 151-3)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "purpura fulminans symptoms bleeding disorders", "log": "The information indicates that hemarthrosis is a symptom commonly associated with hemophilia, particularly in cases of severe clotting factor deficiency. However, it is noted that hemarthrosis is not typically seen in von Willebrand disease (VWD), which is relevant to the patient\u2019s presentation of persistent bleeding after a dental procedure. Given that the patient is presenting with bleeding following a tooth extraction and has no prior bleeding issues, hemarthrosis may not be the most likely symptom to present alongside his current condition.\n\nAction: search_docs  \nAction Input: \"purpura fulminans symptoms bleeding disorders\"  ", "type": "AgentAction"}}, "Purpura are slightly larger (3 to 5 mm) hemorrhages. Purpura can result from the same disorders that cause petechiae, as well as trauma, vascular inflammation (vasculitis), and increased vascular fragility.\n\nseptic shock, acute renal failure, acidosis, hypoxia, hypotension, and death. Purpura fulminans has been associated primarily with\n\nPurpura Fulminans (See also Chaps. 180 and 325) Purpura fulminans is the cutaneous manifestation of DIC and presents as large ecchymotic areas and hemorrhagic bullae. Progression of petechiae to purpura, ecchymoses, and gangrene is associated with congestive heart failure, septic shock, acute renal"]]},"38": {"question": "A 74-year-old man presents to the emergency department with shortness of breath that started about 30 mins ago. He is also experiencing chest pain on deep inspiration. He has several significant medical conditions including obstructive pulmonary disease, hypertension, and dyslipidemia. He used to smoke about 3 packs of cigarettes every day until last year when he quit. He was in the emergency room 2 weeks ago for a hemorrhagic stroke which was promptly treated. He currently weighs 97.5 kg (215 lb). His respirations are 20/min, the blood pressure is 110/ 80 mm Hg, and the pulse is 105/min. On physical examination, Homan\u2019s sign is positive. An ECG and chest X-ray are performed. His current oxygen saturation is at 87% and D-dimer results are positive. He is wheeled in for a CT scan. Which of the following treatments would this patient be an ideal candidate for?", "options": {"A": "Greenfield filter", "B": "Unfractionated heparin", "C": "Subcutaneous fondaparinux", "D": "Warfarin"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for information on the ideal treatment for a patient suspected of having a pulmonary embolism, considering his medical history and current condition.", "tool_input": "ideal treatment for pulmonary embolism in elderly patients with recent hemorrhagic stroke\" \n", "log": "Given the patient's presentation and medical history, including shortness of breath, chest pain on inspiration, positive Homan's sign, and a positive D-dimer, there is a high suspicion for a pulmonary embolism (PE). The treatment options provided include anticoagulation therapies and a filter for preventing further emboli.\n\nAction: I will search for information on the ideal treatment for a patient suspected of having a pulmonary embolism, considering his medical history and current condition. \nAction Input: \"ideal treatment for pulmonary embolism in elderly patients with recent hemorrhagic stroke\" \n", "type": "AgentAction"}}, "I will search for information on the ideal treatment for a patient suspected of having a pulmonary embolism, considering his medical history and current condition. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "ideal treatment for pulmonary embolism in elderly patients with recent hemorrhagic stroke\" \n", "log": "I need to take action to search for relevant information regarding the ideal treatment for a patient suspected of having a pulmonary embolism, particularly in the context of an elderly patient with a recent hemorrhagic stroke.\n\nAction: search_docs  \nAction Input: \"ideal treatment for pulmonary embolism in elderly patients with recent hemorrhagic stroke\" \n", "type": "AgentAction"}}, "The treatment of pulmonary embolism is as follows: 1.\n\nImmediate anticoagulant therapy, identical to that outlined for the treatment of DVT, should be initiated.\n\n2.\n\nRespiratory support, including oxygen and bronchodilators and an intensive care setting, if necessary.\n\n3.\n\nPulmonary emboli (PE) should be treated with fibrinolytic agents if massive and in some cases if submassive. Surgical pulmonary embolectomy is an option for the treatment of massive PE with hemodynamic instability in patients who have contraindications for systemic fibrinolysis or those in whom it\n\n3.\n\nAlthough massive pulmonary emboli are usually quickly fatal, rarely pulmonary embolectomy is successful.\n\n4.\n\nPulmonary artery catheterization with the administration of thrombolytic agents bears further evaluation and may be important in patients with massive pulmonary embolism.\n\n5."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for specific recommendations regarding anticoagulant therapy in elderly patients with a history of recent hemorrhagic stroke and suspected pulmonary embolism.", "tool_input": "anticoagulant therapy for pulmonary embolism in patients with recent hemorrhagic stroke\" \n", "log": "The information retrieved emphasizes the importance of immediate anticoagulant therapy for treating pulmonary embolism, particularly in the context of deep vein thrombosis (DVT). However, given the patient's recent hemorrhagic stroke, certain anticoagulants may not be suitable.\n\nAction: I will search for specific recommendations regarding anticoagulant therapy in elderly patients with a history of recent hemorrhagic stroke and suspected pulmonary embolism.  \nAction Input: \"anticoagulant therapy for pulmonary embolism in patients with recent hemorrhagic stroke\" \n", "type": "AgentAction"}}, "I will search for specific recommendations regarding anticoagulant therapy in elderly patients with a history of recent hemorrhagic stroke and suspected pulmonary embolism. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anticoagulant therapy for pulmonary embolism in patients with recent hemorrhagic stroke\" \n", "log": "I need to take action to search for specific recommendations regarding anticoagulant therapy in elderly patients with a history of recent hemorrhagic stroke and suspected pulmonary embolism.\n\nAction: search_docs  \nAction Input: \"anticoagulant therapy for pulmonary embolism in patients with recent hemorrhagic stroke\" \n", "type": "AgentAction"}}, "Agnelli G, Becattini C, Kirschstein T: Thrombolysis vs heparin in the treatment of pulmonary embolism. Arch Intern Med 162: 2537, 2002\n\nThe treatment of pulmonary embolism is as follows: 1.\n\nImmediate anticoagulant therapy, identical to that outlined for the treatment of DVT, should be initiated.\n\n2.\n\nRespiratory support, including oxygen and bronchodilators and an intensive care setting, if necessary.\n\n3.\n\nThis patient has pulmonary embolism secondary to a deep venous thrombosis (DVT). Options for treating this patient include unfractionated heparin or low-molecular-weight heparin followed by warfarin, with INR goal of 2\u20133; parenteral anticoagulation for 5\u20137 days followed by edoxaban; or rivaroxaban,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for guidelines or recommendations specifically addressing anticoagulant therapy in patients with a recent history of hemorrhagic stroke who are suspected of having a pulmonary embolism.", "tool_input": "guidelines anticoagulant therapy pulmonary embolism recent hemorrhagic stroke\" \n", "log": "The information retrieved indicates that immediate anticoagulant therapy is crucial for treating pulmonary embolism. However, the patient's recent hemorrhagic stroke raises concerns about the safety of certain anticoagulants. Unfractionated heparin and low-molecular-weight heparin are mentioned as possible options, but the choice may depend on the severity of the stroke and the risk of rebleeding.\n\nAction: I will search for guidelines or recommendations specifically addressing anticoagulant therapy in patients with a recent history of hemorrhagic stroke who are suspected of having a pulmonary embolism.  \nAction Input: \"guidelines anticoagulant therapy pulmonary embolism recent hemorrhagic stroke\" \n", "type": "AgentAction"}}, "I will search for guidelines or recommendations specifically addressing anticoagulant therapy in patients with a recent history of hemorrhagic stroke who are suspected of having a pulmonary embolism. is not a valid tool, try one of [search_docs]."]]},"39": {"question": "An investigator performs a twin study to evaluate the effects of a novel drug that decreases serum glucose by inhibiting a transporter on the basolateral membrane of proximal convoluted tubule cells. The results of the study are shown.\nTest Control\nSerum glucose (mg/dL) 82.4 99\nDipstick urine glucose negative negative\nUrine anion gap positive negative\nThe drug most likely inhibits transport of which of the following substrates?\"", "options": {"A": "Glutamine", "B": "Sodium", "C": "Alanine", "D": "Leucine"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "twin study effects of drug on serum glucose transport inhibition sodium glutamine alanine leucine", "log": "To determine which substrate is most likely inhibited by the drug described, I need to analyze the effects of the drug on serum glucose and the urine anion gap. The positive urine anion gap in the test group suggests that there is an increase in unmeasured anions, which could be due to the inhibition of sodium transport. This might affect glucose reabsorption as well. I will search for more information about the transport mechanisms involved in glucose and the substrates listed.\n\nAction: search_docs  \nAction Input: \"twin study effects of drug on serum glucose transport inhibition sodium glutamine alanine leucine\"  ", "type": "AgentAction"}}, "Vasilakou D et al: Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med 2013;159:262.\n\nVerkman AS et al: Small-molecule inhibitors of urea transporters. Subcell Biochem 2014;73:165.\n\ninterest in both enteral and parenteral glutamine supplementation. However, recently reported data from two large randomized controlled clinical trials in which critically ill patients received glutamine supplementation demonstrated Brunicardi_Ch02_p0027-p0082.indd   6901/03/19   6:50 PM 70BASIC\n\nD. One resulting in impaired glucose uptake"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "sodium glucose transport mechanisms proximal convoluted tubule", "log": "The search results indicate that sodium-glucose cotransporter 2 (SGLT2) inhibitors are relevant to the context of serum glucose regulation and transport mechanisms. Since the urine anion gap is positive in the test group, it suggests altered sodium transport, which aligns with the functioning of SGLT2. This suggests that the drug likely inhibits sodium transport, which is crucial for glucose reabsorption in the proximal convoluted tubule.\n\nAction: search_docs  \nAction Input: \"sodium glucose transport mechanisms proximal convoluted tubule\"  ", "type": "AgentAction"}}, "convoluted tubule depends on active Na transport.\n\nIn the first half of the proximal tubule, Na+ uptake into the cell is coupled with either H+ or organic solutes, includ ing glucose (Fig. 34.1 ). Specific transport proteins mediate entry of Na+ into the cell across the apical membrane. For example, the Na+/H+ antiporter, NHE3, (see\n\njunction. The high [Cl\u2212] of tubular fluid provides the driving force for diffusion of Cl\u2212 . Some glucose is also reabsorbed in the second half of the proximal tubule by a mechanism similar to that described in the first half of the proximal tubule, except that the Na+/glucose symporter (SGLT1 gene)"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "effects of sodium transport inhibition on glucose reabsorption", "log": "The information gathered from the search results reinforces the understanding that sodium transport is closely linked to glucose reabsorption in the proximal convoluted tubule. The involvement of sodium-glucose cotransporters (SGLT) indicates that inhibiting sodium transport would likely disrupt glucose reabsorption, leading to decreased serum glucose levels. \n\nAction: search_docs  \nAction Input: \"effects of sodium transport inhibition on glucose reabsorption\"  ", "type": "AgentAction"}}, "glucose stimulates Na+ and fluid absorption; this effect is\n\nGlucose is freely filtered by the renal glomeruli and is reabsorbed in the proximal tubules by the action of sodium-glucose transporters (SGLTs). Sodium-glucose transporter 2 (SGLT2) accounts for 90% of glucose reabsorption, and its inhibition causes glycosuria and lowers glucose levels in patients\n\nIn the normal individual, the proximal convoluted tubule reabsorbs almost all of the glucose filtered by the glomeruli. Ninety percent of the glucose reabsorption occurs through SGLT2 (Figure 15\u20132), but inhibiting this transporter using the currently available drugs will result in glucose excretion"]]},"40": {"question": "A 24-year-old gravida 1 is admitted to the hospital after a tonic-clonic seizure at 37 weeks gestation. At the time of presentation, she complains of a severe headache, double vision, and nausea. Her vital signs are as follows: blood pressure, 165/90 mm Hg; heart rate, 91/min; respiratory rate, 9/min; and temperature, 37.0\u2103 (98.6\u2109). The rapid dipstick test performed on admission unit shows 3+ proteinuria. The fetal heart rate is 118/min. On examination, the patient is lethargic (GCS 12/15). There is 2+ pitting leg edema. The neurologic examination is significant for left eye deviation towards the nose, paralysis of the left conjugate gaze with a paralytic left eye, and right hemiplegia. Meningeal signs are negative. Which of the following findings would be expected if a head CT scan is performed?", "options": {"A": "Regions of hyperdensity within the cerebellar hemispheres", "B": "Hyperattenuating material in the subarachnoid space", "C": "Regions of hyperdensity in the left pons", "D": "Subcortical hypodense region with surrounding irregular hyperdense margins"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for information regarding expected CT scan findings in patients with similar presentations, particularly focusing on the differential diagnoses such as stroke or hemorrhage.", "tool_input": "search_docs(\"head CT findings in eclampsia or stroke\") \n", "log": "I need to analyze the clinical scenario provided in the question to determine what findings would be expected on a head CT scan. The patient is experiencing severe headache, seizures, and has neurological deficits, which could suggest a possible stroke or other intracranial pathology. The presence of 3+ proteinuria and hypertension could indicate preeclampsia or eclampsia, but the neurological signs are particularly concerning for a possible hemorrhagic event or ischemic stroke.\n\nAction: I will search for information regarding expected CT scan findings in patients with similar presentations, particularly focusing on the differential diagnoses such as stroke or hemorrhage.\n\nAction Input: search_docs(\"head CT findings in eclampsia or stroke\") \n", "type": "AgentAction"}}, "I will search for information regarding expected CT scan findings in patients with similar presentations, particularly focusing on the differential diagnoses such as stroke or hemorrhage. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "head CT findings in eclampsia or stroke\"  \n", "log": "I need to perform a search for relevant information regarding head CT findings in patients with eclampsia or stroke.\n\nAction: search_docs  \nAction Input: \"head CT findings in eclampsia or stroke\"  \n", "type": "AgentAction"}}, "FIGURE 60-3 A 37-year-old gravida with intrapartum eclampsia at term. A noncontrast computed tomography axial head image demonstrates a large intraparenchymal hemorrhage.\n\nHeadaches and visual symptoms are common with severe preeclampsia, and associated convulsions deine eclampsia. The earliest anatomical descriptions of brain involvement came from autopsy specimens, but CT and MR imaging and Doppler studies have added many important insights.\n\n\u25a0Emergent head CT without contrast (see Figure 2.10-2) to differentiate ischemic from hemorrhagic stroke and to identify potential candidates for thrombolytic therapy.\n\nTABLE 2.10-5.  Clinical Re\ufb02 exes\n\nMCA stroke can cause CHANGes:"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will summarize the findings from the search to determine which of the provided options aligns with the expected CT findings in this clinical scenario.", "tool_input": "N/A\n", "log": "I need to analyze the information obtained from the search to identify the expected CT findings in cases of eclampsia or stroke. The mention of intraparenchymal hemorrhage suggests that this could be a possible finding in the patient's case, given her symptoms and presentation.\n\nAction: I will summarize the findings from the search to determine which of the provided options aligns with the expected CT findings in this clinical scenario.\n\nAction Input: N/A\n", "type": "AgentAction"}}, "I will summarize the findings from the search to determine which of the provided options aligns with the expected CT findings in this clinical scenario. is not a valid tool, try one of [search_docs]."]]},"41": {"question": "A 45-year-old male presents to your office following a diagnosis of an autosomal dominant disease. He has started therapy and has a strong family support system. He endorses a decrease in appetite over the last two weeks that he attributes to sadness surrounding his diagnosis and a depressed mood but denies any suicidal ideation. He continues to enjoy working in the yard and playing with his children. On physical examination you notice involuntary quick jerky movements of his hands and feet. Which of the following would you expect to see in this patient?", "options": {"A": "Caudate and putamen atrophy", "B": "Depigmentation of the substantia nigra pars compacta", "C": "Atrophy of the subthalamic nucleus", "D": "Lesion in the vermis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for information regarding the expected findings in patients with autosomal dominant diseases that involve involuntary movements, particularly focusing on the options provided.", "tool_input": "search_docs(\"caudate and putamen atrophy, depigmentation of the substantia nigra, atrophy of the subthalamic nucleus, lesion in the vermis in autosomal dominant diseases\") \n", "log": "I need to analyze the symptoms and the context provided in the question. The patient has an autosomal dominant disease, demonstrates involuntary movements, and has a depressed mood. The involuntary movements suggest a movement disorder, which is often associated with certain neurodegenerative diseases.\n\nAction: I will search for information regarding the expected findings in patients with autosomal dominant diseases that involve involuntary movements, particularly focusing on the options provided.\n\nAction Input: search_docs(\"caudate and putamen atrophy, depigmentation of the substantia nigra, atrophy of the subthalamic nucleus, lesion in the vermis in autosomal dominant diseases\") \n", "type": "AgentAction"}}, "I will search for information regarding the expected findings in patients with autosomal dominant diseases that involve involuntary movements, particularly focusing on the options provided. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "caudate and putamen atrophy, depigmentation of the substantia nigra, atrophy of the subthalamic nucleus, lesion in the vermis in autosomal dominant diseases\"  \n", "log": "I need to perform a search to find relevant information about the expected neurological findings in autosomal dominant diseases associated with involuntary movements. \n\nAction: search_docs  \nAction Input: \"caudate and putamen atrophy, depigmentation of the substantia nigra, atrophy of the subthalamic nucleus, lesion in the vermis in autosomal dominant diseases\"  \n", "type": "AgentAction"}}, "the putamen, and loss of the pigmented cells of the substantia nigra may be found in cases with extrapyramidal features. More widespread degeneration in the central nervous system (CNS), including involvement of the posterior columns and the spinocerebellar fibers, is often present.\n\npredominantly affects the striatum. Progressive atrophy of the heads of the caudate nuclei, which form the lateral margins of the lateral ventricles, can be visualized by MRI (Fig. 449-8), but the putamen can be equally or even more severely affected. More diffuse cortical atrophy is seen in the\n\nBurns JM, Galvin JE, Roed CM, et al: The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 64:1397, 2005.\n\nByers RK, Banker BQ: Infantile muscular atrophy. Arch Neurol 5:140, 1961."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "_Exception", "tool_input": "Invalid Format: Missing 'Action Input:' after 'Action:'", "log": "The information obtained suggests that in cases of autosomal dominant diseases associated with involuntary movements, such as Huntington's disease, there is often atrophy of the caudate and putamen. The details indicate that the striatum, which includes the caudate and putamen, is predominantly affected. \n\nAction: I will now evaluate the options based on the gathered information. \n", "type": "AgentAction"}}, "Invalid Format: Missing 'Action Input:' after 'Action:'"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "_Exception", "tool_input": "Invalid Format: Missing 'Action Input:' after 'Action:'", "log": "I need to clarify the options based on the observation regarding the expected findings in the patient\u2019s condition.\n\nAction: None needed at this moment; I will analyze the options based on the previous observations.\n", "type": "AgentAction"}}, "Invalid Format: Missing 'Action Input:' after 'Action:'"]]},"42": {"question": "A 69-year-old man with hypertension and congestive heart failure is brought to the emergency department because of a 9-day history of worsening shortness of breath and swelling of his legs. His respirations are 25/min, and blood pressure is 160/98 mm Hg. Pulse oximetry on 5 L O2 via nasal cannula shows an oxygen saturation of 92%. Examination shows 2+ pretibial edema bilaterally. Crackles are heard at both lung bases. The patient's symptoms are due in part to an increase in the rate of bradykinin breakdown. The substance responsible for bradykinin breakdown is primarily produced in which of the following?", "options": {"A": "Pulmonary endothelium", "B": "Liver", "C": "Atria", "D": "Zona glomerulosa"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'bradykinin breakdown location')", "tool_input": "'bradykinin breakdown location'", "log": "I need to determine where bradykinin breakdown primarily occurs in the body. This will help in identifying the correct answer from the options provided. \n\nAction: search_docs(query: 'bradykinin breakdown location')  \nAction Input: 'bradykinin breakdown location'  ", "type": "AgentAction"}}, "search_docs(query: 'bradykinin breakdown location') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'bradykinin breakdown location'", "log": "I need to search for information regarding the location of bradykinin breakdown in the body to answer the question correctly.\n\nAction: search_docs  \nAction Input: 'bradykinin breakdown location'  ", "type": "AgentAction"}}, "Bradykinin is formed in other exocrine glands, such as the lacrimal and sweat glands. Its presence in sweat may be partly responsible for the dilation of cutaneous blood vessels.\n\nHallett M, Khoshbin S: A physiological mechanism of bradykinesia. Brain 103:301, 1980.\n\nHardie RJ, Pullon HW, Harding AE, et al: Neuroacanthocytosis:\n\nA clinical, haematological, and pathological study of 19 cases. Brain 114(Pt 1A):13, 1991.\n\nelevated plasma levels of bradykinin, particularly in the venous effluent of an involvedextremity,andreducedlevelsofprekallikreinandhigh-molecular-weight kininogen, from which bradykinin is cleaved. The parallel decline in the complement substrates C4 and C2 reflects the action of activated C1"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'where is bradykinin metabolized or broken down'", "log": "The information obtained does not directly answer the question about where bradykinin breakdown primarily occurs. I need to refine my search to focus specifically on the metabolic pathways or organs involved in the breakdown of bradykinin.\n\nAction: search_docs  \nAction Input: 'where is bradykinin metabolized or broken down'  ", "type": "AgentAction"}}, "by tissue kallikrein. Kallidin can be converted to bradykinin by an arginine aminopeptidase. The two kinins are present in plasma and urine. Bradykinin is the predominant kinin in plasma, whereas Lys-bradykinin is the major urinary form.\n\nThe pathway for the formation and metabolism of kinins is shown in Figure 17\u20134. The two major kinins in humans are bradykinin and Lys-bradykinin or kallidin. Bradykinin is released from HMW kininogen by plasma kallikrein, whereas kallidin is released from LMW kininogen by tissue kallikrein.\n\nelevated plasma levels of bradykinin, particularly in the venous effluent of an involvedextremity,andreducedlevelsofprekallikreinandhigh-molecular-weight kininogen, from which bradykinin is cleaved. The parallel decline in the complement substrates C4 and C2 reflects the action of activated C1"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'bradykinin breakdown site in the body'", "log": "The information gathered still does not directly indicate the primary site of bradykinin breakdown. I need to focus on specific organs or tissues that are known for metabolizing bradykinin.\n\nAction: search_docs  \nAction Input: 'bradykinin breakdown site in the body'  ", "type": "AgentAction"}}, "Bradykinin is formed in other exocrine glands, such as the lacrimal and sweat glands. Its presence in sweat may be partly responsible for the dilation of cutaneous blood vessels.\n\nThere is evidence that bradykinin may play a beneficial, protective role in certain cardiovascular diseases and ischemic stroke-induced brain injury. On the other hand, it has been implicated in cancer and some central nervous system diseases.\n\nelevated plasma levels of bradykinin, particularly in the venous effluent of an involvedextremity,andreducedlevelsofprekallikreinandhigh-molecular-weight kininogen, from which bradykinin is cleaved. The parallel decline in the complement substrates C4 and C2 reflects the action of activated C1"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'bradykinin metabolism breakdown site'", "log": "The information obtained still does not provide a clear answer regarding the primary site of bradykinin breakdown. I need to search for more specific information regarding the metabolic processes involved in bradykinin breakdown.\n\nAction: search_docs  \nAction Input: 'bradykinin metabolism breakdown site'  ", "type": "AgentAction"}}, "The pathway for the formation and metabolism of kinins is shown in Figure 17\u20134. The two major kinins in humans are bradykinin and Lys-bradykinin or kallidin. Bradykinin is released from HMW kininogen by plasma kallikrein, whereas kallidin is released from LMW kininogen by tissue kallikrein.\n\nelevated plasma levels of bradykinin, particularly in the venous effluent of an involvedextremity,andreducedlevelsofprekallikreinandhigh-molecular-weight kininogen, from which bradykinin is cleaved. The parallel decline in the complement substrates C4 and C2 reflects the action of activated C1\n\nby tissue kallikrein. Kallidin can be converted to bradykinin by an arginine aminopeptidase. The two kinins are present in plasma and urine. Bradykinin is the predominant kinin in plasma, whereas Lys-bradykinin is the major urinary form."]]},"43": {"question": "An anxious mother brings her daughter into the clinic on her 5th birthday. She was forwarded a recent email by her aunt that stated that the pesticide-coated fruit in school lunches is the number one killer in children in the modern era. You assure her that that pesticides are not the number one killer, nor are they even in the top three killers of children in this age group. What are the top causes of death of American children aged 5-9, in order from most common to least?", "options": {"A": "Heart disease, malignant neoplasms, chronic lower respiratory disease", "B": "Unintentional injury, malignant neoplasms, congenital anomalies", "C": "Malignant neoplasms, heart disease, unintentional injury", "D": "Unintentional injury, suicide, malignant neoplasms"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'top causes of death American children aged 5-9'", "log": "I need to find the most recent data on the top causes of death for American children aged 5-9 to accurately answer the question. \n\nAction: search_docs  \nAction Input: 'top causes of death American children aged 5-9'  ", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'causes of death American children aged 5-9 2023'", "log": "The observation indicates that the leading causes of death in children are accidents (unintentional injuries), cancer (malignant neoplasms), and congenital defects. This suggests that the top causes of death for American children aged 5-9 are likely to align with these findings. \n\nAction: search_docs  \nAction Input: 'causes of death American children aged 5-9 2023'  ", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'current leading causes of death American children aged 5-9 2023'", "log": "The observations so far indicate that unintentional injuries and malignant neoplasms are significant causes of death among children, but I need more current information to confirm the exact ranking and any changes in the data since 2010. \n\nAction: search_docs  \nAction Input: 'current leading causes of death American children aged 5-9 2023'  ", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'leading causes of death children 5-9 2023 statistics'", "log": "The repeated observations are not providing updated information or clear rankings beyond 2010. However, based on the previous findings, the leading causes of death for children aged 5-9 are likely still consistent with unintentional injuries, malignant neoplasms, and congenital anomalies.\n\nAction: search_docs  \nAction Input: 'leading causes of death children 5-9 2023 statistics'  ", "type": "AgentAction"}}, "TABLE 2.4-5. Leading Causes of Death by Age Group\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal.\n\nhere were 6.1 infant deaths per 1000 live births in 2013 compared with 6.8 in 2001 (MacDorman, 2015). The three leading causes of infant death-congenital malformations, low birthweight, and sudden infant death syndrome-accounted for almost half of all deaths (Heron, 2015). Infants born at the"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'leading causes of death American children aged 5-9 2023 report'", "log": "The observations continue to suggest that the leading causes of death in children align with unintentional injuries, cancer, and congenital defects. However, I still need to confirm the exact ranking of these causes specifically for children aged 5-9 in 2023.\n\nAction: search_docs  \nAction Input: 'leading causes of death American children aged 5-9 2023 report'  ", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\nTABLE 2.4-5. Leading Causes of Death by Age Group"]]},"44": {"question": "A 3-year-old boy is brought to the emergency room by his mother with fever and difficulty breathing after receiving the BCG vaccine. He has never had a reaction to a vaccine before. He has a history of 2 salmonella infections over the past 2 years. He was born at 35 weeks\u2019 gestation and spent one day in the neonatal intensive care unit. His parents' family histories are unremarkable. His temperature is 101\u00b0F (38.3\u00b0C), blood pressure is 80/55 mmHg, pulse is 135/min, and respirations are 24/min. On examination, he appears acutely ill. He has increased work of breathing with intercostal retractions. A petechial rash is noted on his trunk and extremities. A serological analysis in this patient would most likely reveal decreased levels of which of the following cytokines?", "options": {"A": "Interferon alpha", "B": "Interferon gamma", "C": "Interleukin 1", "D": "Tumor necrosis factor alpha"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cytokines decreased in BCG vaccine reaction or severe illness in children\"  \n", "log": "I need to determine which cytokine levels would likely be decreased in this 3-year-old boy based on the symptoms presented, particularly considering his recent BCG vaccination and acute illness with respiratory distress and a petechial rash. \n\nAction: search_docs  \nAction Input: \"cytokines decreased in BCG vaccine reaction or severe illness in children\"  \n", "type": "AgentAction"}}, "infection after vaccination with Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG), the strain of M. bovis that is used as a live vaccine against M. tuberculosis. Because the IL12 p40 subunit is shared by IL12 and IL23, IL12 p40 deficiency results in a broader infectious disease risk due to\n\nDifferent cytokines contribute to specific types of immune responses.\n\nBCG vaccination induces TST reactivity, which tends to wane with time. The presence or size of TST reactions after vaccination does not predict the degree of protection afforded."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cytokine profile BCG vaccine reaction children\"  \n", "log": "The search did not provide a clear answer regarding the specific cytokines that would be decreased in this scenario. I need to refine my search to focus more on the immune response to BCG vaccination in children and the specific cytokine profiles associated with severe illness or reactions to the vaccine.\n\nAction: search_docs  \nAction Input: \"cytokine profile BCG vaccine reaction children\"  \n", "type": "AgentAction"}}, "infection after vaccination with Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG), the strain of M. bovis that is used as a live vaccine against M. tuberculosis. Because the IL12 p40 subunit is shared by IL12 and IL23, IL12 p40 deficiency results in a broader infectious disease risk due to\n\nDifferent cytokines contribute to specific types of immune responses.\n\nof infants and young children from serious disseminated forms of childhood TB, such as tuberculous meningitis and miliary TB. BCG vaccine is safe and rarely causes serious complications. The local tissue response begins 2\u20133 weeks after vaccination, with scar formation and healing within 3 months."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "decreased cytokines BCG vaccine adverse reactions\"  \n", "log": "The search results still do not provide a direct answer to the question regarding which specific cytokine levels would be decreased in this child after the BCG vaccine reaction. I need to focus on the immune response mechanisms related to BCG vaccination and the typical cytokine responses in severe infections.\n\nAction: search_docs  \nAction Input: \"decreased cytokines BCG vaccine adverse reactions\"  \n", "type": "AgentAction"}}, "infection after vaccination with Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG), the strain of M. bovis that is used as a live vaccine against M. tuberculosis. Because the IL12 p40 subunit is shared by IL12 and IL23, IL12 p40 deficiency results in a broader infectious disease risk due to\n\nBCG vaccination induces TST reactivity, which tends to wane with time. The presence or size of TST reactions after vaccination does not predict the degree of protection afforded.\n\nB. pertussis organisms. Despite their efficacy (average estimate, 85%; range for different products, 30\u2013100%), whole-cell pertussis vaccines are associated with adverse events\u2014both common (fever; injection-site pain, erythema, and swelling; irritability) and uncommon (febrile seizures, hypotonic"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Cytokines decreased in severe infection or vaccine reaction in children\"  \n", "log": "The search results have not provided relevant information regarding the specific cytokines that would be decreased in a child experiencing a severe reaction to the BCG vaccine. I need to focus on the immune response to BCG vaccination and potential cytokine deficiencies associated with such reactions.\n\nAction: search_docs  \nAction Input: \"Cytokines decreased in severe infection or vaccine reaction in children\"  \n", "type": "AgentAction"}}, "Different cytokines contribute to specific types of immune responses.\n\nno longer stimulates cytokine release.\n\nseveral cytokines such as IFN-\u03b3, TNF-\u03b1, and IL-2 in response to such stimulation. A similar progression occurs for T cells in humans after immunization with a vaccine against yellow fever virus."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "BCG vaccine cytokine response children severe illness\"  \n", "log": "The search results still do not provide a clear answer regarding the specific cytokines that would be decreased in this scenario. I need to focus on the immune response mechanisms related to severe infections or adverse reactions to vaccines, particularly the BCG vaccine.\n\nAction: search_docs  \nAction Input: \"BCG vaccine cytokine response children severe illness\"  \n", "type": "AgentAction"}}, "of infants and young children from serious disseminated forms of childhood TB, such as tuberculous meningitis and miliary TB. BCG vaccine is safe and rarely causes serious complications. The local tissue response begins 2\u20133 weeks after vaccination, with scar formation and healing within 3 months.\n\ninfection after vaccination with Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG), the strain of M. bovis that is used as a live vaccine against M. tuberculosis. Because the IL12 p40 subunit is shared by IL12 and IL23, IL12 p40 deficiency results in a broader infectious disease risk due to\n\n(\u201cBCGitis\u201d) and death have occurred in 1\u201310 cases per 10 million doses administered, although this problem is restricted almost exclusively to persons with impaired immunity, such as children with severe combined immunodeficiency syndrome or adults with HIV infection. BCG vaccination induces TST"]]},"45": {"question": "A 67-year-old man presents to the surgical clinic with swelling of his right leg, fever, and chills for 2 days. The maximum recorded temperature was 38.3\u00b0C (101.0\u00b0F) at home. His right leg is red and swollen from the dorsum of the foot to the thigh with an ill-defined edge. Venous stasis ulcers are present in both of his limbs, but those on the right have a yellow discharge. His vitals include the following: blood pressure is 120/78 mm Hg, heart rate is 94/min, temperature is 38.3\u00b0C (101.0\u00b0F), and respiratory rate is 16/min. On physical examination, there is tenderness and warmth compared with his normal leg. Dorsalis pedis pulses are present on both of the ankles. What is the most likely cause of the right shift of the hemoglobin dissociation curve for his condition?", "options": {"A": "Decrease in 2,3-DPG", "B": "Increase in temperature", "C": "Decrease in temperature", "D": "Increase in CO production"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'right shift hemoglobin dissociation curve causes'", "log": "I need to determine the most likely cause of the right shift of the hemoglobin dissociation curve in the context of the patient's condition, which includes fever and swelling of the leg. A right shift typically indicates a decreased affinity of hemoglobin for oxygen, which can be caused by factors such as increased temperature, increased levels of 2,3-DPG, increased CO2, or decreased pH (acidosis).\n\nAction: search_docs  \nAction Input: 'right shift hemoglobin dissociation curve causes'  ", "type": "AgentAction"}}, "Physiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\noxygen dissociation portion representing the tissue-capillary environment. Shifts of the curve have their greatest efect at the steep portion because they afect oxygen delivery. A rightward shit is associated with decreased hemoglobin ainity for oxygen and hence increased tissue-capillary oxygen :0\n\nOxygen-dissociation curve shift: Hemoglobin from which 2,3-BPG has been removed has high oxygen affinity. However, as seen in the RBC, the presence of 2,3-BPG significantly reduces the oxygen affinity of hemoglobin, shifting the oxygen-dissociation curve to the right (Fig. 3.12). This reduced"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'hemoglobin dissociation curve right shift fever'", "log": "The observation indicates that factors such as temperature and 2,3-BPG levels can influence the shift of the hemoglobin dissociation curve. A right shift is associated with decreased affinity for oxygen, which can occur due to increased temperature or increased levels of 2,3-DPG. Given that the patient has a fever (38.3\u00b0C), it is likely contributing to a right shift.\n\nAction: search_docs  \nAction Input: 'hemoglobin dissociation curve right shift fever'  ", "type": "AgentAction"}}, "Physiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\nthe cold-induced shift of the oxyhemoglobin dissociation curve to the left (see\n\noxygen dissociation portion representing the tissue-capillary environment. Shifts of the curve have their greatest efect at the steep portion because they afect oxygen delivery. A rightward shit is associated with decreased hemoglobin ainity for oxygen and hence increased tissue-capillary oxygen :0"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'right shift hemoglobin dissociation curve fever increase temperature'", "log": "The observation reiterates the factors that can cause a right shift in the hemoglobin dissociation curve, particularly emphasizing the relationship with temperature. Since the patient has a fever, this suggests an increase in temperature, which is known to cause a right shift, thereby decreasing hemoglobin's affinity for oxygen. \n\nAction: search_docs  \nAction Input: 'right shift hemoglobin dissociation curve fever increase temperature'  ", "type": "AgentAction"}}, "the cold-induced shift of the oxyhemoglobin dissociation curve to the left (see\n\nPhysiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\nFever is an elevation of body temperature that exceeds the normal daily variation and occurs in conjunction with an increase in the hypothalamic set point (e.g., from 37\u00b0C to 39\u00b0C). This shift of the set point from \u201cnormothermic\u201d to febrile levels very much resembles the resetting of the home"]]},"46": {"question": "A 75-year-old Caucasian man presents to the emergency department with abdominal pain. The patient states he was at home eating dinner when he began to experience severe abdominal pain. The patient has a past medical history of diabetes, hypertension, and atherosclerosis. He lives at home alone, smokes cigarettes, and drinks 1 to 2 alcoholic drinks per day. The patient is given IV morphine and an ultrasound is obtained demonstrating a dilated abdominal aorta. The patient states that his father died of a similar finding and is concerned about his prognosis. Which of the following is the greatest risk factor for this patient's presentation?", "options": {"A": "Atherosclerosis", "B": "Caucasian race", "C": "Cigarette smoking", "D": "Family history"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "greatest risk factor for abdominal aortic aneurysm", "log": "To determine the greatest risk factor for this patient's presentation of a dilated abdominal aorta, I need to analyze the options provided. Each option represents a potential risk factor associated with abdominal aortic aneurysms (AAAs). \n\n1. **Atherosclerosis**: This is a common risk factor for vascular diseases, including AAAs, as it contributes to the weakening of arterial walls.\n2. **Caucasian race**: Studies have shown that Caucasians are at a higher risk for AAAs compared to other races.\n3. **Cigarette smoking**: Smoking is a significant risk factor for the development and rupture of AAAs.\n4. **Family history**: A family history of AAA can increase the risk, as genetic factors may play a role.\n\nGiven that the patient has a family history of a similar condition, this might suggest a genetic predisposition. However, I need to determine which of these factors is considered the greatest risk according to medical literature.\n\nAction: search_docs  \nAction Input: \"greatest risk factor for abdominal aortic aneurysm\"  ", "type": "AgentAction"}}, "abdominal aortic aneurysm, diabetes. b Risk factors = cigarette smoking, hypertension, low HDL (< 40 mg/dL), a family history of premature CAD, and age (men > 45 years; women > 55 years). An HDL > 60 mg/dL counts as a \u201cnegative\u201d risk factor and removes one risk factor from the total score.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification\n\nto have more exten-sive and larger aneurysms at a younger age.43Brunicardi_Ch23_p0897-p0980.indd   91927/02/19   4:14 PM 920SPECIFIC CONSIDERATIONSPART\u2008IITable 23-8Annualized risk of rupture of abdominal aortic aneurysm (AAA) based on sizeDESCRIPTIONDIAMETER OF AORTA (CM)ESTIMATED ANNUAL RISK OF"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "most significant risk factor for abdominal aortic aneurysm", "log": "The search results indicate that several risk factors contribute to abdominal aortic aneurysms (AAAs), including atherosclerosis, cigarette smoking, age, male sex, and family history. However, the results do not specifically rank these factors in terms of their significance.\n\nGiven that smoking and atherosclerosis are both significant risk factors, and considering the patient's family history, I still need to evaluate which factor is generally regarded as the greatest risk factor in medical literature.\n\nAction: search_docs  \nAction Input: \"most significant risk factor for abdominal aortic aneurysm\"  ", "type": "AgentAction"}}, "Abdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification\n\nabdominal aortic aneurysm, diabetes. b Risk factors = cigarette smoking, hypertension, low HDL (< 40 mg/dL), a family history of premature CAD, and age (men > 45 years; women > 55 years). An HDL > 60 mg/dL counts as a \u201cnegative\u201d risk factor and removes one risk factor from the total score.\n\nto have more exten-sive and larger aneurysms at a younger age.43Brunicardi_Ch23_p0897-p0980.indd   91927/02/19   4:14 PM 920SPECIFIC CONSIDERATIONSPART\u2008IITable 23-8Annualized risk of rupture of abdominal aortic aneurysm (AAA) based on sizeDESCRIPTIONDIAMETER OF AORTA (CM)ESTIMATED ANNUAL RISK OF"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "ranking of risk factors for abdominal aortic aneurysm", "log": "The search results did not provide a clear ranking of the risk factors for abdominal aortic aneurysms. However, they did highlight that both atherosclerosis and cigarette smoking are significant risk factors. Given that the patient has a history of smoking and a family history of AAA, I need to consider which of these factors is generally viewed as the most critical in medical literature.\n\nSince I am still uncertain about the greatest risk factor based on the information retrieved, I will conduct another search to find a more definitive answer regarding the ranking of these risk factors.\n\nAction: search_docs  \nAction Input: \"ranking of risk factors for abdominal aortic aneurysm\"  ", "type": "AgentAction"}}, "abdominal aortic aneurysm, diabetes. b Risk factors = cigarette smoking, hypertension, low HDL (< 40 mg/dL), a family history of premature CAD, and age (men > 45 years; women > 55 years). An HDL > 60 mg/dL counts as a \u201cnegative\u201d risk factor and removes one risk factor from the total score.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification\n\nSex Differences in Abdominal Aortic Aneurysms. Am J Physiol Heart Circ Physiol. 2018.\t46.\tFleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "primary risk factors for abdominal aortic aneurysm", "log": "The search results continue to indicate that the significant risk factors for abdominal aortic aneurysms (AAAs) include atherosclerosis, cigarette smoking, age, male sex, and family history. However, there is still no clear ranking provided in the retrieved documents.\n\nGiven the persistent uncertainty about which of these factors is considered the greatest risk factor, I will attempt one more search to find a definitive source that clearly identifies the most significant risk factor for AAAs.\n\nAction: search_docs  \nAction Input: \"primary risk factors for abdominal aortic aneurysm\"  ", "type": "AgentAction"}}, "abdominal aortic aneurysm, diabetes. b Risk factors = cigarette smoking, hypertension, low HDL (< 40 mg/dL), a family history of premature CAD, and age (men > 45 years; women > 55 years). An HDL > 60 mg/dL counts as a \u201cnegative\u201d risk factor and removes one risk factor from the total score.\n\nAbdominal aortic Usually associated with atherosclerosis. Risk factors include history of tobacco use, \u008f\u00a0age, male aneurysm sex, family history. May present as palpable pulsatile abdominal mass (arrows in A point to outer dilated calcified aortic wall, with partial crescent-shaped non-opacification\n\nAtherosclerosis is the dominant factor in abdominal aortic aneurysms, while hypertension is associated with ascending aortic aneurysms. Other conditions that weaken vessel walls and lead to aneurysms include trauma, vasculitis (see later), congenital defects, and infections, giving rise to"]]},"47": {"question": "A 32-year-old woman presents to her primary care doctor complaining of increased fatigue and cold intolerance after her recent delivery. The patient delivered a healthy 39-week-old boy 3 weeks ago via spontaneous vaginal delivery. Delivery was complicated by postpartum hemorrhage requiring admission to the intensive care unit with blood transfusions. Pregnancy was otherwise uneventful, and the baby is healthy. The mother has had some difficulty with lactation, but is able to supplement her breast milk with formula feeds. On exam, her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 112/78 mmHg, pulse is 62/min, and respirations are 12/min. The patient does not have any neck masses or lymphadenopathy; however, her skin appears dry and rough. Which of the following serum lab abnormalities may be expected?", "options": {"A": "Decreased prolactin", "B": "Decreased thyroid releasing hormone", "C": "Increased follicle stimulating hormone", "D": "Increased luteinizing hormone"}, "output": "**A: Decreased prolactin** (as it is the only option that could potentially relate to hormonal changes in the context of the patient's symptoms).", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "postpartum hypothyroidism lab abnormalities\"  \n", "log": "I need to analyze the clinical scenario presented in the question to determine which serum lab abnormality is most likely. The patient exhibits symptoms such as fatigue, cold intolerance, and dry skin, which may suggest a thyroid disorder, particularly hypothyroidism. This is common in postpartum women, especially after complications like postpartum hemorrhage.\n\nAction: search_docs  \nAction Input: \"postpartum hypothyroidism lab abnormalities\"  \n", "type": "AgentAction"}}, "documented abnormal TSH level (either depressed or elevated) during the first year postpartum, and (iii) absence of a positive TSH-receptor antibody titer (Graves disease) or a toxic nodule. A number of studies describe clinical and biochemical evidence of postpartum thyroid dysfunction in 5% to\n\nIn clinical practice, postpartum thyroiditis is diagnosed infre quently because it typically develops months after delivery and causes vague and nonspeciic symptoms (Stagnaro-Green, 2004). he clinical presentation varies, and classically two clinical phases that may develop in succession are\n\nPostpartum Thyroid Postpartum thyroid dysfunction is much more common than recognized; it is often difficult"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "postpartum thyroiditis lab results hypothyroidism\"  \n", "log": "I need to synthesize the information gathered about postpartum thyroid dysfunction. The symptoms presented by the patient, such as fatigue, cold intolerance, and dry skin, align with hypothyroidism, which could lead to elevated TSH levels and decreased thyroid hormones. I should look for more specific lab abnormalities associated with postpartum thyroid dysfunction.\n\nAction: search_docs  \nAction Input: \"postpartum thyroiditis lab results hypothyroidism\"  \n", "type": "AgentAction"}}, "Postpartum thyroiditis usually begins with a transient hyperthyroid phase between 6 weeks and 6 months postpartum followed by a hypothyroid phase. Only one-fourth of the cases follow this classic clinical picture, and more than one-third have either hyperthyroidism or hypothyroidism alone.\n\ndocumented abnormal TSH level (either depressed or elevated) during the first year postpartum, and (iii) absence of a positive TSH-receptor antibody titer (Graves disease) or a toxic nodule. A number of studies describe clinical and biochemical evidence of postpartum thyroid dysfunction in 5% to\n\nTransient autoimmune thyroiditis is consistently found in approximately 5 to 10 percent of women during the first year after childbirth (Nathan, 2014; Stagnaro-Green, 2011b, 2012a). Postpartum thyroid dysfunction with an onset within 12 months includes hyperthyroidism, hypothyroidism, or both. The"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will analyze the provided options in relation to hypothyroidism.", "tool_input": "None (analyzing options).  \n", "log": "The information indicates that postpartum thyroiditis can present with both hyperthyroid and hypothyroid phases. Given the patient's symptoms of fatigue, cold intolerance, and dry skin, it is likely that she is experiencing the hypothyroid phase. This phase would typically be associated with elevated TSH levels and low levels of thyroid hormones. \n\nNow, I need to consider the options provided in the question. The options relate to hormonal levels that could be affected by hypothyroidism or postpartum conditions.\n\nAction: I will analyze the provided options in relation to hypothyroidism.  \nAction Input: None (analyzing options).  \n", "type": "AgentAction"}}, "I will analyze the provided options in relation to hypothyroidism. is not a valid tool, try one of [search_docs]."]]},"48": {"question": "A 2-day-old male newborn is brought to the physician because he became somnolent and felt cold after breastfeeding. Pregnancy and delivery were uncomplicated. He was born at 40 weeks' gestation and weighed 3538 g (7 lb 13 oz); he currently weighs 3311 g (7 lb 5 oz). Examination shows generalized hypotonia. Serum studies show an ammonia concentration of 150 \u03bcmol/L (N < 50 \u03bcmol/L). Which of the following is the most likely cause of the patient's neurological symptoms?", "options": {"A": "Increased succinyl-CoA concentration", "B": "Increased glutamate concentration", "C": "Decreased acylcarnitine concentration", "D": "Decreased \u03b3-aminobutyric acid concentration"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'newborn elevated ammonia neurological symptoms causes'", "log": "I need to identify the most likely cause of the patient's neurological symptoms based on the information provided, particularly the elevated ammonia level and the clinical presentation of hypotonia and somnolence. This suggests a metabolic disorder, potentially related to urea cycle defects or other metabolic pathways. \n\nAction: search_docs  \nAction Input: 'newborn elevated ammonia neurological symptoms causes'  ", "type": "AgentAction"}}, "Infants with genetic defects in urea synthesis, transient neonatal hyperammonemia, and impaired synthesis of urea and glutamine secondary to genetic disorders of organic acid metabolism can have levels of blood ammonia (>1000 \u03bcmol/L) more than 10 times normal in the neonatal period. Poor feeding,\n\nModerate neonatal hyperammonemia (range, 200 to 400 \u03bcmol/L) is associated with depression of the central nervous system, poor feeding, and vomiting. Seizures are not characteristic. Respiratory alkalosis may occur. This type of hyperammonemia may be caused by partial or more distal blocks in urea\n\nA female neonate appeared healthy until age ~24 hours, when she became lethargic. A sepsis workup proved negative. At 56 hours, she started showing focal seizure activity. The plasma ammonia level was found to be 887 \u00b5mol/l (normal 5\u201335 \u00b5mol/l). Quantitative plasma amino acid levels revealed a"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'metabolic disorders elevated ammonia newborn neurological symptoms'", "log": "The information gathered suggests that the elevated ammonia levels in the newborn are likely indicative of a urea cycle disorder or another metabolic issue that can lead to hyperammonemia. The symptoms of somnolence and hypotonia align with central nervous system depression due to high ammonia levels. I need to analyze the options provided in the context of the metabolic pathways involved in ammonia metabolism.\n\nAction: search_docs  \nAction Input: 'metabolic disorders elevated ammonia newborn neurological symptoms'  ", "type": "AgentAction"}}, "Infants with genetic defects in urea synthesis, transient neonatal hyperammonemia, and impaired synthesis of urea and glutamine secondary to genetic disorders of organic acid metabolism can have levels of blood ammonia (>1000 \u03bcmol/L) more than 10 times normal in the neonatal period. Poor feeding,\n\nA female neonate appeared healthy until age ~24 hours, when she became lethargic. A sepsis workup proved negative. At 56 hours, she started showing focal seizure activity. The plasma ammonia level was found to be 887 \u00b5mol/l (normal 5\u201335 \u00b5mol/l). Quantitative plasma amino acid levels revealed a\n\nlevels can be >1,000 \u00b5mol/l. Such hyperammonemia is a medical emergency, because ammonia has a direct neurotoxic effect on the CNS. For example, elevated concentrations of ammonia in the blood cause the symptoms of ammonia intoxication, which include tremors, slurring of speech, somnolence"]]},"49": {"question": "A 48-year-old woman presents to the emergency room because of severe back pain after a fall. She says that she was walking home from work when she slipped on a patch of ice on the sidewalk. Since she did not have anything to hold onto, she fell backwards and landed on her posterior iliac crests bilaterally. Immediately after the fall, she started experiencing back pain and tenderness that concerned her enough to call for an ambulance. Her past medical history is significant for arthritis, diabetes, and hypertension. On arrival, her temperature is 99\u00b0F (37.2\u00b0C), blood pressure is 129/86 mmHg, pulse is 112/min, respirations are 19/min. Physical exam reveals tenderness to palpation over the middle of her lower back. A drug that may have predisposed this patient to this outcome most likely has which of the following mechanisms?", "options": {"A": "Inhibition of leukotriene and prostaglandin production", "B": "Inhibition of circulating cytokine", "C": "Inhibition of folate processing", "D": "Inhibition of prostaglandin production alone"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'drug mechanisms in arthritis pain predisposition'", "log": "I need to analyze the patient's case to determine which drug mechanism could have predisposed her to severe back pain after a fall. Given her history of arthritis, she may be taking medications that affect inflammation or pain. \n\nAction: search_docs \nAction Input: 'drug mechanisms in arthritis pain predisposition' ", "type": "AgentAction"}}, "Rheumatoid arthritisa,b aControlled trials demonstrate analgesia. bControlled studies indicate benefit but not analgesia.\n\nFIguRE 18-4 Pain transmission and modulatory pathways.\n\nrheumatoid arthritis (Table 338-6)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'medications for arthritis and their mechanisms'", "log": "The search did not yield specific information regarding the mechanisms of drugs that could predispose a patient to back pain after a fall. I need to refine my search to focus more on the types of drugs commonly used in arthritis treatment and their mechanisms.\n\nAction: search_docs \nAction Input: 'medications for arthritis and their mechanisms' ", "type": "AgentAction"}}, "rheumatoid arthritis (Table 338-6).\n\nSingh JA, Saag KG, Bridges SL] r, et aI: 2015 American College of Rheumatology Guideline for the management of rheumatoid arthritis. Arthritis Care Res (Hoboken) 68(1):1, 2016\n\nOsteoarthritis is a very common disease of the elderly. Rheumatoid arthritis is less exclusively a geriatric problem, but the same drug therapy is usually applicable to both types of disease. The basic principles laid down in Chapter 36 and the properties of the anti-inflammatory drugs described"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'NSAIDs mechanisms side effects arthritis'", "log": "The search results are still not providing clear information on the specific drug mechanisms that could predispose this patient to back pain after her fall. I need to focus on common anti-inflammatory medications used in arthritis treatment, particularly those that may lead to complications such as fractures or back pain.\n\nAction: search_docs \nAction Input: 'NSAIDs mechanisms side effects arthritis' ", "type": "AgentAction"}}, "NSAIDs were formerly viewed as the core of all other RA therapy, but they are now considered to be adjunctive therapy for management of symptoms uncontrolled by other measures. NSAIDs exhibit both analgesic and anti-inflammatory properties. The anti-inflammatory effects of NSAIDs derive from their\n\nAdverse effects are generally quite similar for all of the NSAIDs: 1.\n\nCentral nervous system: Headaches, tinnitus, dizziness, and rarely, aseptic meningitis.\n\n2.\n\nCardiovascular: Fluid retention, hypertension, edema, and rarely, myocardial infarction and congestive heart failure (CHF).\n\n3.\n\nfor arthritis/arthralgias. However, two major issues indicate caution in using NSAIDs. First, SLE patients compared with the general populationareatincreasedriskforNSAID-inducedasepticmeningitis, elevated serum transaminases, hypertension, and renal dysfunction. Second, all NSAIDs, particularly"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'mechanisms of action of NSAIDs and their side effects'", "log": "The search results indicate that NSAIDs (non-steroidal anti-inflammatory drugs) have analgesic and anti-inflammatory properties, and their adverse effects include issues that could potentially predispose a patient to complications. However, I need to focus on the mechanisms that specifically relate to the options provided in the question.\n\nAction: search_docs  \nAction Input: 'mechanisms of action of NSAIDs and their side effects'  ", "type": "AgentAction"}}, "NSAID anti-inflammatory activity is mediated chiefly through inhibition of prostaglandin biosynthesis (Figure 36\u20132). Various NSAIDs have additional possible mechanisms of action, including inhibition of chemotaxis, down-regulation of IL-1 production, decreased production of free radicals and\n\nAdverse effects are generally quite similar for all of the NSAIDs: 1.\n\nCentral nervous system: Headaches, tinnitus, dizziness, and rarely, aseptic meningitis.\n\n2.\n\nCardiovascular: Fluid retention, hypertension, edema, and rarely, myocardial infarction and congestive heart failure (CHF).\n\n3.\n\nMUSCULOSKELETAL, SKIN, AND CONNECTIVE TISSUE `\u2009phaRmaCology SECTION III 486 mEChanism NSAID that irreversibly inhibits cyclooxygenase (both COX-1 and COX-2) by covalent acetylation \u008e\u0090\u00a0synthesis of TXA2 and prostaglandins. \u008f\u00a0bleeding time. No effect on PT, PTT. Effect lasts until new platelets are"]]},"placeholder": "placeholder"}]